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Cigarette smoking has been reported to be prevalent in military training 
populations, and associated with lower cardiorespiratory fitness and higher risk of 
training-related injury.  However, it is unclear whether habitual smoking impairs 
development of physical fitness.  It is possible that smoking-induced alterations in 
oxidative stress, inflammation and hormone balance may disrupt training adaptation 
in smokers.  The aim of this programme of work was to identify the influences of 
smoking on physical performance adaptation, selected biomarkers and injury risk in 
a military trainee population.  The first study established that habitual smokers 
comprised 48% of a cohort of 2087 trainees.  Upon closer examination, both at 
entry (Study 2) and during 10 weeks of training (Study 3) smokers exhibited 
chronically elevated oxidative stress and, after commencement of training, evidence 
of significantly higher resting inflammation compared with non-smokers.  
Throughout the full duration of training, performance of smokers in military 
physical fitness tests was significantly worse than non-smokers (Study 4), but 
neither muscular adaptation nor physical performance improvement were impaired 
in smokers in the early stages (10-14 weeks) or over the full duration (26 weeks) of 
training.  It was expected that smokers would experience greater acute 
inflammatory responses to exercise but neither these, nor hormonal responses, 
differed between smokers and non-smokers in response to consecutive days of 
military field exercise (Study 5).  In addition to poorer physical performance in 
smokers, training-related injury incidence was higher in smokers than non-smokers, 
specifically injuries attributed to overuse (Study 6).  Overall, smoking appears to 
cause some physiological alterations which, while not impairing adaptation to 
training, may have adverse implications on health outcomes.  Although the specific 
underlying mechanisms are unclear, habitual smokers exhibit greater injury risk and 
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CHAPTER 1  
 
 
General Introduction  






It is widely established that cigarette smoking adversely impacts health and 
increases risk of numerous chronic diseases (Zeiher, Schächinger & Minners 1995; 
Ambrose & Barua 2004; Doll et al. 2005; Birrell et al. 2008).  Owing to its 
associations with chronic disease states, smoking is considered the greatest 
preventable cause of premature death worldwide (Fagerström 2002; World Health 
Organisation 2004).  Regular smoking is also negatively associated with 
cardiorespiratory fitness (Bernaards et al. 2003) but this has only been widely 
recognised in middle-aged and elderly populations.  Having received little attention 
in scientific research, it is not known whether smoking affects physical fitness in 
young, active populations or an individual’s ability to improve physical fitness.  The 
sparseness of research in this area may stem from there being relatively few 
populations that habitually smoke while also participating in a long-term physical 
training programme.  Evidence from the United States and Scandinavia that military 
training populations have a higher proportion of smokers than the general public 
(Heir & Eide 1997; Klesges et al. 2001) suggests military trainees provide an 
appropriate platform to examine the potential effects of habitual smoking on 
physical fitness development in a young, physically active population. 
In numerous American military populations, cigarette smoking has been 
associated with lower physical fitness and a higher risk of training-related injury 
(Altarac et al. 2000; Knapik, Sharp, et al. 2001; Ward et al. 2003; Haddock et al. 
2007).  However, differences between training environments, practices and training 
duration mean the findings from military populations abroad cannot be easily 
transferred to their British counterparts.  To date, injury incidence and associated 
risk factors have been examined during deployment training of British serviceman 
(Wilkinson et al. 2011) but comprehensive study of injury and fitness in key British 
Army trainee populations have not been completed.  The development of physical 
fitness from during initial military training is imperative for trainees to pass 
successfully into the armed forces and excel under the physical demands of military 
service.  Therefore, greater knowledge of any adverse influence of smoking on 
improvement in physical performance would be beneficial to military organisations.  
Chapter 1 Introduction  
3 
 
Despite this, it appears that only one study has examined the difference in 
performance adaptation between smokers and non-smokers, and was completed in 
British Army Officer cadets (Hoad & Clay 1992).  In this study it was demonstrated 
that performance improvement to a 6 month training programme was significantly 
greater in non-smokers.  To date, however, no other studies have been attempted to 
re-examine this hypothesis or improve on this research, whether in the military or in 
the general public.  Additionally, despite extensive work in military populations, the 
underlying mechanisms induced by smoking that could mediate impaired adaptation 
to training or heightened injury risk still remain unclear. 
Several avenues by which smoking could influence injury risk and recovery 
from exercise have been reported in previous research.  Chronic differences in 
oxidative stress (Basu et al. 2009), inflammation (Helmersson et al. 2005) and 
circulatory hormone levels (Kapoor & Jones 2005) have been observed between 
smokers and non-smokers in middle aged and elderly populations.  Reactive oxygen 
species (ROS) are contained and produced in cigarette smoke (Pryor 1997).  
Accumulation of ROS causes oxidative stress in lung tissue (Barreiro et al. 2010) 
that appears to have a concurrent effect on elevating markers of oxidative stress in 
the circulation (Morrow et al. 1995; Ahmadzadehfar et al. 2006).  A persistent 
elevation in oxidative stress can be harmful to cell membranes, DNA (Nair et al. 
1996) and functional components of cells (Coirault et al. 2007) by protein and lipid 
peroxidation.  Increases in inflammatory mediators and immune cells are observed 
in lung tissue and in the circulation in response to a rise in oxidative stress and 
oxidative damage (Cross, Van der Vliet & Eiserich 1998; van der Vaart et al. 2004; 
Yanbaeva et al. 2007).  Habitual smoking, both through the indirect actions of 
nicotine on endocrine glands, and via signalling from inflammatory cells, induces 
secretion and suppression of several circulatory growth factors and stress hormones 
(Kapoor & Jones 2005; Steptoe & Ussher 2006).  It is possible that these effects are 
associated with smoking in a dose response manner, whereby increased cigarette 
consumption (cigarettes per day) induces greater changes.   
The above processes have been found to be influential in the effective 
maintenance and recovery of muscle and bone from exercise (Basu et al. 2001), and 
healing of connective tissue (Jorgensen et al. 1998).  Coirault et al. (2007) 
demonstrated that inducing an elevation of ROS in muscle cells caused oxidation of 
Chapter 1 Introduction  
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myosin heavy chains and a reduction in muscle contractility.  Similarly, the 
incubation of muscle tissue in inflammatory cytokine interleukin (IL)-6 induced 
protein breakdown (Goodman 1994).  Both oxidative stress and low-grade systemic 
inflammation are implicated in disease-induced muscle atrophy (Schaap et al. 2006; 
Moylan & Reid 2007).  Equally, growth factors promote the maintenance of muscle 
mass by protein synthesis or suppressing protein breakdown (Musarò et al. 1999; 
Musarò et al. 2001; Axell et al. 2006).  Given the relationships described above, 
there is evidence that a disruption to these processes whether at rest or during 
exercise training could be damaging to recovery and/or subsequent adaptation 
necessary to enhance physical performance. 
The majority of research examining chronic levels of oxidative stress, 
inflammatory markers and hormones has studied middle aged and elderly 
populations.  As such, it is unclear whether cigarette smoking in young, otherwise 
healthy smoking populations elicits any chronic changes in these processes, or 
whether these are associated with the magnitude of tobacco exposure (number of 
cigarettes per day and the duration of regular smoking).  Recently, however, it has 
been found that smokers may exhibit differing acute biochemical responses to 
physical work than non-smokers, evidenced by greater increases in oxidative stress 
markers following treadmill running in young active smokers (Bloomer, Creasy & 
Smith 2007).  Given the purported roles and interactions between redox balance, 
endocrine status and chronic inflammation in the maintenance of muscle and bone 
health, if these processes are altered in smokers in a military training population 
these may mediate training adaptation and influence injury risk.  
The Infantry Training Centre, Catterick (ITC(C)), is the largest British Army 
training establishment, and houses the training of all line infantry trainees.  The 
parachute regiment and line infantry courses are both administered at ITC(C) and 
have been shown to have the lowest first time pass rate of trainees in the British 
Army (40-50%; Carter et al. 2006) and the highest medical discharge rate (Blacker 
et al. 2005).  As such, this training environment provides a large representative 
sample of British military trainees where novel research can be performed to 
compare the improvement in performance between smokers and non-smokers in a 
young, physically active population alongside blood biochemical analysis.  
Additionally, despite the purported link between cigarette smoking and injury risk, 
Chapter 1 Introduction  
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smoking habits of trainees at ITC(C) have not been examined, and a comprehensive 
evaluation of injury occurrence has not been completed in this population. 
Based on the above background, this work was commissioned and funded 
by the Army Recruiting and Training Division (Ministry of Defence, UK) to 
examine a number of novel research questions previously unexamined in a British 
Army training population.  This was to collect information that could potentially 
inform on policy for smoking and physical fitness in British Army training as well 
as improving trainee education.   
 
The research described in this thesis will aim to answer the following research 
questions:  
1) What is the prevalence of smoking in military trainees at ITC(C), and what 
is the extent of trainee tobacco exposure?  
2) What are the resting concentrations of selected markers of oxidative stress, 
inflammation and hormones of habitual smokers at entry to training, and is 
there evidence of a dose-response relationship to cigarette consumption in 
these markers? 
3) Is physical performance improvement and muscular adaptation impaired in 
habitual smokers during military training, and do alterations in resting 
markers of oxidative stress, inflammation and hormones reflect any 
differences in adaptation in smokers? 
4) Do habitual smokers exhibit different acute biochemical responses to bouts 
of military exercise that may indicate greater physical strain compared to 
non-smokers? 
5) Does a higher risk of training-related injury exist in habitual smokers at 
ITC(C) when compared to non-smokers?   
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Review of Literature 
2.1 Cigarette smoking 
2.1.1 Smoking statistics 
Habitual cigarette smoking is the greatest preventable cause of chronic 
illness and premature death worldwide (Fagerström 2002; World Health 
Organisation 2004), estimated to be responsible for 5.4 million deaths in 2004 
(World Health Organisation 2004).  In Britain, smoking is currently estimated to 
cause 18% of deaths (~100,000 per year; Britton 2012), and the total economic cost 
of health care services for smoking-related illnesses is ~£2.7 billion (Callum, Boyle 
& Sandford 2011). 
The prevalence of smoking in Britain was approximately 20% in 2010, 
following a slow steady decline from 1998 (Dunstan 2010).  Smoking prevalence is, 
however, highly variable depending on age, marital status and socio-economic 
status.  When socio-economic status is classified by job type, smoking prevalence 
peaks at 30% in manual working males between the ages of 25-34 years (Robinson 
& Bugler 2008; Table 2.1).  Typically, smoking prevalence is inversely proportional 
to age, education and socio-economic status.  In support of this, the opposite 
relationship exists to completing successful smoking cessation (Vangeli et al. 2011).  
Additionally, on average while smoking prevalence is currently similar in males and 
females, married individuals are less likely to smoke than those who live alone or 
cohabit with same sex individuals.   
The average cigarette consumption rate in Britain is ten cigarettes per day, 
and, contrary to prevalence, has remained relatively constant for the last two 
decades (Robinson & Bugler 2008).  The assessment of cigarette consumption has 
also led to research attempting to quantify lifetime tobacco exposure.  Current 
epidemiology research measures this in pack-years, calculated by cigarettes smoked 
daily divided by 20 (1 pack), multiplied by years smoked.   
Limitations exist in smoking epidemiology, however, which may cause both 
prevalence and exposure to be under- or overestimated.  For practical simplicity, 
research tends to group individuals into those who currently smoke, and those who 
Chapter 2 Review of Literature  
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do not.  This assumes little disparity between never-smokers and former regular 
smokers, and disregards the considerable variation in cigarette consumption that 
exists within current smokers.  Smoking behaviour is often self-reported, 
introducing inaccuracies from recollection, and potential error from social bias 
(Kozlowski 1986; Huerta et al. 2005).   For instance, responders tend to round 
cigarette consumption down to the nearest multiple of ten (Kozlowski 1986), 
meaning the majority of figures are likely to be underestimates.  
 
 
Table 2.1. Average percentage smoking prevalence in UK males in 2008 organised 
by age and socio-economic status. Table adapted from the General Lifestyle 









National Average  21   
     
Age     
16-19  18   









Socio-Economic Group   
 
 
Managerial and professional 
     Large Employers and higher managerial 
     Higher Professional 
     Lower Managerial and professional 







     Intermediate 







Routine and Manual 
     Lower Supervisory 
     Semi-Routine 
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2.1.2 Cigarette composition 
 The constituents of cigarettes have been of considerable interest in tobacco 
control research, both in the interests of public health (Pryor 1997; Baccarelli et al. 
2002; Hecht 2006) and smoking addiction (Jarvis 1987; Vangeli et al. 2011).  
Unfortunately, research is hindered by the composition of branded cigarettes often 
kept confidential by the manufacturer.  As such, while it is known that cigarettes 
can be composed of thousands of substances, only a few hundred have been 
extensively researched (Baker, Pereira da Silva & Smith 2004).  Given the complex 
chemical reactions during combustion, establishing which inhaled products result 
from which original constituents presents a challenge (Smith & Fischer 2001).   
Research has centred on examining substances after combustion in an 
attempt to describe the composition of inhaled tobacco smoke (Baker et al. 2004; 
Calafat et al. 2004; Wilson et al. 2008).  However, considerable variation exists in 
the length, filters and rate of combustion of different branded cigarettes, which 
further alter the composition of tobacco smoke (Hoffmann & Hoffmann 1997).  
Generally, mainstream cigarette smoke (smoke inhaled directly from a lit cigarette) 
has been shown to contain ~4700 identified constituents (Hoffmann & Hoffmann 
1997; Wilson et al. 2008).  Approximately 500 of these are volatile compounds and 
3500 are semi- or non-volatile, all existing either as gas or as suspended particulate 
matter (Hoffmann & Hoffmann 1997; Wilson et al. 2008).  It has been observed that 
a minimum of 60 of these substances are widely established carcinogens (Hecht 
2006).  Specific research attention has been given to tar and nicotine content of 
cigarettes.  The former has been observed to be a strong predictor of cigarette 
toxicity and associated lung disorders, and the latter the primary factor in tobacco 
dependence (Hoffmann & Hoffmann 1997; Fowles, Bates & Noiton 2000).   
 
2.1.3 Smoking and health 
It is well established that cigarette smoking adversely affects long term 
health.  Smoking is implicated in the pathology of cardiovascular (He et al. 1999) 
and pulmonary diseases (He et al. 1999; Birrell et al. 2008; Taylor 2010), metabolic 
and immunological disorders (Al-Delaimy et al. 2002; Sopori 2002; Birrell et al. 
Chapter 2 Review of Literature  
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2008), and is thought to be the cause of one third of all cancers (Doll et al. 2005; 
Robinson & Bugler 2008).  There is also considered to be a dose-response 
relationship, whereby greater cigarette consumption increases risk of developing 
associated illness (Law et al. 1997).  Smoking is also associated with a shorter 
lifespan.  In a longitudinal study detailing the lives of doctors over 50 years, it was 
observed that smokers, on average, lived 10 years less than non-smokers (Doll et al. 
2005), and it was estimated that 50% of smokers died as a result of smoking-
induced illness (Doll et al. 1994). 
Following inhalation of tobacco smoke, the complex interplay of processes 
within host defence and the circulation, as well as the composition of the smoke, 
create a challenge for researchers to establish the pathology of specific illnesses.  
However, it is generally considered that the inciting mechanisms involve carbon 
monoxide, reactive oxygen species (ROS), and the obstructive effect of particulate 
matter.  Carbon monoxide, formed from incomplete combustion of particulates, has 
a higher affinity to haemoglobin than oxygen (Von Burg 1999).  Subsequently, the 
inhalation of carbon monoxide impacts on circulatory oxygen transport (Silverstein 
1992) and can cause local tissue hypoxia (Leone et al. 2008).  Free radicals 
produced in cigarette smoke cause local increases in oxidative stress within lung 
tissue and alveoli (Pryor 1997; Taylor 2010), causing oxidative damage (Nair et al. 
1996).  Both oxidative damage to tissue and the presence of particulate matter 
stimulate a local influx of neutrophils and phagocytic macrophages (Tidball 2005).  
This is supported by acute increases in pro-inflammatory cytokines observed 
immediately after smoke inhalation (Van der Vaart et al. 2004).  While it will be 
discussed in more detail later, it is observed that smoking has a similar impact 
within the circulation (Helmersson et al. 2005; Basu et al. 2009), which is 
associated with the pathogenesis of many long-term health conditions. 
 
2.1.3.1 Smoking and cardiovascular disease risk 
Smoking is associated with higher risk of cardiovascular disease, myocardial 
infarction and atherosclerosis (He et al. 1999; Smith & Fischer 2001; Bazzano et al. 
2003).  Long-term smokers often exhibit chronic low-grade systemic inflammation 
(Levitzky et al. 2008; Sunyer et al. 2009) and elevated blood pressure (Al-Safi 
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2005).  Alongside carbon monoxide-induced hypoxia of cardiac muscle in animal 
models (Penney & Formolo 1993; Loennechen et al. 1999; Sørhaug et al. 2006), 
these factors are possible mediators in the increased risk of myocardial infarction.  
It is likely that the elevated presence of fibrinogen (Sunyer et al. 2009) and 
endothelial cell dysfunction (Celermajer et al. 1993; Poredos, Orehek & Tratnik 
1999; Tanriverdi et al. 2006) in smokers accelerates the formation of atherosclerotic 
plaques (Celermajer et al. 1994; Zeiher et al. 1995). 
 
2.1.3.2 Smoking and pulmonary health 
There is some ambiguity, however, as to whether smoking adversely effects 
lung capacity, or lung structure and function (Gold et al. 1996; Anthonisen, Connett 
& Murray 2002).  Several studies have found that, when compared to non-smokers, 
no differences in lung capacity are evident in smokers (McCarthy, Craig & 
Cherniack 1976), but parameters indicating the rate of expiration are reduced (De & 
Tripathi 1988).  Increased populations of mast cells and abnormalities in lung 
compartments have been implicated in altered airway structure and function in 
smokers (Ekberg-Jansson et al. 2005; Just et al. 2005). The accumulation of 
particulate matter within the lungs and the damage to lung tissue from habitual 
smoking are thought to be functional in the development of chronic obstructive 
pulmonary disease (Gualano et al. 2008; Taylor 2010), a condition where the 
immune response in the lung tissue becomes impaired and airways become 
chronically inflamed.   
 
2.1.3.3 Other health effects associated with smoking 
Smoking alters immune function, subsequently increasing risk of 
immunological disorders (Sopori 2002; Birrell et al. 2008).  Macrophages isolated 
from the bronchoalveolar lavage of smokers have been shown to have impaired 
function and induce different cytokine responses in comparison to those in non-
smokers (Mio et al. 1997; Birrell et al. 2008).  Wound healing is also impaired in 
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smokers, possibly mediated by increased inflammation, reduced blood flow and 
tissue hypoxia (Sherwin & Gastwirth 1990; Silverstein 1992).  
Typically, between adolescence and young adulthood, smokers have lower 
body fat than non-smokers despite similar caloric intake (Klesges et al. 1990). This 
also manifests in weight gain upon smoking cessation (Klesges et al. 1992).  This is 
understood to be, in part, owing to the effects of nicotine on appetite suppression, 
altered substrate utilisation and increased nervous activity (Seeley & Sandoval 
2011; Martínez de Morentin et al. 2012).  As such, this disparity is not from health-
promoting behaviour, as smokers typically exhibit lower physical activity (Larsson 
& Orlander 1984) and less healthy diets (Beser et al. 1995; Palaniappan et al. 2001; 
de Castro & Taylor 2008).  In agreement, evidence has shown smokers to have 
lower dietary intake of macronutrients, reduced levels of antioxidants and be more 
at risk of being nutrient deficient compared to non-smokers (Reilly et al. 1996; Dyer 
et al. 2003; de Castro & Taylor 2008).   
 
2.1.4 Smoking and physical fitness 
Epidemiological evidence has shown that habitual smoking is associated 
with lower cardiorespiratory fitness (Bernaards et al. 2003; Kobayashi et al. 2004).  
However, it is difficult to disregard that this association may exist from smokers 
typically exhibiting lower physical activity and participation in sports (Larsson & 
Orlander 1984; Larson et al. 2007).  Ideally then, to accurately examine the impact 
of smoking on long term fitness, studies should assess individuals of similar ages, 
with similar physical activity levels and body composition, or take appropriate steps 
to control for these factors.  The acute effect of smoking on physical performance in 
exercise tasks has also been examined, generally observing a negative impact, and 
will be discussed later in this section.  Consequently, many assertions have been 
formulated from the assumption that the acute effects of smoking may be 
cumulative and chronically impact exercise performance. 
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2.1.4.1 Chronic effects on physical performance associated with smoking 
Surprisingly few studies have examined the difference in physical fitness 
parameters between habitual smokers and non-smokers.  A longitudinal study 
completed by Bernaards et al. (2003) observed, between the ages of 13 and 36, 
maximal oxygen uptake (ܸܱ̇ଶmax) and maximum heart rate were negatively 
correlated with cigarette consumption both with and without correction for physical 
activity and body mass.  Kobayashi et al. (2004) observed that ܸܱ̇ଶmax values 
made relative to body mass were significantly lower in smokers, likely owing to 
greater fat mass in the smoking individuals.  Potential mechanisms for the negative 
influence of chronic smoking on cardiorespiratory fitness are typically altered 
airway size (McCarthy et al. 1976), impaired pulmonary muscle function (Barreiro 
et al. 2010), less efficient respiratory exchange (Gläser et al. 2011), reduced oxygen 
transport to muscles (Rönnemaa et al. 1999) and higher blood pressure (Al-Safi 
2005).  
Other physical fitness parameters have also been shown to be lower in 
smokers when compared to non-smokers.  A study examining lower back pain 
showed reduced force production in habitual smoking individuals (Al-Obaidi et al. 
2004).  Trends have also been elucidated for lower bench press performance and 
flexibility in smoking versus non-smoking police officers (Boyce et al. 2006).  
Conversely, in smokers and non-smokers matched for age and physical activity, two 
studies have shown that while maximal strength and contractile speed were similar 
between groups, it was fatigue resistance that was reduced in habitual smokers 
(Morse et al. 2007; Wüst et al. 2008).  Lower muscular oxidative capacity and 
stimulation frequency of muscle in smokers were theorised as possible reasons for 
these findings (Larsson & Orlander 1984; Morse et al. 2007; Wüst et al. 2008).  
Interestingly, studies in long term smoke exposure in rats suggested 
differing muscle morphology, specifically lower muscle cross sectional area 
alongside fewer type I oxidative fibres compared to controls (Larsson et al. 1988).  
Although this effect was only evident in hypertensive animals, in humans similar 
findings have previously been observed in smoking and non-smoking twins 
(Larsson & Orlander 1984).  Research to determine the underlying mechanisms for 
altered muscle morphology has remained inconclusive.  However, it is considered 
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that the accumulation of the acute effects of smoking a cigarette on subsequent 
exercise performance may contain the mechanisms for the discussed findings. 
 
2.1.4.2 Acute effect of smoking on physical performance 
Previously, specific attention has been given to the acute effects of cigarette 
smoking or smoke exposure on exercise performance.  It is known that the act of 
smoking a cigarette increases resting heart rate and blood pressure (Rotstein et al. 
1991).  Similarly, in response to subsequent exercise, habitual smokers exhibit 
increased heart rate for a given work load and delayed heart rate response to 
exercise (Sidney et al. 1993).  Research has shown an immediate negative effect of 
smoke exposure on attainment of ܸܱ̇ଶெ஺௑ 	and anaerobic threshold (Hirsch et al. 
1985).  However, this study administered unrealistic smoke exposure, with 
individuals smoking three cigarettes an hour for five hours prior to exercise.  More 
recently, studies have observed smoking immediately prior to exercise reduces time 
to exhaustion (Mendonca, Pereira & Fernhall 2011) possibly mediated by reduced 
power output or maximum attainable heart rate (Flouris et al. 2010; Mendonca et al. 
2011).  Additionally, Morse et al. (2008) reported that inhalation of carbon 
monoxide decreased muscular time to fatigue in electrically induced muscle 
contractions. 
Interestingly, the effect of administration of nicotine in non-smoking cyclists 
was a significant 17% improvement in time to exhaustion (Mündel & Jones 2006).  
Nicotine has well established effects on alertness and cognitive performance, but 
similar levels of perceived exertion, ventilation and heart rate response were 
observed between trials.  It is reasonable to conclude, then, that nicotine may have 
an advantageous effect on non-smokers where nicotine tolerance is low, and neither 
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2.2 Military training 
Basic military training has the aim of producing and identifying effective 
soldiers, physically and mentally able to perform required occupational tasks.  
Although training will vary between countries and their internal branches of armed 
forces, the overarching aims and structure are typically relatively similar.  Military 
training consists of a mixture of physical, drill and skill-based training alongside 
classroom teaching.  Within this structure there are also short periods (~3-15 days) 
of intense field training exercises.  Some nations have compulsory enlistment, 
where a set term of military service must be completed by every male of a particular 
age preceded by basic training.  For others, joining a military career is voluntary, 
and following training there is a minimum duration of service.  For basic training of 
soldiers, as opposed to higher ranking officers, most countries employ between 8 
and 14 weeks for basic training (Booth et al. 2006; Tanskanen, Uusitalo, et al. 
2011).  
   
2.2.1 British Army training 
In the British Army, individuals can enter into officer training or “other 
ranks” below that of officer.  Officer training is a set training duration at Sandhurst, 
and is followed by further training for a specific role.  Entry for “other ranks” will 
contain a basic training course, where different training regiments train for various 
specialties.  The British Army take on standard entrants aged between 17 and 33 
years old. 
Standard entrants wishing to join the British infantry complete a 26-week 
Combat Infantryman’s Course (CIC), which consists of 14 weeks of standardised 
basic infantry training, and a further 12 weeks of training specific to their regiment. 
The Infantry Training Centre, Catterick (ITC(C)) is the largest training 
establishment in the British Army, and is responsible for the training of all divisions 
of line infantry, and Guard and Parachute regiments.  Every two weeks, new intakes 
of up to three platoons (~50 trainees per platoon) of line infantry recruits are 
initiated. As such, ITC(C) sees in excess of 3000 recruits per annum. Apart from the 
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exceptionally arduous training of the Parachute Regiment, CIC at ITC(C) has the 
lowest first-time pass rate into the British Military at 40-50% (Carter et al. 2006).   
Recruits wishing to join other services in the British Army attend an Army 
Training Regiment (ATR) establishment specific to their choice of prospective 
trade.  As each member of the armed forces must fundamentally be able to function 
in the infantry, all recruits first complete the standardised template for basic infantry 
training, similar to that of CIC, followed by training specific to their desired service.  
 
2.2.2 British Army physical training 
Military basic training is composed of a large variety of physical fitness 
training.  Arguably the most representative physical task of infantry personnel is to 
carry heavy burdens continuously over long distances.  As such, the main fitness 
objectives of basic training are to increase aerobic capacity and performance in 
endurance exercise while carrying load.  Military training contains wide varieties of 
runs, circuit training and loaded marches where mass carried and distance covered 
progress over training duration.  Research into physical demands of CIC has shown 
that energy demand increases substantially to a peak over the first six weeks of 
training (Carter et al. 2006).  This suggests that the development of the required 
physical fitness is not expected until near the end of training. Rather, the first six 
weeks are designed to progress trainees to fitness goals.   
The physical fitness of trainees is monitored during physical training 
sessions and in a number of testing environments.  The Army Physical Fitness Test 
(PFT) consists of a timed best-effort 2.4 km run, and the completion of press ups 
and sit ups when allowed 2 minutes for each exercise.  Completed at the start, 
middle and end of military training, this assesses progression through the course. 
Performance in the basic combat fitness test, a loaded march scenario, is also 
monitored at specific points during training as an indicator of readiness for the 
occupational demands of battle.  Both tests have pass-criteria highlighting 
individuals who may need further training or not be up to the physical standards 
required.  It has been shown in previous work that performance in equipment carry 
and marching tasks are strongly correlated with various physical performance 
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measures such as static lift strength and run times (Rayson, Holliman & Belyavin 
2000).  Additionally, research has found that owing to the load bearing nature of 
many military tasks, anthropometric measures such as lean body mass are strong 
predictors of occupational performance (Vanderburgh 2008).  Military training, 
therefore, has several different physical fitness goals for trainees to attain in 
preparation for military service.  
It should be noted that the majority of physical training in military 
populations is completed in groups or as a platoon.  This means trainees of very 
different fitness levels will often run long distances as a group at a specific 
predetermined intensity.  Although this may hinder fitter individuals from 
progressing to higher fitness goals, it is conducive to the majority of recruits 
reaching a particular fitness standard.  Alongside physical training, field exercise 
has components of physical effort required.  Field exercise typically involves a 
number of days in an outdoor “wild” environment outside the training camp itself, 
testing navigation and survival skills. 
 
2.2.3 Military field exercise 
Field training is designed to test a variety of physical and survival skills over 
several days.  As such, it is considered the most comparable environment to 
conditions that may be experienced during war deployment.  Therefore, a volume of 
research has examined several aspects of field training, including hormone 
responses and energy balance.  Training ranging from 8 to 15 days, has shown an 
average of ~6 hours of non-continuous sleep per day, typically disrupted to 
complete military tasks (Nindl et al. 2003; Kyröläinen et al. 2008; Tyyskä et al. 
2010).  Alongside this, the frequency of marching and low caloric intake can 
produce substantial energy deficit (Kyröläinen et al. 2008).  It is suggested that 
extended periods of training of this nature can have profound effects on increasing 
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2.2.4 Injury in military training 
Although the positive health benefits of physical activity are well 
established, the commencement of exercise in any population carries with it a 
higher risk of musculoskeletal injury.  Owing to the arduous and often 
unaccustomed nature of physical training to new military trainees, there is a high 
incidence of training-related injury (Knapik et al. 1993; Carter et al. 2006).  The 
potential loss of service time, long-term rehabilitation and possibility of re-injury 
associated with an injury is of great cost both economically to the military, and to 
the individual trainee.  Therefore, the examination and prevention of injuries during 
training is of considerable interest to military organisations.  In this regard, research 
describing injury incidence (Kaufman, Brodine & Shaffer 2000; Knapik, Canham-
Chervak, et al. 2001), identifying risk factors for training injuries (Altarac et al. 
2000; Knapik, Sharp, et al. 2001; Blacker et al. 2008) and interventions for the 
possible prevention of injury (Knapik et al. 2004; Bullock et al. 2010) have been 
conducted within military populations.  
Research into injury incidence is abundant in United States (US) and 
Scandinavian military populations but has reported highly variable results with rates 
as high as 51% in US infantries (Knapik et al. 1993), 40% in US marines (Almeida 
et al. 1999), 24% in Norwegian basic training (Heir & Eide 1997) and 32% in Royal 
Norwegian Navy personnel (Morken, Magerøy & Moen 2007).  Studies in British 
training establishments have reported the prevalence as high as 46 and 49% of 
recruits sustaining an injury (Etherington & Owen 2002; Greeves 2002).  In a large-
scale study of the kind not previously undertaken on British Military trainees, 
Blacker et al. (2005) investigated the rates of training-related injuries referred to 
remedial instructors in several different British training establishments, where 
values ranged from 1.4% to 26.5% over training courses and locations.  It is evident 
that differences in training content and environment that are inherent with different 
training locations alter injury risk, even within the same military organisation.  
There has not been a comprehensive injury incidence research study completed at 
ITC(C).  
The proportion of medical discharge from recruit training owing to training-
related injury has been reported in several locations.  The percentage of medical 
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discharge in male and female junior entrants at ATR Bassingbourn was 1.4% and 
12.8%, respectively, and 1.6% in standard entrants at ATR Pirbright (Etherington & 
Owen 2002; Blacker et al. 2005).  Injury incidence in junior and standard recruits 
across all British training establishments except ITC(C) showed an average of 18% 
of recruits who sustained an injury were later medically discharged as a result 
(Greeves 2006).  When corrected for number of days in training, ITC(C) has the 
highest medical discharge rate among recruits in the British military (Blacker et al. 
2005).  As such, it is evident that research to better understand the nature of 
training-related injuries may aid strategies to improve first-time pass out rate. 
The types of injuries most commonly reported in military populations are 
musculoskeletal overuse injuries predominantly in the knee and lower leg (Kaufman 
et al. 2000).  Predominantly diagnosed injuries in a review containing several 
military populations were lower back pain, muscle strains, ankle sprains, shin 
splints, lower-leg stress fractures and overuse knee injuries such as patella-femoral 
syndrome, patellar tendinitis and ilio-tibial band syndrome (Jones et al. 1993; Jones 
& Knapik 1999; Kaufman et al. 2000).  In British Army recruit training, injuries to 
the back, foot and knee were the most common comprising 50% of reported injuries 
(Greeves 2006).  In ATR Pirbright lower limb injuries accounted for 82.9% of all 
training injuries (Etherington & Owen 2002).  Injuries of this nature are highly 
representative of military training, which often involves repetitive exhaustive load-
bearing exercise that largely affect the lower-limb and supporting musculature.     
Frequency of injury type is highly variable between populations, with stress 
fractures highest (13.4%) in Naval Special Warfare Training (Kaufman et al. 2000), 
ankle sprains (6.2%) highest in US marine recruits (Almeida et al. 1999) and lower 
back pain (7.8%) highest in Army infantry basic training (Jones et al. 1993). Like 
absolute injury prevalence, this suggests injury type is also highly dependent on the 
type of training performed by different military organisations.  However, it should 
be noted that in all injury incidence research, some variability between studies can 
be, in part, explained by differences in the methodology behind defining and 
recording injuries and detailing anatomical locations. 
The time-loss from injury is also responsible for the impact of injury on the 
military.  In military populations the time-loss caused by injury has been shown to 
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be often substantially higher than from illness (Jones & Knapik 1999).  Knapik et 
al. (1993) documented limited-duty days (days when unable to fully perform on 
duty) from injury for several injury types, reporting fractures most severe (103.2 
days lost/injury) followed by sprains (16.7 days lost/injury).  Training loss of this 
nature has serious negative implications towards physical performance, skills 
training and, if not adequately rehabilitated, risk of re-injury.     
Risk factors appear in two defined groups, intrinsic (within the individual) 
and extrinsic (external, environmental factors such as equipment or clothing). The 
most commonly reported risk factors for injury in military populations are low 
aerobic fitness, gender and cigarette smoking.  Observed military risk factors from 
the literature are summarised in Table 2.2.  Military researchers have identified 
several risk factors for injury including intrinsic factors: low aerobic fitness, low 
levels of previous physical activity (Kaufman et al. 2000; Knapik, Sharp, et al. 
2001); previous injury to the same site (Schneider, Bigelow & Amoroso 2000), 
female gender (Greeves 2006), age, ethnicity and some biomechanical factors 
(Kaufman et al. 2000); and extrinsic factors such as cigarette smoking (Etherington 
& Owen 2002), footwear type and training location (Blacker et al. 2008).       
 
2.3 Smoking in the military 
This section will highlight some of the issues surrounding smoking within 
military populations.  Given the numerous effects on health and physical fitness 
discussed above, there are many potential avenues for adverse effects of habitual 
smoking on operational performance in the military.  Previous research has 
attempted to examine the variation in smoking prevalence both in different branches 
of military populations and in different nations; the attitudes surrounding tobacco 
use within the military; and the increased risk of training-related injury associated 
with smoking.  Despite comprehensive coverage of many influences of smoking in 
current research, few studies have looked at the effect of habitual smoking on 
physical performance or development of fitness in military training. 
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Table 2.2. Risk factors for injury in various military populations. 
Risk Factor  Supporting Literature 
Lower aerobic fitness (ܸܱ̇ଶ 
max or military 
performance variables) 
 
ܸܱ̇ଶ: Knapik et al. (2001); 3km run time: 
Reynolds (1999), Heir & Eide (1997); 2.4km run 
time: Blacker et al.(2005), Blacker et al.(2008), 
Greeves et al. (2007), Jones et al. (1993) 
Lower previous physical 
activity 
 Knapik et al. (2001), Heir & Eide (1997), Jones et 
al. (2000) 
Previous injury  Schneider (2000), Etherington & Owen (2002) 
Cigarette smoking 
 Altarac (2000), Etherington & Owen (2002), 
Knapik (2001), Reynolds (1999) 
Age 
 
Low age bracket: Reynolds (1999), Knapik 
(2001), Blacker et al. (2005). Higher age bracket: 
Jones et al. (1993), (for stress fracture), Lappe et 
al. (2001) 
Non-white Ethnicity  Blacker et al. (2008), Schneider (2000) 
Female gender  Greeves et al. (2006) 
Biomechanical factors  Kaufman et al. (2000) 
High and low flexibility  (In men) Knapik et al. (2001) 
Low body Mass/BMI  Blacker et al. (2008) 
 
 
2.3.1 Smoking prevalence in the military 
While military populations are required to maintain certain levels of health 
and physical fitness, smoking prevalence is higher than in the general population 
(Hooper et al. 2008; Dunstan 2010).  The smoking prevalence of key studies 
examining military populations are summarised in Table 2.3, organised by trainees 
and those within active service.  It would appear that the average smoking 
prevalence in the military from current research is ~30%.  Considerable variation 
exists however, between trainees and individuals in active service, as well as by 
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country and the military organisation being examined.  Furthermore, where a set 
term of military service is compulsory in specific countries, or when smoking is 
banned during some basic military training courses, prevalence can be confounded. 
The largest variation in results within current research appears to be 
nationality, where conscripts from Scandinavian countries have reported 48-51% 
prevalence, compared to substantially lower values in US and UK branches of 
armed forces.  However, given that both Norway and Switzerland exercise 
compulsory enlistment for a fixed term, these values could be an indication of 
national average for young adult males. In the British military, reported values 
range from one study reporting 45% in infantry soldiers (Reynolds et al. 1999), to 
13% in Royal Marines (Munnoch & Bridger 2007).  Similar variation is reported in 
US branches of the military.  Perhaps most profound, however, is different smoking 
prevalence within the same, or similar, populations.  Both Chisick et al. (1998) and 
Klesges et al. (2001) examined trainees of all branches of the US Military but found 
substantially different results, with the former observing a range of 6-27%, and the 
latter 29-45%.  While some of this variation can be attributed to training location 
and smoking restrictions during training, it is clear that using robust methods when 
measuring smoking prevalence is critical to maintaining validity.   
Smoking prevalence in trainees is similar to that of active-duty personnel.  
In four studies, trainees during basic training have reported smoking prevalence as 
low as 6% and 22% in the US Air force (Chisick, Poindexter & York 1998; Sherrill-
Mittleman et al. 2009), 13% in Royal Marines (Munnoch & Bridger 2007) and 24% 
in the Norwegian Army (Heir & Eide 1997).  In contrast, however, Altarac et al. 
(2000) and Klesges et al. (2001) observed higher smoking prevalence in US Army 
trainees than values reported in service (Chisick et al. 1998; Rae Olmsted et al. 
2011).  As smoking is often negatively associated with age, it would seem 
reasonable that the recruit populations would have a greater number of smokers 
than their active duty counterparts.  This may be, in part, explained by a number of 
factors concerning attitude to smoking within the military, discussed later in this 
section.    
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Table 2.3. Average prevalence and number of smokers reported in key papers 
organised by trainee and active service populations 
Study (Author/Year)  Population 
 Total Sample 
Size 




       
  Trainees     
(Altarac et al. 2000)  US Army  1087  35 
       
(Munnoch & Bridger 
2007)  UK Royal Marines 
 1115  13 
       
(Chisick et al. 1998) 
 
US Army 












       
(Heir & Eide 1997)  Norwegian Infantry  480  51 
       
(Miedinger et al. 2006)  Swiss Army  2604  48 
       
(Greeves 2006)  UK Army  1854  37 
       
(Klesges et al. 2001) 
 
US Army 












       
(Sherrill-Mittleman et 
al. 2009)        US Air Force 
 35986  22 
       
  Active Service     
(Chisick et al. 1998) 
 
US Army 












       
(Hooper et al. 2008)  UK Armed Forces  1382  28 
       
(Reynolds et al. 1999)  UK Light Infantry  194  45 
       
(Rae Olmsted et al. 
2011)  
US Army 












       
(Fear et al. 2010)  





Royal Air Force 
 
10272  30 
       
(Schei & Søgaard 1994)  Norwegian Military  2112  51 
       
*Values estimated from the assumption of an identical ratio of drop out to data 
collected from US Air Force  
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2.3.2 Smoking exposure in the military 
The predominance of studies examining military populations have sought to 
measure prevalence rather than the total exposure of individuals to tobacco.  These 
studies would typically categorise those who are smokers and non-smokers from 
enlistment data or in self report questionnaires at the time of the study.  Studies that 
have examined the number of cigarettes smoked per day in active service, have 
found the average to fall between 10 and 20 (Boos & Croft 2004; Haddock et al. 
2007; Fear et al. 2010).  At present little information is known about the smoking 
characteristics of individuals during or prior to joining military training.  Without 
accurately attaining habitual smoking duration it is not possible to estimate lifetime 
tobacco exposure in these populations.  Gathering this information and 
demonstrating the severity of smoking exposure may aid studies in estimating the 
potential health risks of habitual smokers during and following military service.     
 
2.3.3 Attitudes to smoking in the military 
The incidence of smoking in the military may be explained by inherent 
psychological and social influences.  Cigarette smoking can act as stress relief 
(Fidler & West 2009) and a communal bonding activity (Nelson, Pederson & Lewis 
2009), that may indirectly lend support in stressful situations, often encountered in 
military service.  This is reinforced by evidence that cigarette consumption 
increases with war deployment (Boos & Croft 2004; Smith et al. 2008).  Similarly, 
it is likely that the long-term health effects of smoking are not of major concern to 
those involved in high-risk occupations.  Furthermore, smokers are often associated 
with greater risk taking behaviour (Zuckerman & Kuhlman 2000), a personality trait 
that may be conducive to military service, and therefore prevalent in these 
populations.  These factors are not hindered by the ease of access to cheap tobacco 
in military environments (Nelson et al. 2009).   
The above factors, and studies that have shown the disparity between trainee 
and active duty smoking prevalence, have led some researchers to believe that the 
military training environment may indirectly promote tobacco use (Nelson et al. 
2009).  Indeed, research has shown that products have been marketed specifically to 
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military populations by tobacco companies (Joseph, Muggli, et al. 2005), and there 
exist tobacco-funded recreation and welfare programs (Arvey & Malone 2008).  It 
is actually unclear how military training environments affect smoking status, as 
very few studies have measured smoking status prior to- and following- military 
training.  One study observed that during military training the proportion of those 
who take up smoking is higher than those who quit (Schei & Søgaard 1994).  
Additionally, a tendency for non-smokers to begin smoking upon joining military 
training has also been shown (Ebbert et al. 2006).  On the contrary though, it would 
seem possible that physical fitness and health requirements associated with military 
training would cause either smoking prevalence to reduce or smoking cessation to 
occur prior to entry.    
An association between smoking incidence and both military rank and 
socioeconomic status has been observed (Fear et al. 2010).  It is clear that 
environmental factors prior to training such as education and lifestyle during 
upbringing markedly affect the likelihood of habitual smoking in later life.  
Research findings have led military organisations to implement education and 
cessation programs to clarify the risks of smoking to personnel, and the benefits of 
cessation or abstinence from smoking (Arvey & Malone 2008).  However, the 
success of these programs is not clear.  Although these measures are positive, it 
seems that further work into the severity of the adverse influence of smoking and 
alterations to tobacco control measures in military environments would be 
necessary to cause any drastic alterations in attitudes to smoking in these 
populations.  
 
2.3.4 Smoking and the risk of training-related injury 
Cigarette smoking is the most widely reported independent risk factor for 
training-related injury in military populations (Reynolds et al. 1999; Altarac et al. 
2000; Knapik, Sharp, et al. 2001; Etherington & Owen 2002).  It has been reported 
that habitual cigarette smokers can have 1.7 times the relative risk of training-
related injury than non-smokers (Munnoch & Bridger 2007).  There has also been 
observed a dose-response association, where risk of injury increases with cigarette 
consumption (Knapik, Sharp, et al. 2001).   
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Presently, it is unclear what underlying mechanisms there are, if any, for the 
association between higher injury risk and smoking.  However, given the associated 
effects on health, physical fitness and physiological processes from smoking, any 
mechanisms for the effect on injury susceptibility are likely to be numerous and 
complex.  Mechanisms for the potential influence of smoking on injury risk in 
habitual smokers have been postulated.  In military populations, reduced physical 
fitness (Kobayashi et al. 2004) and lifetime physical activity (Conway & Cronan 
1992), both concomitant with smoking, may be particularly functional in 
establishing a higher risk of injury.  It has been theorised that the group nature of 
physical training in the military means less fit individuals may be trained far in 
excess of their ability.  In this way, having reduced physical fitness may increase 
likelihood of injury from training (Knapik, Sharp, et al. 2001; Knapik et al. 2004).   
Additionally, recovery from training could be impaired in smokers.  If 
recovery is impaired, non-smokers will be in a relatively better state for the 
completion of progressive exercise training, and have a lesser risk of injury.   The 
typically lower dietary intake (Klesges et al. 1990), impaired immune function 
(Arcavi & Benowitz 2004) and slower wound recovery (Sherwin & Gastwirth 
1990) in smokers suggest recovery from exercise or injury could be lessoned.  
Recovery may also be affected by smoking-induced alterations in oxidative and 
inflammatory processes (Cross et al. 1998; van der Vaart et al. 2004), and will be 
discussed in further detail later.  
Smoking has a profound adverse effect on bone health and metabolism 
(Wong, Christie & Wark 2007). Whilst having a direct effect on the risk of stress 
fractures, this may also have structural implications on soft tissue and supporting 
musculature.  In terms of injury risk, this would be particularly detrimental in 
repeated bouts of continuous exercise, and subsequently harmful in military 
training.  Lastly, greater risk-taking behaviour (Zuckerman & Kuhlman 2000) 
observed in smokers may increase the likelihood of inciting events. 
 
2.3.5 Smoking and fitness in military training 
The effect of smoking on physical fitness in military populations has rarely 
been examined.  Where physical fitness is typically lower in smokers, it is 
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challenging to disassociate this from lower physical activity in smokers.  In several 
studies, physical fitness has been shown to be lower in smokers in military 
populations (Zadoo, Fengler & Catterson 1993; Ward et al. 2003; Haddock et al. 
2007).  Haddock et al. (2007) showed that smoking status was a strong predictor for 
poorer performance in a number of physical fitness domains at entry to training.  
Indeed, smokers have been linked to having poorer training outcomes and poorer 
run performance in a Scandinavian military population (Marti et al. 1988).  The 
development of muscular fatigue is more rapid in smokers (Morse et al. 2007; Wüst 
et al. 2008) and, alongside this, reduced force production in back muscles (Al-
Obaidi et al. 2004) may affect carrying tasks.  This is particularly important as both 
carrying and back extension strength are deemed robust indicators of effective 
military occupational performance (Rayson et al. 2000).  Given the potential effects 
on physical fitness, smoking may have some influence on how well trainees 
perform in training.  However, while completing a standardised training programme 
with comparable baseline fitness, it has not been examined whether smokers’ 
change in fitness substantially differs from non-smokers.   
It is unclear, therefore, whether smoking has an effect on the development of 
physical fitness in a physically active population.  One study examining a British 
Army officer training population over six months observed significantly greater 
improvements in performance of strength and endurance tests in non-smokers than 
smokers (Hoad & Clay 1992).  Despite this, no research has been completed to 
further test this hypothesis.  
 
 
2.4 Physiological effects associated with smoking 
As discussed, research examining the development of physical fitness in 
habitual smokers is sparse, and it is unknown whether differing adaptive responses 
to exercise training exist in comparison to non-smokers. Given the high incidence 
of smoking in military training, and the already well-established effect on injury 
risk, further understanding would be particularly valuable.  In this section, a number 
of physiological processes that are affected by smoking will be introduced and 
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discussed.  These mechanisms centre around the chronic effect of smoking, 
highlighting the possible physiological state of a long-term habitual smoker.  How 
these processes might serve as mechanisms for mediating the adaptive response to 
exercise training will be discussed in section 2.5.  Figure 2.1 summarises these 
proposed pathways. 
For the coming sections of this literature review and for the purpose of this 
thesis a number of terms will be used to aid the description of how smoking or 
training may interact with selected biochemical markers.  The term “physiological 
state” or “physiological status” will refer to the resting levels of the selected 
oxidative stress, inflammatory and endocrine markers analysed in this research, 
which indicates the chronic balance of these markers in the examined group.  As 
such, “adaptation” of a oxidative stress, inflammation or endocrine markers will 
refer to a change in the resting concentration between distal time-points such as 
between weeks of training.  Conversely, the term “biochemical response” will refer 
to acute, or short-term, changes in the selected biochemical markers in response to a 
stimulus, such as a bout of exercise, with the implication that markers will return to 
pre-stimulus level relatively transiently.   
 
2.4.1 Oxidative stress 
Classically, oxidative stress is defined as an imbalance of the cellular 
environment caused by the inability of a biological system to detoxify ROS, or 
reduce subsequent oxidative damage, at the rate of production.  Reactive oxidants, 
or oxygen radicals, are oxygen-containing molecules with unpaired electrons, which 
are subsequently chemically volatile.  Several processes stimulate the production of 
oxidants.  Often, these are necessary pathways where oxidants serve as 
intermediates or by-products.  Normal cells will always tend towards maintaining a 
reducing environment, which is the addition of electrons, and a decrease in 
oxidation number.  This state of reduction is maintained by closely regulated 
enzymes as part of antioxidant defence, and requires a constant influx of metabolic 
energy (Comporti et al. 2008).  ROS then oxidise surrounding molecules in a 
perpetual chain, either until another oxidant is reached or the reaction is neutralised 
by antioxidant defence.  When the biological system cannot control the 
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accumulation of ROS the cellular environment shifts away from reduction and 
towards oxidation, resulting in oxidative stress.  This imbalance, and the presence 
of high levels of ROS, can oxidise lipids potentially causing damage to DNA, and 
structural and functional components of the cell.   
However, with growing understanding, the functional significance of the 
cellular environment of redox-sensitive cells suggests further complexity, and the 
definition of the term “oxidative stress” may continue evolving (Powers, Smuder, et 
al. 2010).  Advances in redox biology have shown that the redox balance within the 
cell has multiple implications for cell signalling, and potentiating transcription 
factors for mediating future oxidative environments (Powers & Jackson 2008).  This 
has suggested that short-term acute imbalances in oxidation and reduction can be 
beneficial (Powers, Duarte, et al. 2010), while the persistent shift of cellular 
environments in favour of oxidation is deleterious.  For instance, long-term 
elevations of oxidative stress are implicated in the ageing process (Harman 1956; 
Ashok & Ali 1999; Biesalski 2002) and the pathology of many chronic diseases 
(Lambeth 2007; Valko et al. 2007).  The toxicity of oxidative by-products and the 
modification of lipoproteins from oxidative damage influence atherogenesis, and 
endothelial cell and macrophage dysfunction (Witztum 1993; Cross et al. 1998; 
Young & McEneny 2001). 
The physiological quantification of oxidative stress has been made possible 
by advancements in the measurement of by-products from lipid peroxidation, 
metabolites from oxidation reactions, redox-sensitive molecules and the presence of 
antioxidant enzymes (Morrow 2005; Powers, Smuder, et al. 2010). Additionally, in 
animal models and humans, it is also possible to measure the effectiveness of anti-
oxidant defence, known as total antioxidant capacity (TAC), with measurement 
methods reviewed here (Young 2001).  It is understood that measuring multiple 
markers of oxidation and TAC is the most rigorous method for establishing whether 
oxidative stress is present, by observing the overall redox status of the tissue 
(Powers, Smuder, et al. 2010).  Research has subsequently examined both acute and 
chronic levels of oxidative stress, TAC, and dietary antioxidant supplementation. 
 





Fig 2.1. A schematic overview of the proposed effects of smoking on markers of 
oxidative stress, inflammation and endocrine status, and the potential subsequent 





Chapter 2 Review of Literature 
31 
 
2.4.1.1 Markers of oxidative stress  
Direct quantitation of the magnitude of oxidative stress within a biological 
system presents many challenges to researchers.  Reliable markers of oxidative 
stress must be unique to the specific process examined, and subsequently respond to 
imbalances in redox status, and be chemically stable with sufficient half-life to 
remain detectable (Powers, Smuder, et al. 2010).  Typically, substantial production 
of ROS induces inter- and extra- cellular degradation of lipids through peroxidation.  
Oxidative damage can also occur to cellular proteins and DNA.  As such, the 
techniques currently used in research to quantify oxidative stress in a biological 
system are markers of this oxidative damage.  Researchers must therefore decide 
which techniques and markers are suitable for their research question.  Detailed 
commentary of markers of DNA damage, lipid and protein peroxidation is beyond 
the scope of this literature review, but several of the more commonly used markers 
of lipid peroxidation will be discussed. 
Currently, the recommended “gold-standard” for measurement of oxidative 
stress is F2-isoprostanes (Powers, Smuder, et al. 2010).  Isoprostanes are 
prostaglandin-like compounds that are produced as a by-product of oxidation of 
polyunsaturated fatty acids.  F2-isoprostanes are produced from peroxidation of 
arachidonic acid in a process solely catalysed by endogenous free radicals, making 
them a reliable in vivo indicator of oxidative damage.  Additionally, compared to 
other markers the relative stability and longer half-life of F2-isoprostanes and the 
ability to detect levels in both plasma and urine mean it is particularly appropriate 
for human research (Morrow et al. 1995).  Isoprostanes can be measured using a 
number of methods (including enzyme-linked immune-sorbent assay (ELISA)) but 
have the advantage of being detectable by gas chromatography/mass spectroscopy 
(GC-MS) which, though costly, is a highly reliable measurement technique.  Assays 
are available for the measurement of F2-isoprostanes but have been reported to have 
variable results and further work is needed to reach the precision of other 
measurement techniques.  
Malondialdehyde (MDA) is the principal product of peroxidation of 
polyunsaturated fatty acids, and one of the most widely examined markers of lipid 
peroxidation (Del Rio, Stewart & Pellegrini 2005).  As a relatively stable molecule, 
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research has predominantly examined chronic levels of MDA in disease 
pathogenesis.  MDA has been shown to increase during infection, and have diurnal 
variation that correlates with white blood cell count (Akbulut et al. 2003).  
Similarly, MDA correlates with biomarkers of T-cell activation, concurrent with 
cancer generation and atherosclerosis (Kolanjiappan, Manoharan & Kayalvizhi 
2002; Tamer et al. 2002; Akbulut et al. 2003; Bakan et al. 2003).  These properties 
mean chronic elevations in MDA have been used as a marker of severity of 
oxidative stress and human disease (Romero et al. 1998).  Although MDA is 
considered one of the most reliable markers of oxidative stress aside from 
isoprostanes, the measurement technique can be performed in a variety of ways that 
can greatly affect reliability.  MDA is measured using the thiobarbituric acid (TBA) 
assay which relies on MDA reacting with TBA to form the TBA-MDA adduct 
which is then quantified.  The principal problem with this assay is that many 
biological compounds can react with TBA, meaning a number of steps must be 
taken to reduce the possibility of cross-reaction and overestimation of MDA 
concentration.  It is considered that including a lipid derivation step and using high-
performance liquid chromatography (HPLC) greatly improve the accuracy of the 
assay.  
Other more highly reactive markers of lipid peroxidation also exist which 
possess relatively short half-lives, but are involved in the aetiology of rapid cellular 
damage from oxidative stress (Fogarty et al. 2011).  One such example is lipid 
hydroperoxides (LOOH) produced from the peroxidation of both saturated and 
unsaturated fats.  LOOH are volatile and unstable, and can be produced from 
numerous mechanisms within biological systems (Powers, Smuder, et al. 2010).  As 
such, measurement of LOOH is particularly valuable following a stimulus where a 
rise in oxidative stress is expected so that causality is relatively assured, and 
alongside a more stable measure of lipid peroxidation such as MDA.  Like MDA, 
there are several methods for detecting LOOH but the most commonly used and 
reliable are ferrous ion assays that require several biochemical steps but are 
relatively inexpensive to perform. 
Other markers of oxidative stress, such as aldehyde-protein conjugates and 
markers of protein oxidation are available that can be measured using more 
conventional methods such as ELISA or western-blot techniques but have a number 
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of disadvantages compared to those discussed above.  For this reason these are less 
widely used in human physiology unless measured alongside a panel of other 
markers of oxidative signalling. 
 
2.4.2 Smoking and oxidative stress 
Typically, long-term habitual smokers exhibit chronically elevated systemic 
markers of oxidative stress in comparison to non-smokers (Morrow et al. 1995; 
Reilly et al. 1996; Helmersson et al. 2005; Isik, Ceylan & Isik 2007).  It is theorised 
that this may be a mediating factor in the higher prevalence and earlier onset of 
chronic diseases in smokers (Ambrose & Barua 2004; Ahmadzadehfar et al. 2006; 
Faux et al. 2009).  Cigarettes are known to contain substances that produce free 
radicals when combusted (Pryor 1997), directly affecting the oxidative environment 
within lung tissue.  Substantial elevation in oxidation occurs in the lung tissue (Faux 
et al. 2009), causing an inflammatory-immune response.  The first line of host 
defence is well equipped to manage an acute increase in oxidative stress.  However, 
over repeated occurrences the high volume of ROS and particulate matter in smoke 
is suggested to vitiate lung tissue and function (Taylor 2010).  Furthermore, 
smoking appears to attenuate the function of phagocytes within the lung (Hodge et 
al. 2007) and alter control of local inflammatory mediators (McCrea et al. 1994) 
whereby an increased production of oxygen radicals intended for immune defence 
are released into the surrounding environment (Cross et al. 1998; Gonçalves et al. 
2011).  These processes have a cascade effect on elevating oxidative stress and 
inflammation on a local and systemic level (Van der Vaart et al. 2004). 
In fluid extracted from within the lungs, and from circulatory blood samples, 
oxidative stress is shown to transiently elevate following smoke exposure (Faux et 
al. 2009).  However, smoking appears to influence different aspects of oxidative 
stress in the acute act of smoking than in response to habitual exposure (Seet et al. 
2011).  This was observed by measuring a panel of biomarkers, observing several to 
remain constant despite overnight abstinence from smoking, and others to respond 
transiently to smoking (Seet et al. 2011).  As such, although the smoking of 
multiple cigarettes will maintain elevated diurnal oxidative stress, there is evidence 
to suggest that different aspects of oxidative stress contribute to the chronic state.  
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After prolonged regular smoking, habitual smokers develop chronic 
oxidative stress.  This effect follows a dose-response, where concentrations of 
markers are proportional to average cigarette consumption (Reilly et al. 1996). This 
is evidenced by significantly elevated biomarkers of oxidative stress in individuals 
smoking >30 cigarettes.day-1 (Reilly et al. 1996) in comparison to non- and 
moderate- smoking groups.  In young otherwise healthy adults, oxidative stress 
markers reduce to levels similar to non-smokers after several weeks of cessation 
(Morrow et al. 1995; Pilz et al. 2000).  Similarly, decreased in vitro oxidation was 
observed with one month of smoking cessation (Van den Berkmortel et al. 2000).  
However, it is understood that this response is inversely proportional to age and 
total duration of smoking, with the rationale that the ability to manage oxidative 
stress becomes impaired with continued smoke exposure.  As such, elderly long-
term smokers will likely exhibit chronic oxidative stress, and markers of ill health 
from smoking, for an extended period even following smoking cessation. 
Smoking may also reduce the effectiveness of antioxidant defence.  
Concentrations of antioxidant micronutrients are reduced in comparison to non-
smokers (Faruque et al. 1995; Alberg 2002), seemingly owing to higher oxidative 
stress levels and lower dietary antioxidant intake (Marangon et al. 1998; Bloomer 
2007).  Concordantly, the majority of studies show TAC is lower in smokers, 
although it has been suggested that persistent oxidative stress in smokers may in 
fact modify and increase TAC (Charalabopoulos et al. 2005).  This was, however, 
accompanied by a reduced resistance of lymphocytes to hydrogen peroxide-induced 
damage, suggesting immunity was still impaired.  The smoking-induced rise in 
oxidative stress produces an inflammatory-immune response, activating 
inflammatory mediators, signalling a local influx of phagocytes, leukocytes and 
monocytes.  There is a resultant increase in systemic inflammation, which can also 
potentiate further oxidative processes (Cross et al. 1998). 
 
2.4.3 Inflammation 
Inflammation is a complex process within the human immune system 
characterised by systemic or local influx of a cell cascade in response to infection or 
tissue damage.  It is generally considered that a short term inflammatory response is 
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necessary for the process of repair, where inflammatory mediators and signalling 
molecules travel to the site of insult.  Molecules called cytokines are produced in 
the cascade to signal the release of immune cells such as neutrophils, monocytes, 
phagocytes and macrophages for neutralisation of foreign microbes.  Appearance of 
cytokines in the circulation trigger the “acute phase response”, where acute phase 
proteins are produced, causing the influx of platelets, adhesion molecules and 
fibrinogen to sites of injury to begin the healing process (Ershler & Keller 2000; 
Arcavi & Benowitz 2004).  Following a normal immune-inflammatory response, 
several anti-inflammatory processes are then initiated to counteract the elevated 
inflammatory state (Steensberg et al. 2003; Fischer 2006).  Subsequent to 
completion of the healing process, markers of the process reduce to near 
undetectable levels. 
Where the transient increase in inflammatory processes is considered 
beneficial to recovery, chronically elevated inflammation is associated with chronic 
disease states (Hirschfield & Pepys 2003).  Plasma concentrations of inflammatory 
markers are elevated in individuals suffering from cardiovascular disease (Pearson 
et al. 2003), obesity (Ford 1999), cancer (Ono 2008) and osteoporosis (Mundy 
2007).  Basal low grade inflammation is pathologic in the development of 
atherosclerosis (Jialal, Devaraj & Venugopal 2004; Kuo et al. 2007) and coronary 
heart disease (Danesh et al. 2004).  Resting markers of inflammation increase with 
age (Ershler & Keller 2000; Krabbe, Pedersen & Bruunsgaard 2004), supporting the 
premise that low-grade inflammation may also be involved in the ageing process.  
 
2.4.3.1 Markers of inflammation 
Owing to the clinical significance of inflammation, biomarkers of the 
process have been extensively researched.  The pleiotropic cytokine 
interleukin(IL)– 6 is a central marker in both pro- and anti- inflammatory processes 
(Scheller et al. 2011) as well as immune, neural and bone cell signalling  (Kurihara 
et al. 1990; Tamura et al. 1993).  IL-6 stimulates the production of several hepatic 
proteins as part of the acute phase response (Ershler & Keller 2000).  Alongside 
this, IL-6 has immunological function, stimulating differentiation of B cells (Lotz et 
al. 1988), subsequently activating lymphocytes (Lotz et al. 1988; Luger et al. 1989).  
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Research has suggested IL-6 is predominantly a myokine, produced from skeletal 
muscle during contraction (Pedersen & Febbraio 2008).  However, like its 
functions, the sources of IL-6 are numerous, with observations of hepatic 
production as well as from adipose tissue (Giannopoulou et al. 2005; Pedersen & 
Febbraio 2008).   Consequently, elevations in acute phase proteins, neutrophils and 
macrophages follow circulatory increases in IL-6 (Ershler & Keller 2000; Febbraio 
& Pedersen 2002).  Subsequent to this, IL-6 triggers anti-inflammatory markers IL-
1ra and IL-10 (Steensberg et al. 2003).  As such, IL-6 can be observed as a single 
central signalling molecule that can give a reliable representation of the current 
inflammatory state of an individual.  
Interleukin-6 stimulates the production of C-reactive protein (CRP) from the 
liver (Ershler & Keller 2000).  As an acute phase protein CRP is present in very low 
levels in the circulation and increases substantially as part of the inflammatory 
cascade.  In instances of severe infection, CRP has been observed to increase in 
concentration by up to 10000 times (Hirschfield & Pepys 2003).  In a clinical 
setting, CRP is used as a marker of atherothrombotic events, infection or illness and 
is typically proportional to severity.  Clinical thresholds have been established 
(Clyne & Olshaker 1999), where chronic concentrations of CRP are risk factors of 
disease and can be predictive of future events (Ridker et al. 1998; Ridker et al. 
2002).  CRP has been linked to endothelial cell dysfunction (Fichtlscherer et al. 
2000), formation of foam cells and activation of vascular smooth muscle, which 
over prolonged periods accelerate atherogenesis (Jialal et al. 2004; Kuo et al. 2007).  
Median population resting values range between 0.8-2 mg⋅L-1, with >3 mg⋅L-1 being 
clinically indicative of increased cardiovascular disease risk, and >10 mg⋅L-1 during 
acute infection or immune stress (Clyne & Olshaker 1999; Woloshin & Schwartz 
2005).  In cases of severe burns or sepsis, CRP can rise as high as 200 mg⋅L-1 
(Clyne & Olshaker 1999; Luzzani et al. 2003).  
Ordinarily, in acute inflammation elevations in CRP and IL-6 are concurrent 
(Sipe 1990).  However, owing to a longer half-life in CRP, following an 
inflammatory response CRP remains in the circulation longer (Heinrich, Castell & 
Andus 1990).  As such, the duration of time after an inflammatory stimulus is 
integral for drawing accurate conclusions from the measurement of these markers.  
Factors such as stress, sleep disruption, recent physical activity or illness, can affect 
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both pro- and anti- inflammatory processes (Irwin et al. 2006; Plaisance & 
Grandjean 2006; Frey, Fleshner & Wright 2007; O’Connor & Irwin 2010).  During 
states of chronic inflammation, however, IL-6 and CRP can be elevated 
independent of one another (Dixon et al. 2009).  
Other markers of inflammation exist that respond acutely to an 
inflammatory stimulus or as part of immune control.  Often these markers have 
clear pro- or anti-inflammatory functions.  Tumor necrosis factor (TNF) – α and IL-
1b are typically the first molecules to be present in the circulation to initiate the 
systemic inflammatory response and the acute phase cascade (Bruunsgaard 2005).  
As discussed earlier, when the inflammatory response is transient these cytokines 
are then followed by anti-inflammatory markers such as IL-1ra and IL-10 in order 
to return inflammation to normal levels.  These markers can be measured using 
commercially available assays.  However, owing to their transient nature, when an 
inflammatory rise is not present the majority of these markers can be undetectable 
in human tissue and present considerable inter-individual variability. 
Lastly, liver transaminases, such as alanine aminotransferase (ALT), have 
received research attention as novel indicators of cardiovascular disease risk 
(Yamada, Tomiyama, et al. 2006; Mochizuki et al. 2012).  Specifically, when 
elevated, ALT can be indicative of liver disorders and has been positively 
associated with inflammatory biomarkers and cardiovascular disease risk in middle 
aged men (Yamada, Tomiyama, et al. 2006).  Alongside CRP, ALT is significantly 
elevated in individuals with coronary artery disease (Masoudkabir et al. 2011).   
 
 
2.4.4 Smoking and inflammation 
Smoke exposure induces local and systemic elevations in primary 
inflammatory cells.  Inflammatory cytokine release is evident in the airways and 
lungs in the hour following smoking (Flouris et al. 2009).  However, smoke 
exposure suppresses the effectiveness of the immunological response. In 
bronchoalveolar lavage fluid of young smokers, despite a greater population of 
immune cells when compared to never-smokers, cytokine signalling and phagocytic 
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ability of macrophages is suppressed (McCrea et al. 1994; Hodge et al. 2007).  
Similarly, smoke exposure in mice results in elevations in cytokines accompanied 
with immunosuppression (Gualano et al. 2008).  Effective macrophage function in 
lung tissue is pivotal for mediating inflammation and preventing excessive 
oxidative stress following smoking.  However, in this state, the protective 
mechanisms of neutrophils and macrophages against particulate matter and tissue 
damage associated with smoking are impaired, resulting in further harm to tissue by 
release of oxygen species into the surrounding cellular environment (Cross et al. 
1998; Gonçalves et al. 2011).  This leads to a dose-response relationship between 
smoke exposure and cytokine concentrations observed in lung tissue (Kuschner et 
al. 1996).   
The combined accumulation of oxidative stress and inflammatory mediators 
in the smoke exposed lungs elicit a systemic response.  In smokers, it is unknown 
whether the inflammatory rise is solely as a result of oxidative stress.  Additionally 
it has also not been elucidated what proportion or aspect of the oxidative state 
results from cigarette smoke and what results from the immune-inflammatory 
response.   However, chronic low-grade inflammation, similar to that of chronic 
disease states, is typically observed in smokers (Andelid et al. 2007; Jang et al. 
2007).  Additionally, Helmersson et al (2005) demonstrated increased circulatory 
IL-6 and oxidative stress marker prostaglandin F2α in tandem.  Large scale studies 
have reported elevated levels of CRP in smokers in middle aged and elderly 
populations (Bazzano et al. 2003; Levitzky et al. 2008), as well as young otherwise 
healthy smokers (O’Loughlin et al. 2008) when compared to age-matched never-
smokers.  Similar results have been found in cross-sectional studies alongside 
elevated white blood cell count and fibrinogen (Tuut & Hense 2001; Wannamethee 
et al. 2005), further associating smoking with cardiovascular disease risk and 
reduced vascular health.  
The direct link between smoking and chronically increased inflammation is 
starting to be revealed with further understanding of gene expression and 
modification in habitual smokers.  The interaction between smoking and the IL-6 
promoter gene has been observed and is related to the systemic elevation in CRP 
and IL-6 in smokers in a dose-dependent manner (Sunyer et al. 2009).  Further to 
this, evidence exists for particular genotypes to be more susceptible to a greater IL-
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6 response from smoking (Jang et al. 2007; Shin et al. 2007).  As will be discussed 
later, the role of oxidative stress in mediating transcription factors of inflammatory 
cytokine release is evidenced (Close et al. 2005).  Interaction of these processes 
provides the basis for how concurrent elevation of inflammation and ROS on a 
systemic level in smokers can culminate in local tissue dysfunction, as described in 
skeletal muscle and endothelial cells (Barreiro et al. 2010; Barbieri et al. 2011). 
 
2.4.5 Smoking and hormones 
Smoking and smoking-induced inflammation have a profound effect on 
circulatory hormone concentration (Kapoor & Jones 2005; Steptoe & Ussher 2006).  
Hormones are chemical messengers synthesised by endocrine glands and secreted 
into the circulation to be transported to a specific target tissue.  Tissue 
responsiveness to hormones is determined by receptors on the destination cell 
surface or within the cytoplasm.  Different endocrine glands each produce and 
secrete specific hormones in response to signalling from neural input, and the 
presence of other hormones or cells in circulation.  The influence of chronic 
smoking on hormones is largely from the pharmacological effects of nicotine or 
subsequent to physical processes stimulated by smoking, such as increased heart 
rate.  Consequently, habitual smokers have been shown to have altered hormone 
concentrations in comparison to typical values in non-smokers, specifically resting 
levels of testosterone (Zmuda et al. 1997), cortisol (Kirschbaum, Wüst & 
Strasburger 1992) and insulin-like growth factor(IGF)-1 (Renehan et al. 2004), 
amongst others (Perkins & Fonte 2002; Jorde et al. 2005).   
Insulin-like growth factor-1 is a peptide hormone produced predominantly 
from the liver, stimulated primarily by growth hormone, but is also locally produced 
by numerous tissues within the body.  Alongside roles promoting growth and 
development especially during maturation, IGF-1 has purported functions in 
maintenance of soft tissue and bone (Yakar et al. 2001; Juul 2003), glucose 
homeostasis and regulation of metabolism (Nindl & Pierce 2010).  Long-term 
smoking is associated with a decline in IGF-1, ostensibly in proportion to cigarette 
exposure (Landin-Wilhelmsen et al. 1994).  It appears smoking also may reduce 
production of circulating binding proteins (Kaklamani et al. 1999; Holmes, Pollak 
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& Hankinson 2002).  It has been suggested that the likely mechanism for reduced 
IGF-1 concentration in smokers is reduced growth hormone, with Kapoor & Jones 
(2005) postulating this would be mediated by central effects on the hypothalamus.   
The effect of nicotine acting on the hypothalamus is also the proposed 
pathway for smoking-induced increase in cortisol.  Nicotinic binding sites on the 
hypothalamus (Kellar, Dávila-García & Xiao 1999), by stimulating corticotrophin 
releasing hormone and adrenocorticotrophic hormone increase cortisol secretion in 
smokers (Steptoe & Ussher 2006).  Cortisol concentration in saliva  (Kirschbaum et 
al. 1992; Badrick, Kirschbaum & Kumari 2007) and serum (Field et al. 1994) is 
greater in chronic smokers, and decreases in response to long-term smoking 
cessation (Frederick et al. 1998).  Some studies have shown no differences in 
cortisol between smokers and non-smokers (Kirschbaum, Scherer & Strasburger 
1994; Tsuda et al. 1996). However, as cortisol follows a circadian rhythm, the 
discrepancies in these studies may stem from varied timing of blood sampling 
(Steptoe & Ussher 2006).  Alongside these mechanisms both IGF-1 and cortisol are 
down- and up-regulated, respectively, by the appearance of IL-6 in the circulation 
(Steensberg et al. 2003; Joseph, Kenny, et al. 2005). 
In comparison to IGF-1 and cortisol, the effect of smoking on testosterone is 
more equivocal.  Testosterone is a steroid hormone produced in the testes in men 
and ovaries in women, but can also be secreted, to a lesser extent, from the adrenal 
gland.  Researchers examining the effect of habitual smoking on testosterone 
concentration have observed mixed results, with some authors reporting greater 
(Gray et al. 1991; Field et al. 1994; Svartberg et al. 2003; Svartberg & Jorde 2007), 
others reporting lesser (Zmuda et al. 1997), or others reporting no measureable 
difference (Harman et al. 2001; Richthoff et al. 2008) when compared to non-
smokers.  There are a number of interlinked explanations for these inconsistencies 
that appear from the literature (Gray et al. 1991; Kapoor & Jones 2005).  Studies 
have measured a variety of fractions of testosterone in serum and saliva, namely 
free, bioavailable or total testosterone, which may account for some of the variation 
in results.  Examination of the methods for measuring testosterone has indicated 
there are a number of differences in assays and blood sample timing that are pivotal 
for correctly determining testosterone concentrations (Gray et al. 1991).  The 
majority of circulatory testosterone (65-80%) is bound to sex hormone binding 
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globulin (SHBG), and is therefore biologically inactive.  Another 20-40% is loosely 
bound to albumin, and is available for receptor binding, while a final ~2% is the 
free fraction.  It is understood that the combination of albumin bound and free 
fractions make up the bioavailable fraction, but this definition is made unclear by 
assay variation.  Several assay types will cause the unbinding of testosterone from 
albumin and SHBG ostensibly measuring the total concentration of testosterone, 
where some claim to directly measure bioavailable testosterone, and others employ 
a calculation to estimate bioavailability from the albumin bound fraction.  Similar to 
cortisol, testosterone follows a diurnal rhythm meaning that not only bioavailability 
could differ, but total concentration may differ depending on timing of blood 
sampling. 
 
2.5 Physiological mediation of physical adaptation to training 
Oxidative stress, inflammation and aspects of endocrine status were 
introduced in section 2.4 alongside how these can be influenced by habitual 
smoking.  Research examining the biomarkers presented above has observed their 
acute responses to exercise and the potential roles of redox balance, inflammation 
and hormones in adaptation to exercise training.  In this section, the extant evidence 
for how these factors may respond to exercise and potentially mediate physical 
adaptation to long-term exercise training will be presented.  The enhancement of 
muscle strength, size, fatigability and contractility via adaptation to exercise 
requires a balance of physiological processes that mediate protein degradation and 
protein synthesis, the availability of nutrients, and the proliferation of satellite cells 
for alterations in muscle cell properties, with subsequent remodelling of muscle.  
The optimal cellular environment for these adaptive responses and for effective 
recovery from exercise is constantly re-defined.  Given evidence discussed in 
section 2.4, it is proposed that the process of adaptation may be disrupted by 
chronic levels of oxidative stress, inflammation and alterations in hormone balance 
in a habitually smoking individual. 
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2.5.1 Oxidative stress and exercise training 
Exercise causes an increase in the presence of ROS in the circulation, with 
specific complexes of the electron transport chain within muscle mitochondria 
shown to be the predominant source of superoxide during exercise (Barja 1999; 
Muller, Liu & Van Remmen 2004).  There is evidence of oxidant release and 
oxidative enzymes in the sarcoplasmic reticulum (Xia et al. 2003), transverse 
tubules (Hidalgo et al. 2006) and subcellular sources within muscle cells (Powers & 
Jackson 2008), demonstrating how muscular contractions can increase local 
generation of ROS (McArdle, Van der Meulen, et al. 2004). Though originally 
thought to be potentially harmful to muscle cells, the understanding of the role of 
oxidants in muscle has greatly advanced.  It is now known that transient elevations 
in ROS during exercise are favourable for muscle function.  By incubating isolated 
animal muscle in antioxidant enzymes, oxidative intermediates have been shown to 
be essential for optimal muscle contraction in un-fatigued muscle (Reid, Khawli & 
Moody 1993).  It was speculated that oxygen radicals are obligatory for excitation-
contraction coupling (Reid et al. 1993).  This was later demonstrated by 
antioxidants impairing contractile ability by lowering ROS in the muscle cell 
cytosol (Reid & Moylan 2011).     
Alongside the immediate functional benefits on muscle contraction, oxygen 
species may also have an effect on muscular adaptation to exercise.  The work of 
Close and colleagues (2005) on the potential role of ROS in muscle damage 
proposed that cellular oxidation does not exacerbate the magnitude of damage and 
instead appears to signal an adaptive response.  Evidence shows that ROS signal 
transcription factors that modulate the expression of specific genes in response to 
contraction (Ammendola et al. 1995; Lander et al. 1996).   Associated genes, such 
as NFkB, are identified to have pivotal roles in the modulation of inflammatory 
mediators and the generation of antioxidant enzymes (Close et al. 2005).  
Furthermore, the transcription factors and associated inflammatory response 
positively influence cell regeneration (Jackson et al. 2002; McArdle, Vasilaki & 
Jackson 2002), potentially repairing oxidative damage and improving muscle 
health.  As such, transient increases in oxygen radicals appear to trigger an adaptive 
response to modify the system to more effectively manage future oxidative states.   
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In the long term, high-intensity endurance training appears to result in more 
prolific generation of antioxidant enzymes and intermediates (Sen et al. 1992), 
specifically glutathione in muscle cells (Marin et al. 1993; Leeuwenburgh et al. 
1997).  The adaptive response to oxidative events in muscle also contains protective 
mechanisms against future cellular damage (Ji 2007), in part via expression of heat 
shock proteins (McArdle, Dillmann, et al. 2004) and cytoprotective proteins 
(McArdle et al. 2001).  With examination of repeated contractions, the oxidation 
required to trigger these responses is reversible within 60 minutes (McArdle et al. 
2001), indicating the transient nature of beneficial oxidative stress in muscle. 
Reactive oxidants, however, have different functions depending on the state 
of the muscle tissue.  The situation observed in un-fatigued muscle as discussed 
above differs from the cellular environment during persistent exhaustive 
contractions.  Here, the accumulation of ROS is substantial enough to result in a 
prolonged state of oxidative stress.  The progressive insensitivity to calcium which 
occurs in fatiguing muscle is accelerated by the oxidative state, altering contractile 
ability (Andrade et al. 1998; Moopanar & Allen 2005) and oxidising contractile 
myosin  (Yamada, Mishima, et al. 2006).  Andrade et al. (1998) observed 
improvements in force production in isolated myofibrils with the presence of 
hydrogen peroxide for brief periods, but prolonged exposure significantly decreased 
force.  Similarly, repeated bouts of modest peroxide concentrations did not hinder 
pathways for contraction, allowing force to remain relatively constant over time 
(Andrade, Reid & Westerblad 2001).  In the same experiment, solely the highest 
concentrations of peroxides examined decreased calcium uptake and increased 
resting in mouse muscle fibres (Andrade 2001).  These findings allude to a 
concentration-dependent limit of oxidative stress in muscle, as opposed to a dose-
response relationship, whereby there is an upper-limit of the presence of ROS 
beneficial for contractile function.   
Given the existing literature, it would seem that it is the redox balance 
within muscle cells that is not only important for optimal myofibrillar function, but 
for the successful signalling of protective adaptation to exercise (Jackson 2009; 
Jackson & McArdle 2011).  Within human physiology, the direct correlation 
between circulatory biomarkers and their accumulation within local tissues is 
equivocal.  However, it is reasonable to suggest that chronically elevated circulatory 
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oxidative stress in smokers may disrupt levels of cellular oxidants.  This may 
highlight potential causation behind reduced fatigue resistance in muscle with 
smoke exposure  (Morse et al. 2007; Wüst et al. 2008).  With a graded exercise test, 
by comparing pre- and post-exercise levels of MDA in smokers and non-smokers, 
Bloomer et al. (2007) identified that smokers experienced a significantly greater 
oxidative stress response.  The chronic oxidative state of smokers may facilitate the 
progression, or shorten the time needed, to reach the upper limit of oxidation in the 
cellular environment.  Equally, as smokers typically display lower antioxidant 
levels than non-smokers, the ability to sustain high intensity exercise may be 
reduced.  As such, it is proposed that elevated endogenous ROS in smokers may 
impair the adaptive responses of muscle to exercise training in comparison to non-
smokers, either by altering the short term function of muscular contraction or 
disrupting cellular pathways of signalling for adaptation. 
 
2.5.2 Inflammation and exercise training 
 Long-term physical training has an anti-inflammatory effect on resting 
inflammation (Petersen & Pedersen 2005).  Endurance exercise interventions lasting 
from 3-9 months have reduced markers of resting inflammation in middle-aged 
sedentary populations (Mattusch et al. 2000; Giannopoulou et al. 2005; Thompson 
et al. 2010), although others have seen no effects (Marcell et al. 2005; Nakajima et 
al. 2008).  Furthermore, longitudinal data has shown that inflammation is inversely 
proportional to regular physical activity level (Mattusch et al. 2000; Fallon, Fallon 
& Boston 2001; Dixon et al. 2009) and endurance capacity (Kuo et al. 2007).  This 
supports the prescription of exercise as a method of controlling resting 
inflammation (Mathur & Pedersen 2008). 
Exercise stimulates a transient elevation in inflammation.  Typically, IL-6 
and other inflammatory cytokines are observed in greater numbers in circulation 
immediately following exercise (Febbraio & Pedersen 2002).  Muscle-derived IL-6 
is produced during muscular contraction, with substantial increases shown 
following maximal rowing (Nielsen et al. 1996), and marathon running (Ostrowski, 
Schjerling & Pedersen 2000; Ostrowski et al. 2001).  The extent to which IL-6 
increases appears to be influenced by the duration and intensity of exercise 
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(Pedersen et al. 1998).  Greater cytokine responses were observed to 60 min of 
running at 75% ܸܱ̇ଶ max compared to 65% and 55% ܸܱ̇ଶ max (Scott et al. 2011), 
eliciting greater time to return to pre-exercise levels.  Equally, IL-6 response 
appears to be proportional to duration when performing steady state exercise 
(Febbraio & Pedersen 2002; Fischer 2006).  This elevation in IL-6 gives rise to 
CRP which can continue to develop over approximately 24 hours following 
exercise (Mendham et al. 2011).  Particularly unaccustomed exercise and severe 
muscle damage can result in consecutive days of elevated CRP, although this may 
be partly attributed to a delayed response of IL-6 to eccentric exercise (MacIntyre et 
al. 2001).   
Similar to the immune response to infection and injury, on a transient basis 
an elevation in inflammation is perceived to be beneficial to adaptation and 
recovery from exercise in comparison to a chronic elevation.  The difference being 
that the potent pro-inflammatory cytokines that elevate in response to infection are 
not stimulated by exercise, and instead IL-6 is the first inflammatory mediator 
observed in circulation (Mathur & Pedersen 2008).  However, chronic low-grade 
inflammation, as observed in chronic disease states, up-regulates pro-inflammatory 
cytokines and is implicated in the local accumulation of cytokines in muscle and 
subsequent mechanisms in disease-induced muscle atrophy (Ershler & Keller 2000; 
Schaap et al. 2006).  In longitudinal studies both resting CRP and IL-6 levels are 
shown to be inversely proportional to muscle strength and cardiovascular fitness in 
elderly populations (Taaffe et al. 2000; Church et al. 2002; Visser et al. 2002; 
Hamer & Molloy 2009).  
Acute increases in IL-6 in muscle augments protein synthesis, while longer 
duration infusion has an opposing effect (Goodman 1994).  Local infusion of IL-6 
in rat muscle to levels comparable with chronic resting inflammation in elderly 
humans reduces growth factors and signalling for adaptation (Haddad et al. 2005).  
Equally, Bodell et al. (2009) observed that a rat infusion model of IL-6 resulted in 
13% lower content of myofibrillar protein and lower body mass during growth.  
Although these studies examined rats during natural growth, muscle biopsies in 
healthy adult men following infusion of IL-6 for three hours exhibited 50% reduced 
protein synthesis compared to controls (Van Hall et al. 2008).  This may explain 
resting levels of IL-6 and CRP being negatively associated with protein synthesis 
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rates (Toth et al. 2005).  It has also been shown that IL-6 has a key role in the 
regulation of growth factors in circulation as well as their actions on the 
maintenance of muscle (Steinacker et al. 2004; Fischer 2006; Adams 2010), which 
will be discussed in section 2.5.3.    
A positive adaptation to long-term exercise is the concurrent reduction in 
resting inflammation.  The persistent elevation of inflammation within the 
circulation elicits numerous subsequent effects that may induce damage to muscular 
cells and delay recovery (Tidball 2005).  Elongation of the transient exercise-
induced inflammatory response increases the appearance of pro-inflammatory 
cytokines, several inflammatory mediators and neutrophils (Pedersen et al. 1998; 
Bruunsgaard 2005).  The role of neutrophils following muscle injury or damage is 
to clear damaged tissue by release of cytotoxic molecules, for development of new 
tissue, but this can damage healthy muscle cells (Tidball 2005).  Additionally, 
although the molecular mechanisms underlying proliferation and differentiation of 
muscle satellite cells are ill-defined, it has been suggested that these may involve 
the balance of inflammatory cells in the muscle cellular environment  (Sun et al. 
2007).   
 
2.5.3 Hormones and adaptation to exercise training 
It has been discussed how both redox balance and inflammatory mediators 
can be influential in the process of adaptation to training.  It appears that there may 
be a role of hormones in mediating adaptation and recovery to exercise training, but 
is continually under discussion.  While it is clear both in neonates and during 
growth and maturation, that growth factors and anabolic hormones such as IGF-1 
and testosterone have necessary functional roles in the development of tissue, the 
significance of these roles in training response later in life and on a diurnal basis are 
argued.  
In acute response to both low- and high-intensity exercise, IGF-1 has 
predominantly been shown to remain unchanged (Meckel et al. 2009; Stokes et al. 
2010; Wahl et al. 2010), and exercise training research focuses on more long-term 
temporal alterations in IGF-1 and its binding proteins.  In cross sectional studies, 
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IGF-1 has been associated with better health outcomes, greater physical fitness and 
strength (Cappola et al. 2001; Nindl & Pierce 2010; Nindl et al. 2011), and 
maintenance of muscle (Baumgartner et al. 1999) and bone mass (Joseph, Kenny, et 
al. 2005).  IGF-1 is also involved in the regulation of metabolism, specifically via 
maintenance of glucose homeostasis and insulin sensitivity (Yakar et al. 2001).  It is 
this reason that energy balance and dietary intake can exert considerable effect on 
IGF-1 concentration (Nindl & Pierce 2010).  As such, during consecutive days of 
training involving energy deficit IGF-1 becomes significantly reduced (Nindl, 
Barnes, et al. 2007) and specific binding proteins can be useful markers of 
overtraining (Elloumi et al. 2005).  As such, a reduction in IGF-1 over time has 
been considered an indicator of metabolic or physiological stress (Nindl, Alemany, 
et al. 2007). 
Animal models have shown the importance of IGF-1 in development of 
tissue during growth and maturation, and in maintenance of muscle in more 
advanced ages.  Locally produced IGF-1 in muscle has been shown to prevent 
muscle mass decline in degenerative mice (Barton et al. 2002), induce hypertrophy 
(Musarò et al. 2001) and maintain regeneration of muscle fibres in healthy mice 
(Musarò et al. 1999).  Similarly, Adams & McCue (1998) infused IGF-1 into rat 
muscle and reported a 9% greater total mass compared to the contralateral muscle.  
However, where another mouse model showed greater muscle hypertrophy in 
animals with greater IGF-1, this result was only reported in muscles during normal 
pre-natal growth (Shavlakadze et al. 2010).  It is this evidence that causes the role 
of IGF-1 as a major regulator of muscle mass in fully matured humans to be 
debated (Stewart & Pell 2010).  
In humans, the balance of IGF-1 and IGF-binding proteins are modulated 
following resistance exercise to promote maintenance of muscle by increasing 
bioavailability (Izquierdo et al. 2006).  There is also a chronic training response of 
IGF-1, where the modulation of IGF-1 binding proteins in response to training 
differs between well-trained and untrained individuals (Rosendal et al. 2002).  
The interaction of IL-6 with IGF-1 is also important for adaptation and 
development of muscle tissue.  Several pathways have been shown whereby 
cytokine signalling and IGF-1 mediate one another (Adams 2010).  Lieskovska et 
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al. (2002) observed that over expression of IL-6 caused down-regulation of IGF-1 
and an impairment of growth.  Furthermore, the process of muscle regeneration is 
accelerated by the signalling of cytokines by IGF-1 (Pelosi et al. 2007).  While it 
has been shown that hypertrophy stimulated from mechanical loading can be 
achieved without the presence of IGF-1 (Spangenburg et al. 2008), it would appear 
that the role of IGF-1 is pivotal in the effectiveness and rapidity of muscular 
regeneration and maintenance of muscle mass via mediation of inflammatory 
processes (Clemmons 2009). 
Testosterone and cortisol are widely regarded as modulators of skeletal 
muscle remodelling (Crewther et al. 2011).  With a role in promoting protein 
synthesis and decreasing protein degradation, testosterone is termed an “anabolic” 
hormone.  The chief role of cortisol on metabolism is the stimulation of 
gluconeogenesis and glycogenolysis, but also acts to increase degradation of protein 
and reduce protein synthesis, thereby primarily catabolic in nature.  As such, the 
balance between the two is considered an indicator of tissue state of health.  In acute 
response to exercise, concentrations of both hormones typically elevate (Hayes, 
Bickerstaff & Baker 2010; Vingren et al. 2010; Cadore et al. 2012). 
In animal models, the removal of testosterone secretion results in a reduction 
in muscle strength (Brown, Fisher & Hasser 2001), and muscle mass is regained 
with testosterone supplementation (Krotkiewski, Kral & Karlsson 1980).  The 
exogenous use of testosterone induces hypertrophy in animals (Ustünel, Akkoyunlu 
& Demir 2003) and in young (Bhasin et al. 2001) and elderly men (Sinha-Hikim et 
al. 2006).  These relationships are characterised by greater muscle fibre cross 
sectional area, reduced muscular fatigue, elevated proliferation of satellite cells and 
greater improvement in fat-free mass than controls (Bhasin et al. 1997; Bhasin et al. 
2001; Sinha-Hikim et al. 2002; Axell et al. 2006; Sinha-Hikim et al. 2006).  In 
longitudinal and cross-sectional studies, testosterone is positively associated with 
greater muscle mass (Baumgartner et al. 1999).  As suggested, cortisol has an 
opposing effect to testosterone on muscle metabolism, inducing a reduction in 
protein synthesis rate 18 hours following infusion (McNurlan et al. 1996), meaning 
a decrease in cortisol should reduce the magnitude of degradation in muscle cells 
during training.    
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However, these studies have shown positive training effects with exogenous 
testosterone supplementation or loss of muscle mass with testosterone inhibition.  
Research observed that training eliciting high and low acute elevations in 
endogenous testosterone produced no differing effect on protein synthesis (West et 
al. 2009).   As such, the emergent theory is that within normal physiological levels, 
hormones that mediate muscle growth work on a permissive basis, and that transient 
elevations are not effective in a dose-response manner (West et al. 2010).  
Therefore, it may be that resting basal levels of testosterone and cortisol are more 
relevant for how effectively adaptation will occur during a period of training. 
Chronic increases and decreases in resting testosterone and cortisol have been 
observed in response to periods of training in trained (Kraemer et al. 1998; Kraemer 
et al. 1999; Ahtiainen et al. 2004; Kraemer et al. 2006), but not untrained 
individuals (Ahtiainen et al. 2004; Crewther et al. 2011).  Unfortunately, it has not 
been made clear how well changes in performance are concurrent with alterations in 
resting levels of these hormones, and therefore the possible implications on 
muscular adaptations to exercise.  
 
 
In light of the extant literature presented above, it appears that physiological 
effects of smoking have been recognised in middle-aged and elderly populations, 
usually with the aim of discussing health outcomes, but whether these effects exist 
in young, active populations is not clear.  It would be of interest to determine 
whether smoking impairs development of physical fitness.  Furthermore, it would 
be worthwhile to examine oxidative stress, inflammation and hormonal markers 
alongside performance adaptation during training in case potential underlying 
mechanisms for any observed effects of smoking on adaptation are highlighted.  
Given the proposed roles oxidative stress, inflammation and endocrine status upon 
adaptation, examining any differences at rest during training or in acute response to 
exercise between smokers and non-smokers may be prudent. It is clear that smoking 
habits in military training populations are highly variable but it is possible that if 
prevalence is higher than in the public general public any adverse effects of 
smoking may affect a substantial number of trainees.  As such, determining the 
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smoking habits within a military trainee cohort alongside physical fitness 
parameters and risk of injury in smokers compared to non-smokers could provide a 
comprehensive profile of how smoking can affect military training populations, 
with potential relevance to other young, otherwise healthy smoking populations.  
 










CHAPTER 3  
 
 
General Methods   





3.1 Study location 
Data collection for the work in this thesis was completed between the 




All participants involved in the research were male trainees either 
undertaking the 26-week Combat Infantryman’s Course (CIC) (Studies 1-4 and 6) 
or the 26-week Parachute Regiment Course (Study 5) at ITC(C).  Inclusion criteria 
were the same as successful admission into the military course, meaning 
participants were aged between 17 and 33 years and successfully passed the week 1 
Army medical examination.  
 
3.3 Military training and experimental control 
  During this programme of research participants followed the normal 
training syllabus with only minor modifications to allow for data collection where 
necessary.  All of these modifications were discussed with platoon staff to ensure 
normal practice was not affected.   
Despite this programme of work being field-based, the military training 
environment does introduce standards of experimental control that are not feasible 
in free-living work.  Military trainees follow a strict timetable that ensures that in 
each training week each platoon will typically experience identical waking and 
meal times.  Similarly, standardised menus and canteens on the military camp limit 
potentially substantial variability in diet composition.  Equally, during military 
training exercise is also largely standardised and completed in classes or groups, 
meaning it is unlikely for trainees to participate in more or less exercise training 
than their counterparts in a given training week. 
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With particular relevance to smoking behaviour and environmental tobacco 
exposure (passive smoking), it should be noted that this research took place 
following the introduction of the UK smoking ban, meaning smoking could only 
take place outside in designated smoking areas at a specific distance from places of 
work.  At ITC(C), military trainees were allowed out to specific shelters if a 
cigarette break was deemed appropriate.  This means those who did not smoke were 
unlikely to be subject to many instances of passive smoking.  
 
3.4 Notes on ethical considerations 
All studies in this programme of work were approved by the Ministry of 
Defence Research Ethics Committee.  All trainees gave informed consent to take 
part in the research (Appendix A).  Throughout the research every effort was made 
to dispel social bias or military and environmental pressure on individuals to take 
part.  All smaller scale population studies (Studies 2, 3 and 5) were preceded by a 
verbal brief of the research project by a member of the project team without the 
presence of military staff, and at each time point participants were reminded that the 
participation in the research was voluntary and would not in any way affect their 
military careers.  In the larger scale epidemiological studies (Studies 1, 4 and 6) 
administration of a questionnaire to an annual trainee intake by project investigators 
was not possible.  As such, project researchers briefed select members of military 
staff on how to explain the nature of the research.  These staff members were then 
observed administering this brief and the associated questionnaire to trainees on 
several occasions throughout the duration of research.   
 
3.5 Smoking behaviour 
3.5.1 Smoking/tobacco exposure and cigarette consumption 
Unless otherwise stated, during this thesis smoking or tobacco “exposure” 
refers to the estimated lifetime exposure to tobacco in pack-years, calculated by 
cigarettes smoked daily divided by 20 (1 pack), multiplied by years smoked.  The 
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term “cigarette consumption” refers to rate of cigarette consumption in average 
cigarettes per day.  
 
3.5.2 Lifestyle questionnaire 
Volunteers for all studies were asked to complete the Military Pre-training 
Questionnaire (MPQ) to determine individual smoking characteristics (Appendix 
B).  The questionnaire was completed in a suitably quiet environment during the 
first physical fitness session during week 1 of training.  In Study 5 the questionnaire 
was also administered in the final week of training of the Parachute Regiment.  The 
MPQ was designed to assess risk factors for training-related injury in the military.  
Previous testing using weighted kappa analysis for reliability and validity found all 
smoking questions to have between “substantial” (0.6-0.8) and “near perfect” (0.8-
1.0) strength of agreement in test-retest reliability scores (Robinson et al. 2010).  
For the purpose of this research the questionnaire recorded details on smoking 
status, smoking history and smoking behaviour prior to joining the army.  For Study 
4 physical activity constructs included in the MPQ were used to give an estimate of 
physical activity prior to entry to training.  For use in other research projects not 
attached to this thesis the questionnaire also collected data on injury history, diet 
and alcohol intake.  Questions consisted mainly of multiple choice tick box answers 
with some questions asking for a numerical value.  The questionnaire has a Flesch 
Reading Ease Score of 70.1% and a Flesch-Kincaid Grade Score of 7.0, which is 
equivalent to a UK reading age of 12.  In order to ensure accuracy and validity, all 
questionnaires were equipped with a security strip to conceal identification and 
maintain anonymity until collected by study investigators.  It was also made clear to 
participants in the verbal brief and on the front cover of the questionnaire that 
results would not be seen by military staff and would not in any way influence their 
military careers.   
 
3.5.3 Smoking status 
Questionnaire items were designed to allow clear distinctions between 
habitual current smokers, occasional smokers, former smokers and non-smokers 
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from participant responses.  Regular smokers were defined by those who answered 
item Q5-4 (“How often do you smoke at the moment?”) by marking the box 
“Regularly (at least one cigarette/roll-up a day)”.  Occasional smokers were defined 
as those who answered item Q5-4 by marking the box “Occasionally (less than one 
cigarette/roll-up a day”).  Former smokers were defined by those who answered 
“No” to item Q5-3 (“Do you smoke cigarettes at all now?”) and subsequently 
answered “Yes” to Q5-11 (“Did you use to smoke regularly?”).  Non-smokers were 
defined as those who answered “No” to item Q5-1 (“Have you ever smoked a 
cigarette (including roll-ups)?”) or “No” to both items Q5-3 (“Do you smoke 
cigarettes at all now?”) and Q5-11 (“Did you used to smoke cigarettes regularly?”).   
 
3.5.4 Smoking groups 
In studies 2, 3 and 6 current smokers were split into subgroups based on 
reported number of cigarettes smoked per day (cigarette consumption).  The light 
smoking (LS) group comprised trainees reporting 1-9 cigarettes per day, moderate 
smoking (MS) 10-19 cigarettes per day and heavy smoking (HS) by ≥20 per day.  
These groups agree with the predominance of research that categorise light smokers 
as those smoking below the mode cigarette consumption of 10, and heavy smokers 




A shortened version of the MPQ, solely containing items related to smoking, 
was administered in studies 1, 3 and 4 to capture any changes in smoking status 
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3.5.6 Estimated physical activity 
The MPQ collected information on self-reported physical activity and 
exercise behaviour using constructs based on the Leisure Time Exercise 
Questionnaire (LTEQ).  Physical activity was separated into three categories, light, 
moderate and vigorous for which respondents give an average frequency per week 
for each. A previously described weighting system was used to compile a total 
physical activity score from each respondent whereby the frequency of light, 
moderate and vigorous exercise behaviours were weighted by 1, 3 and 9, 
respectively, and summated (Godin & Shephard 1985).     
 
3.6 Anthropometric data 
3.6.1 Body mass and height 
In studies 2, 3 and 5 anthropometric data were collected. Body mass and 
height were measured using a set of calibrated weighing scales accurate to + 0.05 
kg (Seca, Hamburg, Germany) and a stadiometer (Leicester, UK), respectively.  
 
3.6.2 Estimated body fat percentage 
In studies 2, 3 and 5 body fat percentage was estimated using measurements 
of skin fold thickness (Durnin & Womersley 1974) on four sites of the upper body 
(Biceps brachii, triceps brachii, sub-scapular and supra-iliac) using callipers 
(Holtain LTD., Crymych, UK).  Waist circumference was also measured at the 
thinnest point of participant torso by tape measure.   
 
3.6.3 Lower leg characteristics 
In Study 3 muscle and fat characteristics of the lower leg were measured 
using peripheral quantitative computed tomography (pQCT).  The dominant leg of 
each individual was used for the scan.  Muscle area, fat area, muscle density and 
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total density (muscle and fat) were measured by pQCT.  Fat to muscle area ratio 
was calculated from these data.    
 
3.6.4 Lung function 
Lung function was measured in studies 2 and 3 by spirometer (Micro 
Medical) for forced expiratory volume over one second (FEV1), forced vital 
capacity (FVC), forced expiratory ratio ([FER= FEV1/FVC)x100]) and peak 
expiratory flow (PEF).     
 
3.7 Physical performance testing 
In Study 3 all the following performance tests were completed. Platoons 
were given a full demonstration of each physical performance test in all visits.  
Verbal encouragement was given throughout and all data were recorded by the 
project researchers. Maximum values were recorded for all variables.   
 
3.7.1 Maximal strength tests 
Peak dynamic strength measures consisted of chest press, seated row and leg 
press exercises using a strength dynamometer (Concept2, Nottingham, UK).  
Participants completed five repetitions of chest and row exercises and ten 
repetitions of the leg press exercise, each with five seconds recovery between 
repetitions. Peak isometric hand-grip and static lift strength were measured using 
portable dynamometers (Takei, Japan). For static lift strength two attempts were 
completed and for hand-grip strength two attempts were completed for each side of 
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3.7.2 Explosive power 
Explosive power was measured by maximum counter-movement jump 
height using a jump mat (FSL, UK).  Participants were given three attempts to jump 
as high as possible.  
 
3.7.3 Army physical fitness test 
The Army physical fitness test (PFT) is implemented at weeks 1, 14 and 24 
of initial training and consists of a timed best effort 2.4 km run and the number of 
press ups and sit ups completed when allowing 2 minutes for each exercise.  
Trainees are allowed to rest at any point and can keep any desired pace until the 
distance or time-limit has expired.  British infantry standards criteria for passing a 
PFT during training are a run time of under 10 mins 30 secs (630 secs) and greater 
than 44 press ups and 50 sit ups in two minutes.  In Study 3 PFT results were 
collected for all trainees at weeks 1 and 14, and in Study 4 at weeks 1, 14 and 24.   
 
3.8 Overtraining questionnaire 
In Study 3, to assess overreaching or overtraining in trainees at weeks 1, 5 
and 10, participants were asked to also fill in a training questionnaire (Brun, 2003).  
The questionnaire contained 54 items assessing mood and symptoms of 
overtraining.  The method of assessment of potential overtraining employed by 
Brun (2003) was also followed, such that if one point were given for every “yes” a 
score of ≥25 would signify possible overtraining.   
 
3.9 Blood sampling 
In studies 2 and 3 blood samples were taken upon waking (0500-600) in 
trainee accommodation lines. Participants abstained from smoking or consuming 
food or drink in the morning until after blood samples had been collected.  All 
blood samples were taken by venepuncture using a tourniquet from an antecubital 
vein using a needle and Vacutainer system (BD Diagnostics, Becton, Dickinson & 
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Co.). Each blood sample was collected using two plain untreated tubes (6 mL) and 
one tube (2 mL) containing EDTA.  Samples in plain tubes were left to clot for 60 
minutes before being spun to separate the serum.  All samples were aliquoted and 
stored at -80°C for blood chemistry analysis. The 2 mL EDTA tubes were kept as 
whole blood for a full blood count analysis.  
In Study 5 the same procedure was followed but samples were collected in 1 
plain untreated tube (6mL), two tubes containing EDTA (6mL & 4mL) and one 
tube containing heparin (4mL).  Additionally, in Study 5 post-exercise blood 
samples were collected at the site of exercise as soon as possible (within 15 mins) 
after exercise completion. 
 
3.10 Biochemical analysis 
3.10.1 Oxidative stress 
Oxidative stress was determined in serum in studies 2 and 3.  
Malondialdehyde (MDA) was determined in serum following the HPLC method 
described by Funes et al. (2009). This method was based on the derivatization of 
MDA using 2-thiobarbituric acid (TBA), leading to the formation of the fluorescent 
MDA-TBA complex. 1,1,3,3-tetraethoxypropane (TEP) in 1% H2SO4 was used as 
stock standard solution and its concentration was determined using its absorbance at 
244 nm and the molar extinction coefficient. Standards were prepared through serial 
dilution of the stock standard. 50 μL of serum or TEP standard were mixed with 50 
μL of 0.05% butylated hydroxytoluene (BHT) in ethanol and 50 μL of 
trichloroacetic acid 20% in HCl 0.6 M. The samples were incubated on ice for 15 
min and then centrifuged at 12,000g for 5 min at 4°C. Then for each sample 100 μL 
of the supernatant was added to 100 μL of TBA 0.6% in water in 2 mL capacity 
plastic centrifuge tubes, and the mixture was incubated at 97°C for 1 h in a dry 
incubator.  Following heat derivatization, samples were placed in an ice-water bath 
for 5 minutes to cool. Subsequently, 300 μL of n-butanol was added to each sample 
to extract the MDA-TBA complex. Tubes were vortex mixed vigorously for at least 
30 seconds then centrifuged at 10,000g for 3 min. Aliquots of 200 μL were removed 
from the n-butanol layer for HPLC analysis. The TBA–MDA chromogen was 
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determined using HPLC and a fluorescence detection system (Waters, Milford, 
USA). The analysis was conducted by injecting 10 μL of sample into a reverse 
phase column (Nova Pak, C18, 3.9x300 mm column) using isocratic mode with 
methanol: potassium phosphate buffer 50 mM, pH 6.8 (40:60, v/v), and a flow rate 
of 1 mL.min-1. The TBA-MDA product was monitored by fluorescence detection 
with excitation at 515 nm and emission at 553 nm.  
The concentration of lipid hydroperoxides (LOOH) was determined in 
serum following the method described by Gay & Gebicki (2002) with slight 
modifications.  This method was based on measurement of the ferric-xylenol orange 
complex in a perchloric acid medium (PCA-FOX assay).  In a 1.5 ml micro-
centrifuge reaction tube, 800 μL of water, 100 μL of serum and 100 μL of a solution 
containing 2.5 mM ferrous ammonium sulphate and 2.5 mM xylenol orange in 1.10 
M perchloric acid were vortex-mixed for 30 seconds. After 30 minutes at room 
temperature in the dark, samples were centrifuged at 12,000g for 5 min at 20°C. 
Then, for each sample 200 μl of the supernatant was removed and placed in a 98 
well plate for absorbance reading at 560 nm in a microplate spectrophotometer 
(BIO-TEK, Power Wave XS). For each sample, a control containing 900 μL of 
water and 100 μL of serum was used. Freshly prepared H2O2 solution was used as 
the stock standard. The concentration of this stock solution was determined using 
the molar extinction coefficient at 240 nm.   
It should be noted that all oxidative stress analysis was undertaken by a 
collaborator in an established research laboratory. All standards and samples were 
analysed in duplicate apart from LOOH which was analysed in triplicate. 
It was the intention to also measure F2-Isoprostanes as a marker of oxidative 
stress in serum.  Unfortunately, resources were not available for GC-MS analysis as 
intended.  Subsequently, bench-top assays from two companies were tested with 
study samples but gave highly inconsistent results or values outside of physiological 
range.  These inconsistencies may have been caused by technical issues with the 
assays or from incorrect pre-treatment of samples.  With limited resources, it was 
decided that sufficient quantification of oxidative stress would be possible using 
analysis of MDA and LOOH to establish differences between smokers and non-
smokers.  





Inflammation was measured in serum in studies 2, 3 and 5.  For chapter 5 in 
particular it is recognised that having analysis of pro- and anti-inflammatory 
cytokines would have been preferable for understanding the time-course of acute 
inflammation but resources and blood sample size were not sufficient to allow for 
further analytes. It was decided that measuring the cytokine IL-6 alongside the 
acute phase protein CRP would be sufficient to show the inflammatory status in the 
population.   
Serum concentrations of IL-6 were also measured by commercially 
available enzyme immunoassays (R&D Systems Inc., Abingdon, UK).  The 
manufacturer’s reported sensitivity and intra-assay coefficient of variance were 0.04 
pg.mL-1 and 7.4%.  Combined intra- and inter-assay coefficient of variance 
calculated from study assay data for IL-6 was 2.00%. 
Serum concentration of CRP was measured by commercially available 
enzyme immunoassays (Diagnostic Systems Laboratories Inc., Webster, Texas, 
USA).  The sensitivity and intra-assay coefficient of variance for this assay were 1.6 
ng.mL-1 and 2.8%.  Combined intra- and inter-assay coefficient of variance 
calculated from study assay data for CRP was 2.22%. 
Serum Alanine transaminase (ALT) was examined in order to assess liver 
health which may alter the production of inflammatory markers.  ALT was 
measured using a commercial assay (Randox Laboratories, NI) using an automated 
spectrophotometer (COBAS, Roche Diagnostics Limited).  The sensitivity and 
intra-assay coefficient of variation for this assay were 3.44 U.L-1 and 1.59%, 
respectively.  








Endocrine status was measured using selected hormones in serum in studies 
2, 3 and in plasma in Study 5.  Cortisol and IGF-1 were measured by commercially 
available enzyme immunoassays (Diagnostic Systems Laboratories Inc., Webster, 
Texas, USA). The manufacturer’s reported sensitivity and intra-assay coefficient of 
variance were 0.1 μg.dL-1 and 5.9% for cortisol, and 0.01 ng.mL-1 and 6.5% for 
IGF-1. Cortisol was converted from μg.dL-1 to nmol.L-1 using a conversion factor of 
27.589. Combined intra- and inter-assay coefficient of variance calculated from 
study assay data for cortisol and IGF-1 were 1.02% and 2.56%, respectively. 
Concentrations of total testosterone were also measured by commercially 
available enzyme immunoassays (R&D Systems Inc., Abingdon, UK).  The 
manufacturer’s reported sensitivity and intra-assay coefficient of variance were 
0.030 ng.mL-1 and 3.3%.  Combined intra- and inter-assay coefficient of variance 
calculated from study assay data for testosterone was 1.35%. 
All standards and samples were analysed in duplicate. 
 
3.10.4 Full blood count 
A full blood count analysis was also completed in studies 2 and 3 by a 
haematological diagnostic system (ADVIA 2120, Siemens, Germany) measuring 
haemoglobin, white blood cell (WBC) count, platelet count, red blood cell (RBC) 
count, haematocrit (HCT), mean corpuscular volume (MCV), mean corpuscular 
haemoglobin (MCH), and neutrophil, lymphocyte, monocyte, eosinophil and 
basophil populations.    
 
3.10.5 Systemic intramuscular proteins and enzymes 
In Study 3, concentrations of an intramuscular protein (myoglobin) and 
enzyme (creatine kinase) were measured in serum.  Given that these are contained 
within muscle, their presence in the circulation (via leakage from damaged muscle 
cells) has been proposed to indicate exercise-induced muscle damage.  The 
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relevance of creatine kinase as an indicator of muscle damage, however, has been 
debated.  Owing to the rapidity of clearance from the circulation, it is argued that 
creatine kinase does not accurately indicate the presence or severity of muscle 
damage and that interpretation must be exercised with caution.  
 
3.11 Injury data 
3.11.1 Injury 
For study 6, injury data were obtained from trainee medical records by 
military medical practitioners.  This was completed retrospectively.  Only injuries 
to the lower limb and lumbar spine were collected.  An injury was defined as 
physical damage to the body that resulted in the trainee seeking medical attention 
(Knapik et al. 2002).  A time-loss injury was defined as when an individual was 
assigned one or more days of limited duty as a result of the injury.  Injuries were 
assigned to classifications of either “acute” or “overuse”.  Acute injuries were those 
caused by a single abrupt excessive overload of the tissue or joint.  Overuse injuries 
were those deemed to be caused by cumulative damage from continual overloading 
of the tissue or joint.  Injuries were split into training-related and non-training-
related injuries based on medical notes.  This allowed the primary outcomes 
measures of “all injuries”, “training-related injuries” and “time-loss training 
injuries”.  Injury type and anatomical location were also assigned.  Injury 
classification information is displayed in Table 3.1.  Specific criteria of types and 
sites were used to identify injuries that be categorised as medial-tibial stress 
syndrome (MTSS) and knee pain, which typically affect military populations.  Knee 
pain was a grouping of all muscle, tendon cartilage, ligament and other soft tissue 
overuse injuries to the knee, while MTSS encompassed stress fracture, muscle 
strain, tendon, non-fracture bone and soft tissue overuse injuries to the tibia/fibula.  
Recurrent injuries were defined as injuries to the same trainee with the same cause, 
injury type, anatomical site and side of body to a previously sustained injury. 
Injury outcome was split into one of four categories; (i) full return to 
training, (ii) return to training with further injury, (iii) medical discharge and (iv) 
non-medical discharge.  The term “further injury” denoted that another injury of 
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any kind occurred after the injury in question.  These subsequent injuries were then 
marked with an injury outcome.  Severity of injury was measured in training time 
lost per injury.  Training time lost was calculated by the number of days between 
first presentation of the injury and the date of outcome.    
 
3.11.2 Training exposure 
Information on training duration, specifically dates of entry and exit were 
compiled by military staff from British Army databases. Total time in training at 
ITC(C) was calculated by the number of days between the date of entry and the date 
of either completion of training or discharge from training, then subtracting the 
training time lost from injury.  For individuals with multiple injuries, the sum of the 
training days lost for each injury was used.  The sum of each of these gave total 
training exposure in trainee-days. 
 
Table 3.1. Injury type criteria 
Training Injury Cause Injury Type Side Anatomical Site 
     
Yes Acute Fracture Left Lumbar Spine 
No Overuse Stress Fracture Right Pelvis 
  Muscle Strain Bilateral Thigh 
  Bruising  Knee 
  Tendon  Tibia/ Fibula 
  Cartilage  Ankle 
  Ligament  Foot 
  Laceration   
  Blister   
  NFCI   
  Non Fracture Bone   
  Non Specific Soft Tissue   
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3.11.3 Incidence of injury and injury type 
Injury incidence (I) gives the average risk of sustaining one or more injuries 
per trainee in the duration of training. This was calculated by the number of trainees 
injured divided by the total number of trainees at risk.  For injury incidence, 95% 
confidence intervals (CI) were calculated using the following formula: 
ܥܫ = 	ܫ	 ± (1.96	 × 	ܵܧ) 
Where I is incidence and SE is standard error.  
For incidence, standard error was calculated with the following formula: 
	ܵܧ = 		ඨ	ܫ	(1 − ܫ)
݊
 
Where n is the sample size. 
Injury proportion was also calculated for injury type, by taking the number 
of instances of a particular type of injury and dividing by the total number of 
injuries. This was used to establish the proportion of total injuries that each injury 
type and site represented.      
 
3.11.4 Relative risk and odds ratio 
In order to compare injury incidence between groups, relative risk (RR) and 
odds ratio (OR) were calculated from injury incidence in each injury classification 
with non-smokers acting as a control group (CON).  The appropriate values for each 
smoking group were substituted as the exposed group (EXP) in the following 
formulae: 
ܴܴ = 	 ܫா௑௉
ܫ஼ைே
 
Where IEXP and ICON are injury incidence in the exposed and control groups, 
respectively. 
Odds ratio (OR) was calculated by the following formula: 
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ܱܴ = ܫ݆݊ݑݎ݁݀ா௑௉ 	ݔ	ܰ݋ݐ	݆݅݊ݑݎ݁݀஼ைே
ܫ݆݊ݑݎ݁݀஼ைே 	ݔ	ܰ݋ݐ	݆݅݊ݑݎ݁݀ா௑௉
 
 Where Injured is the number injured in the specified group. 
To ensure the lower limits of standard error did not contain negative values, 
for both risk and odds ratio, data were log transformed.  Positive and negative 95% 
confidence limits were calculated on the logarithmic scale and reverse transformed 
(formulae appended (C)).  Relative risk and odds ratio were calculated for training-
related injuries in all trainees as well as in smokers and non-smokers. 
 
3.11.5 Clinical incidence and incidence rate 
As injury incidence does not take into account multiple injuries to the same 
trainee, clinical incidence was also calculated.  Clinical incidence is the number of 
injuries sustained per trainee.  With each injury treated as a separate case, this was 
calculated by the total number of injuries divided by the number of trainees at risk.  
Injury incidence rate was also calculated, which is the incidence of an injury per 
training unit time.  This allows the indication of the average number of injuries that 
would be sustained by a trainee depending on duration of training. This was 
calculated by the total number of injures divided by the exposure time (See 
“training exposure”) and presented as injuries per 1000 trainee-days.  Confidence 
intervals (95%) for both clinical incidence and incidence rate were calculated as for 
injury incidence (above), but for incidence rate the values were multiplied by 1000 
to align with 1000 trainee-days.  Standard error for injury incidence rate and clinical 




Where I is either clinical incidence or incidence rate. 
Injury burden is a measure of the cost in training time elicited by an injury 
per unit time.  It was calculated by multiplying incidence rate by average (mean) 
severity of injury (training days lost per injury).  This gives a value of training days 
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lost per 1000 trainee-days.  Confidence intervals (95%) and standard error for 
burden were calculated as above by replacing incidence with burden values. 
 
3.11.6 Rate ratio 
To compare incidence rate between non-smokers and smokers, rate ratio 
was calculated: 
ܴܽݐ݁	ݎܽݐ݅݋ = ቈܫ݆݊ݑݎ݅݁ݏா௑௉ ܧݔ݌݋ݏݑݎ݁ா௑௉⁄
ܫ݆݊ݑݎ݅݁ݏ஼ைே ܧݔ݌݋ݏݑݎ݁஼ைே⁄
቉ 
Where exposure is the number of trainee-days completed in that group. 
Data were log transformed for standard error and confidence interval calculation, 
and then reverse transformed (formulae appended (C)). Burden was compared by 
replacing the numerator and denominator with the burden of the exposed and 
control group, respectively. 
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Smoking Characteristics of British Army Trainees at 
Entry to Initial Training 
 
4.1 Introduction 
Cigarette smoking is considered to be the greatest preventable contributor to 
severe illness and premature death worldwide (Fagerström 2002; World Health 
Organisation 2004).  It is well established that smoking adversely effects long term 
health; increasing risk of heart disease, chronic obstructive pulmonary diseases, 
cancer and immunological disorders (He et al. 1999; Sopori 2002; Doll et al. 2005; 
Birrell et al. 2008; Taylor 2010).  Additionally, smoking may influence otherwise 
healthy active populations by contributing to reduced physical fitness (Bernaards et 
al. 2003), impaired immune function (Arcavi & Benowitz 2004; Kulkarni et al. 
2010) and increased risk of musculoskeletal injury (Reynolds et al. 1999; Altarac et 
al. 2000; Knapik, Sharp, et al. 2001; Etherington & Owen 2002).  In this context, 
where military populations are encouraged to maintain health and high levels of 
physical fitness, it is particularly noteworthy that previous research has found 
smoking prevalence during military service is typically higher than in the general 
population (Hooper et al. 2008; Dunstan 2010)   
The most recent national report describes smoking prevalence in Britain to 
be 20% following a steady decline from 1998 to 2008 (Dunstan 2010).  Smoking 
prevalence is, however, highly variable depending on age and on socio-economic 
class classified by job type, being highest at 30% in both 25-34 year old males and 
in manual working males (Table 2.1).  In military populations, smoking prevalence 
can vary between trainees and individuals in active service, as well as by country 
and the military organisation (Table 2.3).  In three studies, military trainees during 
basic training have compared more favourably with the general public reporting 
smoking prevalence as low as 6.3% and 22% in United States (US) Air force 
trainees (Chisick et al. 1998; Sherrill-Mittleman et al. 2009) and 24% in Norwegian 
basic training (Heir & Eide 1997).  Contrary to this, Altarac et al. (2000) and 
Klesges et al. (2001) observed higher smoking prevalence in US Army trainees than 
values reported in service (Chisick et al. 1998; Rae Olmsted et al. 2011).  Despite 
considerable variation between individual study populations, it would appear that 
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smoking prevalence in trainees is similar to that of active-duty personnel, though 
still greater than the general population (Table 2.3).   
Additionally, it has remained unclear how military training environments 
affect smoking status. It is possible that in order to attain associated physical fitness 
and health requirements, partaking in military training may either act to reduce 
smoking prevalence or cause smoking cessation prior to entry.   However, it has 
been observed that during military training the proportion of those who take up 
smoking is higher than those who quit (Schei & Søgaard 1994).  As such, the 
military training environment may act to promote tobacco use (Nelson et al. 2009).   
Previous studies describing smoking characteristics have often made the 
classification of smokers limited by questioning solely current smoking status 
(“Yes” or “No”) and average frequency (cigarettes per day).  The distinct 
classification of current regular smokers, from former smokers and non-smokers 
has only been made in a handful of studies.  These distinctions and demonstrating 
the severity of smoking exposure may aid studies in estimating the potential health 
risks of habitual smokers during military training.  At present however, very little 
information is known about the smoking characteristics of trainees prior to joining 
active service in the British Army.  Indeed, the smoking behaviour of trainees at the 
largest training facility in the British Army, Infantry Training Centre, Catterick 
(ITC(C)), has not been investigated.  As such, the aim of this study was to describe 
smoking prevalence at ITC(C) and to give a more comprehensive understanding of 





Participants in this study were a cohort of male infantry trainees (n=2087) 
aged between 18 and 33 years old.      
 
Chapter 4 Study 1 
71 
 
4.2.2 Study design 
The study contained two phases.  First, the military pre-training 
questionnaire (MPQ) was administered to trainees in week 1 of training.  Then, as a 
follow up phase, a shortened version of the MPQ solely containing items related to 
smoking was administered during medical examinations on exit from the course.   
Therefore, trainees who completed the follow up questionnaire will have been in 
one of the following three categories (i) at the completion of training, (ii) those 
discharged as of right or (iii) those being discharged for medical reasons. Of those 
who completed the questionnaire 472 trainees matched those who completed the 
first phase of the study and could be included in the follow up analysis 
 
4.2.3 Data analysis 
Analysis of questionnaire responses was completed on SPSS for Windows 
version 16.0.  Percentage prevalence of current smokers, former smokers and non-
smokers are presented.  Mean number of cigarettes smoked per day and years 
smoked were calculated for regular smokers and ex-smokers.  Smoking exposure in 
pack years was calculated by cigarettes smoked daily divided by 20 (1 pack), 
multiplied by years smoked.  Continuous data or numerical responses to 
questionnaire items are presented as mean (±SD).  For written answers or discrete 
data the mode is presented.  Those who failed to answer all appropriate questions or 





4.3.1 Smoking Prevalence in British Army Trainee Training 
At entry to training, the smoking prevalence of British Army trainees 
whether occasionally or regularly was 53%. Of those, 91% were regular smokers (> 
1 cigarette per day).  Therefore, prevalence of current regular smokers was 48%.  
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Non-smokers and former smokers comprised 37% and 9% of trainees in the study, 
respectively.   Of those who had ever tried smoking a cigarette, the average age for 
the first cigarette was 13 (±6) years old.  
 
4.3.2 Smoking exposure of regular smokers 
The mean (±SD) number of years smoked by regular smokers was 6.0 (±3.3) 
years.  The average number of cigarettes smoked per day was 11.5 (±5.8), with the 
most common responses being 10, 15 and 20 cigarettes per day reported by 32%, 
20% and 11% of smokers, respectively.  This gives an average smoking exposure of 
3.4 pack years. 
 
4.3.3 Characteristics of former smokers 
The mean (±SD) number of years smoked by ex-smokers was 4.3 (±3.1) 
years.  Average cigarette consumption per day was 10.6 (±5.9) with the most 
common response being 10 cigarettes, given by 37% of ex-smokers.  The average 
age for starting smoking regularly was 14.5 (±2.4) years old.  Fifty two percent of 
former smokers stopped smoking more than a year prior to commencing military 
training, while 48% stopped during the year prior to commencing training.  
 
4.3.4 Follow-up 
Follow up data (n=472) showed that over the course of training 398 trainees 
(84%) remained the same smoking status.  In this subsample of 472 trainees at entry 
and exit, respectively, the number of non-smokers was 159 (33.7%) and 141 
(29.9%), regular smokers 251 (53.2%) and 290 (61.4%), former smokers 41 (8.7%) 
and 22 (4.7%), and occasional smokers 21 (4.5%) and 19 (4.0%) (Figure 4.1).   Five 
and seven regular smokers became former and occasional smokers, respectively.  
Twelve and six non-smokers, respectively, became regular and occasional smokers.  
Twenty seven former smokers became smokers, twenty five of which smoking > 1 
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cigarette per day.  Fourteen occasional smokers became regular smokers, and three 
became former smokers. 
In the 239 trainees that smoked regularly at both entry and follow up, 
average years smoked and cigarette smoked per day at entry were 6.3 (±3.3) and 
11.7 (±5.6), respectively.  In this same sample at follow up years smoked rose to 6.5 




Fig 4.1. Percentage of non-smokers (white fill), former smokers (diagonal pattern 
fill), occasional smokers (grey fill) and habitual regular smokers (black fill) in the 
complete data set at entry to initial infantry training (n=2087), and in the sub-





























In male trainees at entry to British Army training, smoking prevalence was 
53% compared to 20% in the British general public (Dunstan 2010).  This supports 
the predominance of research which suggests smoking is more prevalent in those at 
entry to the military than general populations.  In regular smokers the mean and 
mode frequency of 11.5 and 10 cigarettes per day, respectively, shows cigarette 
consumption was similar to the national average of 10.  Data from the current study 
suggest that over half of those entering into British Army training at ITC(C) are 
smokers and approximately 60% either currently smoke or have smoked regularly 
before.  Follow up data suggest smoking consumption rate in regular smokers 
increased during training. 
The overall prevalence of current regular smokers was markedly higher than 
rates recently reported in military service of ~30% (Hooper et al. 2008; Fear et al. 
2010).  This does not agree with the general consensus of research, typically 
observing smoking prevalence in training to be similar to those in military service 
(Klesges et al. 2001; Rae Olmsted et al. 2011).  Even with a high smoking 
prevalence of 51% observed in Norwegian trainees (Heir & Eide 1997), the same 
smoking prevalence was reported in a comparable population of active Norwegian 
Army personnel (Schei & Søgaard 1994).  One study found that, when comparing 
smoking behaviours of trainees and serviceman across all branches of the US 
Military, smoking prevalence was higher in enlisted men than during training in all 
military services (Chisick et al. 1998).  It should be noted, however, that in contrast 
to the British military, at the time of the study and subsequently thereafter smoking 
was not permitted during US basic training which may have altered smoking 
behaviour and reduced smoking prevalence prior to enlistment.   
In contrast to overall prevalence, the average cigarette consumption in 
trainees at ITC(C) was lower than the 15 cigarettes per day average recently 
reported in active duty personnel (Fear et al. 2010).  In reality, however, the rates 
reported by Fear et al. (2010) may be positively biased by the study containing 
personnel during wartime deployment, which has been shown to markedly increase 
cigarette consumption rate (Boos & Croft 2004).  Additionally, some of the 
variation in self-reported smoking behaviour between the current study and 
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previous research may be due to differences in measures of anonymity and the 
personnel administering questionnaires.  Where some studies have used civilian 
researchers (Fear et al. 2010; Rae Olmsted et al. 2011) and others military staff 
(Klesges et al. 2001; Hooper et al. 2008), it may be that there is pressure to alter 
questionnaire responses from true smoking behaviour.  The current study employed 
methods to ensure anonymity but used military staff to administer questionnaires, 
which may be improved by using solely research staff.  Unfortunately, in research 
conducted on large cohorts and within military environments the limitations 
described above can be largely unavoidable, highlighting that drawing externally 
valid conclusions from smoking behaviour should be done with care.     
Smoking prevalence within a population has been shown to be influenced by 
factors such as age and socioeconomic class which may explain the high values 
observed in this population.  Fear et al. (2010) showed in military personnel that 
smoking prevalence was highest in the youngest age group (20-24 years) and in the 
lowest tiers of rank/socioeconomic status and education.  As such, it is unsurprising 
that new trainees at the beginning of training, whose aims are to hold ranks below 
officer, would have a high smoking prevalence.   
Given that previous research has shown discrepancies in smoking behaviour 
when comparing trainees with active duty personnel, it would be valuable to 
ascertain how military training itself might affect smoking prevalence or alterations 
in smoking habits.  In the present study, follow up data showed the number of 
regular smokers increased by 16% during training, while all other groups reduced in 
size.  Additionally, average smoking consumption in habitual smokers at follow-up 
rose by ~2 cigarettes per day, reaching similar values to those described by Fear et 
al. (2010).  Though it would seem reasonable that the promotion of health and 
physical fitness in the military training environment might act to reduce smoking 
prevalence, other factors such as stress relief, camaraderie and easy access to cheap 
tobacco products may promote both the commencement and maintenance of 
tobacco use (Nelson et al. 2009).  A study by Ebbert et al. (2006) suggested that 
previous non-smoking individuals often initiated smoking upon entering the 
military.  Additionally, it has been observed that marketing strategies may directly 
encourage smoking behaviour in this population (Joseph, Muggli, et al. 2005).  In 
agreement with the current study, a large cohort of Norwegian conscripts reported 
Chapter 4 Study 1 
76 
 
55.7% of smokers increasing their smoking behaviour during military service 
(Schei & Søgaard 1994).  This supports occasional and former smokers increasing 
or recommencing cigarette consumption as observed in the present study.  
Ultimately however, data from the present study indicate that although regular 
smoking prevalence increased, the majority of those partaking in British infantry 
initial training did not alter smoking status, with 84% of trainees remaining in the 
same smoking classification.  This suggests military training may be most 
influential on the habits of those already smoking habitually.  
This study aimed to describe the current smoking behaviour of British Army 
trainees entering ITC(C).  The strategies used in the study for maintaining security 
and anonymity, and the prior testing of the questionnaire for reliability and validity 
provides confidence that this data accurately represent the smoking behaviour of 
this population.  Smoking prevalence is higher than the British general public and of 
those previously described in similar military populations.  Despite their youth, data 
from this study provides evidence that in some cases the cumulative smoking 
exposure in military trainees may be substantial.  Follow up data shows that 
although regular smoking prevalence increased, undertaking military training did 
not markedly affect smoking status for the majority of trainees.  However, the 
military training environment may have some effect on encouraging regular 
smokers to increase daily consumption, and for occasional and former smokers to 
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The Influence of Smoking Status on Markers of 
Oxidative Stress, Inflammation and Hormone 




It is well established that smoking has adverse effects on health and can 
limit physical fitness.  The development of health and physical fitness of trainees 
undertaking initial military training is imperative for effective entry into the armed 
forces.  Despite this, regular smoking prevalence in a cohort of trainees in the 
British infantry (48%; Chapter 4) is higher than in the general population (29% 
males in 20-24 year age group in UK (Robinson & Bugler 2008) and reported rates 
for those already in service (30%; Fear et al. 2010).  Interestingly, in military 
training where there is a high incidence of injury- and physical performance- related 
drop out (Blacker et al. 2005), smoking has been the most widely identified 
independent risk factor for injury (Reynolds et al. 1999; Altarac et al. 2000; Knapik, 
Sharp, et al. 2001; Etherington & Owen 2002) and linked to poorer training 
outcomes (Marti et al. 1988).  However, the difference between the physiological 
state of smokers and their non-smoking counterparts in this population has not been 
examined.  Although there is evidence that smoking could influence health and 
training outcomes even in a young, relatively active population, the mechanisms 
responsible remain under-researched.  
Chronic cigarette smoking is influential in the development of many chronic 
diseases (Cross et al. 1998; Tanriverdi et al. 2006) as well as impaired wound 
healing (Sherwin & Gastwirth 1990) and increased risk of infection (Arcavi & 
Benowitz 2004).  The possible pathogenesis of such disorders has been attributed to 
the physiological status of smokers when compared to non-smokers, typically 
characterised by chronic elevations in oxidative stress (Reilly et al. 1996) and 
systemic inflammation (Andelid et al. 2007) and alterations in endocrine (Steptoe & 
Ussher 2006) and immune function (Kulkarni et al. 2010).   
Free radicals, produced in the constituents of cigarettes and tobacco smoke, 
induce oxidative stress in smokers (Pryor 1997) and have been associated in the 
Chapter 5 Study 2 
79 
 
chronic smoking-induced rise in systemic inflammation.  Urinary markers of 
oxidative stress increase in response to cigarette smoking (Pilz et al. 2000; 
Helmersson et al. 2005; Basu et al. 2009) and are elevated at rest in habitual 
smokers (Reilly et al. 1996; Helmersson et al. 2005).  Chronic low-grade 
inflammation, indicated by persistent increases in serum interleukin (IL) -6 and the 
acute phase protein CRP (C-Reactive Protein), has been reported in middle aged 
long term smokers (Bazzano et al. 2003; Jang et al. 2007; Levitzky et al. 2008) and 
even in a young, otherwise healthy smoking population (O’Loughlin et al. 2008).  
Importantly, while transient rises can be beneficial as part of an adaptive and/or 
homeostatic process, chronic elevations in both oxidative stress and IL-6 have been 
observed to have maladaptive effects on muscle (Andrade et al. 2001; Visser et al. 
2002), protein break down (Goodman 1994; Yamada, Mishima, et al. 2006) and 
increase susceptibility of cells to oxidative damage (Shin et al. 2007).   
Both smoking and elevated inflammatory cytokine production have also 
been reported to influence the secretion of various hormones.  The presence of 
nicotinic binding sites in the hypothalamus (Kellar et al. 1999) has been implicated 
as a mechanism by which smoking, via corticotrophin releasing hormone and 
adrenocorticotrophic hormone, might result in increased cortisol secretion from the 
adrenal gland (Steptoe & Ussher 2006).  Insulin-like growth factor (IGF) -1 and its 
associated binding proteins are reduced in habitual smokers and correlate with 
cigarettes smoked daily (Renehan et al. 2004).  Increases in circulating IL-6 
concentrations have also been associated with reduced circulating levels of IGF-1 
(De Benedetti et al. 1997; Joseph, Kenny, et al. 2005) and increased circulating 
cortisol concentrations (Steensberg et al. 2003).  Research into the effect of 
smoking on testosterone has demonstrated increased, decreased or unchanged 
concentrations when compared to those in non-smokers (Field et al. 1994; Harman 
et al. 2001; Svartberg et al. 2003; Richthoff et al. 2008).  Some authors have 
hypothesised that basal concentrations of circulating hormones, by contributing to 
the mediation of physiological and metabolic processes, may have implications on 
long-term health, growth and development, and physical recovery during 
consecutive days of exercise training (Kraemer et al. 1998; Kraemer et al. 1999; 
Nindl, Barnes, et al. 2007; Nindl et al. 2011).  
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Research into the adverse effects of smoking on health has predominantly 
studied long term smokers (≥10 years of smoking) who were middle-aged or older 
(≥40 years of age).  In the context of the present study, the military trainee 
population is much younger.  However, a large proportion of the British Army 
training population could have accumulated close to 6 years of regular tobacco 
exposure prior to training (Chapter 4).  As such, it is possible that poorer training 
outcomes in smokers during military training are a result of an impaired 
physiological adaptation to exercise training possibly mediated by differences in 
basal oxidative stress, and inflammatory and endocrine status.  Additionally, 
physiological responses may be proportional to the magnitude of smoking exposure. 
Therefore, within a sample of trainees at entry to British Army infantry 
training we investigated the hypothesis that smokers would exhibit increased 
markers of oxidative stress and systemic inflammation, and altered hormone 
concentrations compared with non-smokers.  Additionally, it was anticipated that a 
dose-response relationship would exist whereby subgroups with greater cigarette 





One hundred and ten male British Army line infantry trainees (age 20.2 ± 3 
yr; mass 74.1 ± 9.8kg, height 1.78 ± 0.07 m) gave written informed consent to take 
part in the study.  Trainees were all from platoons from the same divisional 
company.   
 
5.2.2 Study design 
This study is a single time-point independent group comparison.  In week 1 
of training, resting blood samples, anthropometric data and smoking status (via 
lifestyle questionnaire) were collected.  Blood samples were taken upon waking 
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(0500-0600) and participants abstained from smoking or consuming food or drink 
in the morning until after blood samples had been collected.  On the evening of the 
same day as blood sample collection, body mass, height, waist circumference, 
estimated body fat percentage and lung function were measured.  
 
5.2.3 Blood chemistry analysis 
 Serum was analysed for concentrations of malondialdehyde (MDA), lipid 
hydroperoxides (LOOH), CRP, IL-6, testosterone, IGF-1, cortisol and alanine 
transaminase (ALT) activity.  A full blood count was also completed.  Blood 
biochemistry was compared between non-smokers and current smokers as well as 
subgroups of current smokers based on reported number of cigarettes smoked per 
day (light, moderate and heavy smokers).   
 
5.2.4 Statistical analysis 
Power calculations were performed using G*Power 3.0.  A medium effect 
size (g=0.5) was expected between groups; meaning a sample size of 104 was 
required in order to achieve a statistical power of 0.8.  Effect sizes were calculated 
for biochemical variables in smoking/non-smoker comparisons using the Hedge’s G 
(g) pooled standard deviation method, where small, medium and large effect sizes 
are defined as 0.3, 0.5 and 0.8, respectively.  Statistical analyses were performed 
using SPSS software (SPSS for Windows: Version 16.0).  Normality tests (Shapiro 
Wilk) were performed on all biochemical and blood count variables to determine 
whether data were normally distributed.  To detect statistical differences between 
smokers and non-smokers, independent t-tests were performed in cases when data 
were normally distributed; and independent samples Kruskal-Wallis tests when data 
were non-normally distributed.  To compare the four independent smoking 
subgroups (NS, LS, MS and HS) a one-way unpaired analysis of variance 
(ANOVA) was performed on all biochemical, anthropometric and lung function 
data to determine statistical differences between groups.  It is established that when 
analysing physiological data an ANOVA is robust to skews to the mean (Maxwell 
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& Delaney, 1990) so normality test results were disregarded for subgroup analysis.  
Post-hoc analysis with Ryan-Holm Bonferroni Stepwise adjustment (Atkinson 
2002) was used to determine the location of variance in the event of a significant 
effect of smoking status.  An alpha level of p≤0.05 was used to define the statistical 
significance of within- or between- participant effects.  Greenhouse Geisser 
ANOVA outputs were used in cases where Mauchley’s test of sphericity showed 
data to be aspherical.  Population characteristics are presented as mean ±SD.  Data 
analysed by independent t-test and ANOVA are presented as mean ±SE.  Data 





The sample was made up of 65 smokers and 45 non-smokers.  Smokers 
consumed a mean (±SD) of 11.8 (±5.6) cigarettes per day for an average of 6.3 
(±3.8) years. Of the smokers, light, moderate and heavy smoking groups comprised 
17, 35 and 13 participants, respectively.  Participant characteristics and 
anthropometric data organised by group are displayed in Table 5.1.  Independent t-
test results showed no significant differences (p>0.05) between smokers and non-
smokers in age, body mass, height, body fat percentage or waist circumference.  
Similarly, ANOVA showed no significant differences (p>0.05) between the four 
smoking subgroups.  
 
5.3.2 Oxidative stress markers: smokers versus non-smokers 
Mean serum MDA was significantly higher in smokers (2.09 (±0.08)) than 
non-smokers (1.72 (±0.08)) nmol⋅mL-1 and demonstrated a moderate effect size of 
smoking (p=0.001; g=0.63). No significant difference existed in mean serum LOOH 
concentrations between non-smokers (1.58 (±0.08)) and smokers (1.48 (±0.06)) 
(p=0.353; g=0.19) μmol⋅L-1.  




5.3.3 Inflammatory and endocrine markers: smokers versus non-smokers 
We observed no significant differences in inflammatory markers between 
smokers and non-smokers (p>0.05).  Serum concentration of CRP (Median (IQR)) 
was 0.9 (1.3) mg⋅L-1 among smokers compared to 0.7 (1.3) mg⋅L-1 in non-smokers 
(p=0.116; g=0.18).  Median serum concentrations of IL-6 was 1.3 (1.9) pg⋅mL-1 in 
non-smokers and 1.2 (1.3) pg⋅mL-1 in smokers (p=0.556; g=0.29).  Median serum 
ALT in non-smokers and smokers was 18.0 (±14) U⋅L-1 and 18.5 0 (±8.3) U⋅L-1, 
respectively (p=0.545; g=0.10).   
Among non-smokers, mean serum IGF-1 was 284 (±10) ng⋅mL-1 compared 
to 268 (±9) ng⋅mL-1 in smokers.  Serum testosterone concentrations (Median (IQR)) 
in non-smokers and smokers were 10.1 (5.4) and 10.4 (3.7) ng⋅mL-1, respectively.  
We observed median serum cortisol of 729 (472) nmol⋅L-1 in non-smokers and 663 
(281) nmol⋅L-1 in smokers.  No significant differences existed between groups in 
IGF-1 (p=0.276; g=0.22), testosterone (p=0.201; g=0.25) or cortisol (p=0.183; 
g=0.32).   
 
5.3.4 Oxidative stress markers: non-smokers versus smoking subgroups 
Mean serum MDA concentrations for light (2.09 (±0.10)), moderate (2.05 
(±0.12)) and heavy smokers (2.18 (±0.20)) nmol⋅mL-1 were significantly higher 
than those observed in non-smokers (1.72 (±0.08)) nmol⋅mL-1 (p=0.02; Figure 5.1: 
A).  MDA concentrations in smoking subgroups were not significantly different 
from one another (p>0.05).  There were no significant differences in serum 
concentrations of LOOH between non-smokers (1.58 (±0.08)), and light (1.46 
(±0.12)), moderate (1.51 (±0.09)) and heavy smoking groups (1.44 (±0.15)) μmol⋅L-
1 (p=0.771; Figure 5.1: B). 
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5.3.5 Inflammatory and endocrine Markers: non-smokers versus smoking 
subgroups  
No significant differences were noted between smoking subgroups in 
inflammatory markers.  Mean serum CRP concentrations for non-, light, moderate 
and heavy smokers were 1.2 (±0.3), 1.5 (±0.3), 1.4 (±0.3) and 2.2 (±1.1) mg⋅L-1, 
respectively, and are presented in panel A of Figure 5.2 (p=0.452).  Mean serum IL-
6 concentrations for non-smokers, light, moderate and heavy smokers were 1.9 
(±0.3), 1.4 (±0.2), 1.7 (±0.2) and 1.2 (±0.2) pg⋅mL-1, respectively (p=0.303; Figure 
4.2: B).  Mean serum ALT activity was 22.3 (±1.5), 21.2 (±2.4), 22.5 (±2.7) and 
17.4 (±2.5) U⋅L-1, for non-, light, moderate and heavy smoking groups, respectively 
(p=0.581; Figure 5.3). 
Similarly, hormone concentrations did not significantly differ between 
subgroups. For non-smokers, light, moderate and heavy smokers mean 
concentrations of IGF-1 were 283 (±10), 265 (±21), 268 (±11) and 272 (±21) 
ng⋅mL-1, respectively (p=0.746; Figure 5.4).  Mean serum concentrations of 
testosterone for were 9.7 (±0.5), 9.5 (±0.5), 10.7 (±0.6) and 11.7 (±0.9) ng⋅mL-1 for 
non-smokers, light, moderate and heavy smokers, respectively (p=0.190, Figure 5.5: 
A).  Cortisol concentrations for non-smokers, light, moderate and heavy smokers 
were 787 (±43), 616 (±46), 729 (±43) and 751 (±60) nmol⋅L-1, respectively 
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Table 5.1. Participant characteristics by group 
  Smoking Status 
Variable  Non-smokers (n=45)  Smokers (n=65) 





21 ± 4 
20 ± 3 
20 ± 2 
20 ± 3 





77.5 ± 10.1 
74.5 ± 9.1 
72.5 ± 5.8 
74.9 ± 8.9 





1.80 ± 0.08 
1.78 ± 0.06 
1.77 ± 0.05 
1.78 ± 0.06 





15.4 ± 2.8 
15.7 ± 3.9 
13.9 ± 2.5 
15.3 ± 3.4 
Waist circumference 





79.4 ± 7.5 
79.6 ± 6.7 
78.0 ± 3.9 
79.2 ± 6.4 
LS (n=17): Light smokers (1-9 cigarettes per day), MS (n=35): Moderate smokers 
(10-19 cigarettes per day), HS (n=13): Heavy smokers (≥20 cigarettes per day). 
Data presented are mean ± SD 
 
5.3.6 Full blood count analysis 
Owing to differences in individual sample volume, blood count data for 17 
participants were incomplete and were not used in analysis.  The subsequent 
changes in n accompany the full blood count results in Table 5.2.   
Plasma white blood cell and platelet count; haemoglobin; haematocrit; and 
populations of neutrophils, lymphocytes, monocytes, eosinophils and basophils 
were similar between smokers and non-smokers (p>0.05) (Table 5.2).  Mean red 
blood cell count was significantly higher (p=0.04) in non-smokers (5.17 ± 0.17 
1012⋅L-1) than smokers (5.04 ± 0.04 1012⋅L-1).  Median mean-corpuscular volume 
(MCV) (median (IQR)) was significantly higher (p=0.01) in smokers (84.2 (5.7) fl) 
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compared to non-smokers (82.5 (3.7) fl) and mean average mean corpuscular 
haemoglobin (MCH) (mean±SE) was higher (p=0.042) among smokers (30.2 ± 0.2 
pg) than non-smokers (29.7 ± 1.0 pg).    
ANOVA identified a significant difference between two or more subgroups 
in MCV (p=0.02) (Table appended (D)).  Post hoc analysis revealed that MCV in 
moderate smokers (84.7 ± 0.7 fl) was significantly higher than in non-smokers (82.5 
± 3.4 fl).   
 
5.3.7 Lung function  
One non-smoking participant was unable to take part in spirometry owing to 
an illness meaning the total N for lung function parameters is reduced to 109.  In 
lung function variables independent t-tests showed no significant differences 
existed between non-smokers and smokers in mean (±SD) FEV1 (4.2 (±0.6) vs. 4.2 
(±0.5) L), FVC (4.8 (±0.8) vs. 4.8 (±0.6) L) and PEF (504 (±98) vs. 501 (±115) 
L.min-1) (p>0.05).  Kruskal-Wallis test showed that median (IQR) FER was similar 
between non-smokers (88 (13)%) and smokers (87 (9)%) (p>0.05).  Similarly, 
ANOVA indicated that no significant differences were present between smoking 
subgroups in lung function parameters (p>0.05).   
 
 





Fig 5.1. Comparison of mean serum concentrations of markers of oxidative stress 
MDA (A; nmol⋅mL-1) and LOOH (B; μmol⋅L-1) between non-, light, moderate and 
heavy smokers.  Data are presented as means with standard error bars.  *Significant 
effect of overall smoking status (p=0.001; g=0.63). #Significant difference between 
smoking subgroup and non-smoking group (p<0.05).  


















































# # # 
A 
B 

























Fig 5.2. Comparison of mean serum concentrations of markers of inflammation 
CRP (A; mg⋅L-1) and IL-6 (B; pg⋅mL-1) determined by immunoassay between non-, 
light, moderate and heavy smokers.  Data are presented as means with standard 
error bars.  No significant differences were present between smoking subgroups in 
CRP (p=0.452) or IL-6 (p=0.303). 
 














































Fig 5.3. Comparison of mean serum activity of ALT (U⋅L-1) determined between 
non-, light, moderate and heavy smokers. Graph displays data as group means with 
standard error bars.  No significant differences were present between smoking 
groups in ALT (p=0.581). 
Smoking Group

























Fig 5.4. Comparison of mean serum concentration of IGF-1 (ng⋅mL-1) determined 
by immunoassay between non-, light, moderate and heavy smokers. Graph displays 
data as group means with standard error bars.  No significant differences were 
present between smoking groups in IGF-1 (p=0.746). 































Fig 5.5. Comparison of mean serum concentration of testosterone (A; ng⋅mL-1) and 
cortisol (B; nmol⋅L-1) determined by immunoassay between non-, light, moderate 
and heavy smokers. Data are presented as means with standard error bars. No 
significant differences were present between smoking groups in testosterone 
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Table 5.2. Full blood count data organised by smokers and non-smokers. 








NS (n=36)  S (n=57) 
(HB) 
Haemoglobin 
(g/dl)   
Mean (SE)  13-18 
 
15.3 ( ±0.2)  15.2 (± 0.1) 
WBC (10^9/l)  Median (IQR)  4-11.0  7.9 (2.6)  8.3 (2.4) 
(PLT) Platelets 
(10^9/l)  
Median (IQR)  150-400 
 
258 (68)  259 (73) 
RBC (10^12/l)  Mean (SE)  4.5-6.5  5.2 (±0.1)*  5.0 (± 0.0) 
(HCT) 
haematocrit (%)   
Median (IQR)  0.40-0.54 
 
0.43 (0.03)  0.43 (0.03) 
(MCV) Mean 
corpuscular 
volume (fl)  
Median (IQR)  78-98 
 





Mean (SE)  27.5-32.5 
 
29.7( ±0.2)  30.2 (± 0.2) † 
Neutrophils 
(109⋅L-1)  Median (IQR)  2-7.5 
 3.8 (1.7)  4.1 (1.9) 
Lymphocytes 
(109⋅L-1)  Median (IQR)  1.5-4.0 
 2.8 (0.8)  2.6 (0.9) 
Monocytes 
(109⋅L-1)  Median (IQR)  0.2-0.8 
 0.7 (0.2)  0.7 (0.3) 
Eosinophils 
(109⋅L-1)  Median (IQR)  0.0-0.4 
 0.2 (0.2)  0.2 (0.2) 
Basophils (%)   Median (IQR)    0.0-0.2  0.0 (1.1)  0 (1.1) 
Note: Values are either Mean (Standard Error) or Median (Inter-quartile range) indicated by 
the “measure of central tendency” column. * indicates RBC count is significantly higher in 
NS than S (p=0.04).  † indicates MCV and MCH is significantly higher in S than NS 













The current study made two comparisons in a sample of trainees entering 
infantry training in the British Army.  Firstly, resting hormone concentrations and 
markers of inflammation and oxidative stress were examined in smokers and non-
smokers.  Secondly, smokers were grouped by cigarette consumption and compared 
to non-smokers.  It was expected that oxidative stress, endocrine and inflammatory 
markers at entry to training would differ between smokers and non-smokers and 
differences would intensify with cigarette consumption, subsequently giving some 
indication as to the chronic effect of smoking on this population.  The main finding 
of the study was that habitual smokers exhibited significantly higher markers of 
chronic oxidative stress than non-smokers, and that this was evident in each 
smoking subgroup. There were, however, no significant differences between 
smokers and non-smokers in endocrine and inflammatory markers at entry to 
training.  Additionally, it appears no differences existed in oxidative stress or other 
biochemical markers as a result of greater habitual smoking exposure. 
The current study showed serum concentration of oxidative stress marker 
malondialdehyde (MDA), but not lipid hydroperoxide (LOOH), was significantly 
higher in smokers and smoking sub-groups than in non-smokers (p<0.05).  Owing 
to greater stability than LOOH, MDA is typically utilised to demonstrate long term 
or chronic states of oxidative stress (Del Rio et al. 2005), whereas an elevation in 
highly-reactive hydroperoxides would indicate more recent acute oxidative 
processes (Davison, Hughes & Bell 2005; Fogarty et al. 2011).  As such, the present 
study agrees with previous observations of an elevated resting state of oxidative 
stress in habitual smokers (Reilly et al. 1996; Tanriverdi et al. 2006; Taylor, Bruno 
& Traber 2008).  Acute markers of oxidative stress rise as an immediate response to 
smoking (Morrow et al. 1995).  As blood samples in the present study were taken 
upon waking following overnight abstinence from smoking, this is likely to explain 
similar LOOH levels between groups.  Subgroups organised by increasing cigarette 
consumption exhibited similar MDA levels to one another, offering little evidence 
for the existence of a dose-response relationship between smoking and oxidative 
stress.  Despite several authors reporting an association between oxidative stress, 
hormonal and immune-inflammatory response (Conner & Grisham 1996; van der 
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Vaart et al. 2004; Federico et al. 2007), the present study gives no clear indication 
of an effect of elevated oxidative stress on other biochemical markers in smokers. 
Interleukin-6, alongside a cascade of inflammatory mediators, stimulates the 
production of CRP (Heinrich et al. 1990).  As such, no difference in IL-6 
concentration between smokers and non-smokers (p=0.556) is likely to be 
responsible for similar CRP levels between groups.  This is contrary to numerous 
population- and laboratory- based studies demonstrating CRP (Bazzano et al. 2003; 
Jang et al. 2007; Sunyer et al. 2009) and IL-6 (Levitzky et al. 2008; Sunyer et al. 
2009) to be significantly raised in smokers.    This finding is more surprising given 
the elevation in oxidative stress observed in the current sample. However, research 
in the inflammatory response to smoking predominantly focuses on middle aged or 
elderly long term smokers, presenting the cumulative effect of long term smoking 
combined with the rise in inflammation associated with age (Ershler & Keller 2000; 
Krabbe et al. 2004; Dixon et al. 2009).  We are only aware of one study that 
reported a chronic elevation in CRP in an otherwise-healthy smoking adolescent 
population, using a large sample population (O’Loughlin et al., 2008; N=1501).  
The current sample represents individuals with substantially lower life-time 
smoking exposure meaning changes in levels in inflammation may not have 
developed, possibly explaining the failure for smokers to present significantly 
elevated inflammation despite greater oxidative stress. 
Smoking-induced inflammation and health outcomes have been observed to 
be substantially greater in heavy smoking groups (≥20 cigarettes per day) (Byron, 
Varigos & Wootton 1994; Bernaards et al. 2003).  As CRP levels in smoking 
subgroups did not significantly differ from non-smokers (p=0.452), magnitude of 
cigarette consumption appeared to elicit no effect on increasing basal CRP.  
Although, it should be noted that all smoking groups, especially that of the heavy 
smoking group, exhibited higher CRP values than non-smokers.  The small effect of 
smoking on CRP (g=0.18) and standard error observed within the heavy smoking 
group suggest individual variability may have reduced the ability to recognise an 
influence of smoking on CRP.  When alanine transaminase, an enzyme associated 
with liver function, is elevated it is often accompanied by elevated circulatory CRP, 
likely due to a shared source such as liver damage.  However, ALT did not differ 
significantly between groups (p=0.581) and was within normative range for healthy 
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individuals (Giannini, Testa & Savarino 2005), providing support that inflammatory 
markers in the present study were not affected by liver health. 
Both IGF-1 and cortisol can be mediated by smoking-induced increases in 
circulating IL-6 (Lieskovska et al. 2002; Steensberg et al. 2003; Joseph, Kenny, et 
al. 2005) and the indirect actions of nicotine on hormone release (Kellar et al. 1999; 
Steptoe & Ussher 2006).  In the current study, similar IL-6 levels in all groups may 
explain unaffected IGF-1 and cortisol in smokers, but also suggests that the effect of 
nicotine was negligible, possibly due to overnight smoking abstinence.  Though the 
consensus of research suggests the presence of IGF-1 and circulating binding 
proteins (Kaklamani et al. 1999; Holmes et al. 2002) are reduced in smokers in a 
dose-response manner (Renehan et al. 2004), evidence exists in support of current 
findings, for no measurable difference from non-smokers (Palmer et al. 2003).  The 
above studies examined older populations than the current study, and the 
relationship between IGF-1 and age has been shown to be non-linear and contain 
considerable variation (Renehan, O’Dwyer & Shalet 2000; Juul 2003).  As such, 
like inflammation, if an exposure-related reduction in IGF-1 from smoking exists in 
some populations it may not be easily discernible given the youth and duration of 
smoking exposure in the current population.  It is noteworthy that some authors 
have suggested that smoking, irrespective of circulating concentration, may still 
affect the function  of IGF-1 in glucose homeostasis and bone metabolism (Yakar et 
al. 2001; Juul 2003), with possible negative implications for long-term exercise 
training. 
Several studies have examined testosterone concentrations in smokers, with 
some reporting greater (Gray et al. 1991; Field et al. 1994; Svartberg et al. 2003; 
Svartberg & Jorde 2007), others reporting lesser (Zmuda et al. 1997), and others 
reporting no measureable difference when compared to non-smokers (Harman et al. 
2001; Richthoff et al. 2008), in agreement with the current study.  Some of the 
uncertainty in the area appears to be explained by assay variability and how 
smoking may influence bioavailability of testosterone.  Theoretically, testosterone 
bioavailability is reduced by the presence of sex hormone binding globulin (SHBG), 
which although only measured in a handful of studies, is elevated in smokers (Field 
et al. 1994; English et al. 2001; Svartberg et al. 2003).  As such, smoking may 
solely influence the bioavailable proportion of testosterone and not total 
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testosterone concentration as measured in the present study.  Additionally, smoking 
may affect overall daily secretion of testosterone and cortisol.  If this were the case, 
the circadian rhythm of these hormones, peaking in the early morning and reaching 
a nadir in the early evening, means that timing of blood sampling could be a 
confounding factor (Kapoor & Jones 2005). 
Associations between long term smoking and haematological factors have 
been widely established (Corre, Lellouch & Schwartz 1971; Helman & Rubenstein 
1975; Bain et al. 1992).  Similar to the current study, two such studies found mean 
corpuscular haemoglobin (MCH) and mean corpuscular volume (MCV) to be 
elevated in smokers (Mercelina-Roumans, Ubachs & Van Wersch 1994; Kung, 
Wang & Tseng 2008).  Interestingly, red blood cell count was significantly higher 
in non-smokers than smokers overall. This may suggest that smoking may decrease 
red blood cell count but increase the size and oxygen carrying capacity of the less 
abundant individual cells.  Research to date has not identified the mechanisms 
concerned but it is possible this is an adaptation to excess carbon monoxide 
inhalation from smoking.  Given the importance of oxygen carrying capacity of the 
blood on endurance performance, this may have implications on physical fitness in 
smokers (Bassett & Howley 2000).  In contrast, lung function did not differ as a 
result of smoking, or greater smoking exposure. This may further indicate that 
typical adverse effects of smoking may not have progressed given the relative youth 
of sample compared to populations used in previous research.  
This study was the first to measure oxidative stress and inflammatory and 
hormonal factors at entry to British Army infantry training and attempt to elucidate 
a chronic influence of smoking on this population.  In agreement with previous 
research an indicator of chronic oxidative stress was significantly higher in 
smokers.  However, chronic differences in inflammatory markers or hormone 
concentrations between smokers and non-smokers, or a dose-response to smoking 
were not evident.  Therefore, from the current findings there is no evidence of an 
influence of a chronic state of oxidative stress in habitual smokers on the other 
processes examined.  If causal mechanisms were to exist that underpin the 
association of smoking with injury risk and reduced physical fitness observed in 
epidemiological data using similar populations, they are not highlighted by the 
current study.  Considerable variation in CRP concentrations, especially in heavy 
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smokers, could potentially have obscured inferential measures of the influence of 
smoking in this sample.  Equally, given that in adolescence and young adulthood 
the effects of smoking could be considered reversible by cessation, as evidenced in 
a reduction in markers of oxidative stress following two weeks of cessation in 
smokers (Morrow et al. 1995), the chronic negative effects of smoking may be 
lessened in healthy, young individuals, only becoming evident later in life.  
Differences in these biochemical markers may be more discernible in the presence 
of training stimuli, and thereby influence injury risk and adaptation or recovery in 
smokers during training itself.  
 
  











CHAPTER 6  
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The Influence of Smoking Status on Physical 
Performance Adaptation and Markers of Oxidative 
Stress, Inflammation and Endocrine Status during 10 
Weeks of Military Training 
 
6.1 Introduction 
Initial military training is an intense process of physical fitness development 
involving arduous and often unaccustomed exercise.  In the British Army, Infantry 
training is reported to have the second lowest first-time pass rate (Carter et al, 2006) 
and the highest medical discharge rate (Blacker et al. 2008) of all training 
regiments.  Given the high incidence of smoking in this population (48%: Chapter 
4), it is particularly relevant that long term smoking prior to military training is 
associated with higher risk of training-related injury and poorer training outcomes 
(Marti et al. 1988; Reynolds et al. 1999; Altarac et al. 2000; Knapik, Sharp, et al. 
2001).  Evidence exists for lower physical fitness (Boyce et al. 2006) and reduced 
performance in strength tasks (Al-Obaidi et al. 2004) in habitual smokers.  
However, it is unclear whether smoking negatively impacts the development of 
physical fitness.  We are only aware of one study that has examined this, reporting 
that improvement in performance in an Army prescribed strength and endurance 
test after a six month physical fitness programme was significantly smaller in 
trainees who smoked (Hoad & Clay 1992).   
Chronic disruptions of oxidative stress (Reilly et al. 1996; Cross et al. 1998; 
Isik et al. 2007), inflammation (Andelid et al. 2007) and hormones (Steptoe & 
Ussher 2006) observed in smokers might be possible mechanisms for attenuated 
adaptation to exercise training.  At entry to British infantry training, smokers 
exhibited a significantly elevated resting state of oxidative stress compared to non-
smokers, but levels of several endocrine and inflammatory markers were similar 
(Chapter 5).  It is not known how these markers might alter during a period of 
training and how this might influence improvement in physical performance. 
Smoking causes local and circulatory accumulation of oxidants, or reactive 
oxygen species (ROS), which can cause damage to cellular membranes (Comporti 
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et al. 2008) and DNA (Nair et al. 1996) by lipid and protein peroxidation.  In 
muscle, transient production of ROS are obligatory for optimal skeletal muscle 
function  (Reid et al. 1993) and invoke signalling pathways beneficial for adaptation 
and cell regeneration (Jackson et al. 2002; McArdle et al. 2002; Close et al. 2005; 
Jackson 2005).  However, continual elevation of ROS in muscle restricts 
modulation of redox balance, causes oxidative damage to myosin heavy chains 
(Coirault et al. 2007) and can exacerbate development of muscle damage following 
exercise (Close et al. 2007).   
Smoking-induced oxidative stress is also implicated in the chronic low-
grade inflammation observed in middle-aged (Bazzano et al. 2003; Jang et al. 2007; 
Levitzky et al. 2008), and young, otherwise healthy smoking populations 
(O’Loughlin et al. 2008).  Chronically elevation of the inflammatory cytokine 
interleukin(IL)-6 has been reported, in animal and human models, to have a 
maladaptive effect on muscle size (De Benedetti et al. 1997; Visser et al. 2002), 
protein break down (Goodman 1994; Tidball 2005) and increase susceptibility of 
cells to oxidative damage (Shin et al. 2007).  Equally, prolonged elevated 
endogenous levels of  C-reactive protein (CRP), stimulated by IL-6, closely 
correlates with loss of muscle mass (De Benedetti et al. 1997; Schaap et al. 2006) 
and is inversely proportional to estimated maximal oxygen uptake (Kuo et al. 2007).  
As such, it is proposed that a chronic elevation in these markers in a habitual 
smoking population might reflect disruption of pro-adaptive responses to long-term 
exercise training. 
 Total and bioavailable concentrations of hormones are also influenced by 
smoking and IL-6, reducing circulating insulin-like growth factor (IGF)-1 (Renehan 
et al. 2004; Joseph, Kenny, et al. 2005; O’Connor et al. 2008) and stimulating 
secretion of cortisol (Kirschbaum et al. 1992; Field et al. 1994; Steptoe & Ussher 
2006; Badrick et al. 2007; Steensberg et al. 2003).  IGF-1 plays a role in local 
signalling for hypertrophy of skeletal muscle (Adams & McCue 1998; Rommel et 
al. 2001; Bassel-Duby & Olson 2006) as well as glucose regulation (Yakar et al. 
2001).  Research into the effect of smoking on testosterone has demonstrated higher 
(Gray et al. 1991; Field et al. 1994; Svartberg et al. 2003), lower (Zmuda et al. 
1997) and similar (Harman et al. 2001; Richthoff et al. 2008) concentrations when 
compared to non-smokers.  Examining adaptations in these markers alongside 
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physical performance during military training, and identifying whether these differ 
between smokers and non-smokers, may help to explain any influence of smoking 
on the training response in this population. 
The aim of this study was to investigate whether training would elicit 
different changes in resting markers of oxidative stress, systemic inflammation and 
hormone concentrations in smokers compared to non-smokers.  Physical 
performance variables and lower leg muscle characteristics were also examined to 
determine whether performance improvement and adaptation differed between 





Sixty five male British Army line infantry trainees (age 21 ± 3 yr; mass 75.5 
± 8.4 kg; height 1.78 ± 0.07 m) took part in the study.   
 
6.2.2 Study design 
Smoking status was determined using lifestyle questionnaire at entry to 
training and at weeks 5 and 10.  Blood samples were taken upon waking (0500-
0600) in trainee accommodation lines early in weeks 1, 5 and 10 of training. 
Performance in physical tasks, lung function tests, anthropometric data and lower 
leg muscular characteristics were measured at weeks 1 and 10.  Military fitness test 
performance was also collected at weeks 1 and 14.  An overtraining questionnaire 
was also administered at weeks 1, 5 and 10 to all participants. 
 
6.2.3 Blood chemistry analysis 
 Serum was analysed for concentrations of malondialdehyde (MDA), lipid 
hydroperoxides (LOOH), CRP, IL-6, testosterone, IGF-1, cortisol, myoglobin, 
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creatine kinase and alanine transaminase (ALT) activity. A full blood count was 
also completed.  Blood biochemistry was compared between non-smokers and 
subgroups of current smokers based on reported number of cigarettes smoked per 
day (light, moderate and heavy smokers).   
 
6.2.4 Anthropometric measurements and physical performance testing 
On the evening of the same day as blood sample collection body mass, 
height, estimated body fat, waist circumference and lower leg muscular 
characteristics were measured.  Maximum strength performance in chest press, 
seated row, leg press, static lift exercises was measured alongside jump height. 
Owing to injury some participants did not complete every test within each stage of 
physical performance data collection and were therefore excluded from the analysis 
for that exercise test across all weeks.  The differing group n is detailed in 
associated results tables. These variables were compared solely between non-
smokers and current regular smokers. 
 
6.2.5 Statistical analysis 
Statistical analyses were performed using SPSS software (SPSS for 
Windows: Version 16.0).  Initially, an independent t-test was performed on baseline 
anthropometric data to test for any initial differences between groups.  As the study 
design is a repeated measures independent group comparison with one unpaired 
(smoking) and one paired (time) independent variable all biochemical and 
performance variables were analysed by two-way mixed model analysis of variance 
(ANOVA).  Post-hoc analysis with bonferroni adjustment was used to determine the 
location of variance in the event of a significant interaction or training effect when 
analysing more than two time points or groups.  Tests for normality were not 
performed as it is established that when analysing physiological data an ANOVA is 
robust to skews to the mean (Maxwell & Delaney, 1990). An alpha level of p≤0.05 
was used for defining the statistical significance of within- or between- participant 
effects.  Greenhouse Geisser ANOVA outputs were used in cases where 
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Mauchley’s test of sphericity showed data to be aspherical.  Population 
characteristics are presented mean ±SD.  Unless otherwise stated, all data are 





The sample was made up of 24 non-smokers and 41 smokers.  Smoking 
characteristics (mean (±SD)) at entry to training for participants in the smoking 
group were an average of 12.7 (±6.0) cigarettes per day for 7.2 (±4.5) years (4.5 
pack years).  Of the smokers, light, moderate and heavy smoking groups comprised 
9, 20 and 12 participants, respectively.  Sufficient data for anthropometric and 
performance measures were present for forty six trainees (22 non-smokers, 24 
smokers).  
 
6.3.2 Anthropometric data  
Body mass did not differ between non-smokers and smokers or over time 
(p>0.05).  Irrespective of group, height (p<0.001), estimated body fat percentage 
(p<0.001) and waist circumference (p=0.04) significantly decreased from baseline 
over 10 weeks of training.  No significant differences or interaction effects existed 
between non-smokers and smokers in any anthropometric variable (Table 6.1).  
 
6.3.3 Physical performance data  
ANOVA showed that there were no significant effects of smoking status, 
irrespective of time, on performance in physical tasks over 10 weeks of training 
(p>0.05; Table 6.2).  Irrespective of group, performance in static lift (p<0.001), 
bench press (p=0.004) and leg press (p<0.001) improved significantly from baseline 
as a result of training.  Additionally, ANOVA identified a significant interaction 
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effect in bench press performance (p=0.031) whereby smokers improved 
substantially more than non-smokers as a result of training.     
 
6.3.4 Army physical fitness tests 
Training produced a significant improvement in press up, sit up and 2.4 km 
run performance over 14 weeks irrespective of group (p<0.001).  Additionally, a 
trend that approached significance existed in run performance, whereby 
improvement in non-smokers was greater than in smokers over the 14 weeks 
(p=0.067). No significant differences existed between smoking and non-smoking 
groups in British Army physical fitness test variables (Table 6.3).   
 
Table 6.1. Anthropometric characteristics across training weeks organised by group 
(NS, n=22; S, n=24). Values are means ± SD 
    Week of training 
Variable   Smoking Status  1  10 
Height (m)* 
 NS  1.77 ± 0.08  1.77 ± 0.08 
 S  1.79 ± 0.07  1.79 ± 0.07 
Mass (kg) 
 NS  74.9 ± 9.3  75.4 ± 8.5 
 S  77.6 ± 7.3  77.1 ± 6.2 
Body Fat (%)*  NS  15.7 ± 4.2  14.7 ± .35 




 NS  79.3 ± 6.0  78.7 ± 4.6 
 
S  81.6 ± 5.9  79.3 ± 4.2 
Note: * denotes a significant effect of training (p≤0.05) irrespective of group.  
 
 
6.3.5 Lower leg characteristics (Peripheral Quantitative Computed Tomography) 
No significant interaction or smoking status effects existed in any lower leg 
characteristic (p>0.05; Table 6.4).  Between weeks 1 and 10, irrespective of group, 
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mean muscle area (p<0.001) total density of muscle and fat (p<0.001) significantly 
increased, while fat/muscle area ratio decreased (p=0.012).  No training effects 
existed in fat area (p=0.126) or mean muscle density (p=0.545)  
 
6.3.6 Lung function 
Owing to illness causing several individuals to be unable to complete the 
tests, full data from spirometry were only available for 21 non-smokers and 24 
smokers (Table 6.5).  Irrespective of group, training induced a significant increase 
from baseline in forced expiratory ratio (p<0.001) and peak expiratory flow 
(p=0.035), but a decrease in forced vital capacity (p<0.001).  Forced expiratory 
ratio was significantly higher in non-smokers than smokers (p=0.029).  No 




Mean (±SD) scores on the overtraining questionnaire for weeks 1, 5 and 10 
for non-smokers were 7.1 (±6.6), 12.8 (±9.6) and 10.7 (±8.3) respectively, and 6.9 
(±5.8), 14.7 (±8.0) and 12.3 (±9.4), respectively for smokers.  At no point did group 
averages fall within the range of indicating overtraining.  ANOVA indicated that 
irrespective of group a training effect existed (p<0.001).  Post hoc analysis showed 
that all time points were significantly distinct from one another whereby week 10 
values were higher than week 1, and week 5 significantly higher than week 10.  No 
smoking status or interaction effects existed (p>0.05).  Cumulative symptoms of 
overtraining were more common in non-smokers than smokers across the 10 weeks 
of training.   
 
6.3.8 Oxidative stress markers 
Serum MDA was significantly higher in smokers (p=0.026) than non-
smokers, independent of time (Figure 6.1; Panel A).  In subgroup analysis of MDA 
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concentrations, no significant interaction or group effects existed (p>0.05) at weeks 
1, 5 and 10 between non-smokers, light, moderate or heavy smokers (Figure 6.1; 
Panel B). In both analyses values in week 10 were significantly lower than week 1 
(p<0.05), irrespective of group. 
Serum LOOH at weeks 1, 5 and 10 for non-smokers (1.70 (±0.14); 1.53 
(±0.13); 1.56 (±0.11) μmol⋅L-1) and smokers (1.50 (±0.09); 1.43 (±0.08); 1.38 
(0.08) μmol⋅L-1) were not significantly different irrespective of time, and no 
interaction or training effects existed (p>0.05).  In subgroup analysis, LOOH at 
weeks 1, 5 and 10 contained no significant group, interaction or training effects 
(p>0.05; Figure 6.2).   
 
6.3.9 Inflammatory markers 
Independent of time, serum CRP concentrations at weeks 1, 5 and 10 were 
significantly higher in smokers (1.80 (±0.38); 3.44 (±0.60); 2.93 (±0.55) mg⋅L-1) 
than non-smokers (1.51 (±0.43); 2.22 (±0.45); 1.49 (±0.30) mg⋅L-1) (p=0.047; 
Figure 6.3).  In both groups serum CRP peaked in week 5 before declining by week 
10, but only non-smokers returned to near pre-training levels.  Serum CRP 
concentrations in subgroups did not significantly differ as a result of smoking status 
(p>0.05; Figure 6.3). In both analyses of CRP no interaction or training effects 
existed (p>0.05). 
No significant group, interaction or training effects existed in serum IL-6 
concentrations when comparing non-smokers (1.85 (±0.33); 1.82 (±0.41); 1.41 
(±0.20) pg⋅mL-1) and smokers (1.44 (±0.15); 1.97 (±0.30); 1.79 (±0.26) pg⋅mL-1), or 
between smoking subgroups (p>0.05; Figure 6.4). 
Serum ALT activity for weeks 1, 5 and 10 for non-smokers (26.5 (±2.5); 
34.0 (±3.8); 26.3 (±2.2) U⋅L-1) and smokers (19.7 (±1.4); 28.7 (±1.6); 24.4 (±2.4) 
U⋅L-1) did not significantly differ irrespective of time (p>0.05).  Similarly, subgroup 
analysis reported no significant interaction or group effects (p>0.05).  In both 
analyses a significant training effect existed whereby week 5 values were 
significantly different from those at weeks 1 and 10 (p<0.05; Figure 6.5). 
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Table 6.2. Physical performance characteristics across training weeks organised by group. Values are means ± SD.  







      Week of training 
Variable Type  Variable  Smoking Status (n)  1  10 
 
Max Strength  Static Lift (kg)*  NS (22)  149.4 ± 24.5  159.8 ± 28.2 
  S (24)  154.1 ± 23.8  169.7 ± 31.8 
 Bench Press (kg)*†  NS (22)  72.2 ± 12.3  72.8 ± 12.9 
  S (24)  69.1 ± 8.9  72.8 ± 6.8 
 Leg Press (kg)*  NS (21)  181.9 ± 28.2  201.3 ± 29.0 
  S (24)  189.5 ± 30.0  209.8 ± 22.6 
 Seated Row (kg)  NS (22)  70.9 ± 8.4  70.1 ± 9.1 
  S (24)  71.1 ± 7.2  71.7 ± 6.3 
 Grip Right (kg)  NS (22)  48.0 ± 5.2  48.3 ± 4.8 
  S (23)  48.0 ± 5.2  50.1 ± 5.5 
 Grip Left (kg)  NS (22)  47.8 ± 7.1  47.0 ± 6.2 
  S (24)  48.1 ± 6.8  49.3 ± 5.5 
Explosive power  Jump (cm)  NS (21)  33.5 ± 5.4  35.1 ± 6.3 
  S (24)  34.4 ± 4.6  33.8 ± 3.6 
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Note:  *denotes a significant effect of training (p≤0.05) irrespective of group. † signifies a non-significant interaction trend (p=0.067)  







Note:  * denotes a significant effect of training (p≤0.05) irrespective of group
    Week of training 
Physical Fitness Variable  Smoking Status (n)  1  14 
Press ups*  NS (20)  49.5 ± 14.8  62.0 ± 13.6 
 S (21)  47.0 ± 16.0  61.3 ± 9.2 
Sit ups*  NS (20)  61.8 ± 16.1  70.1 ± 11.6 
 S (21)  55.0 ± 9.3  67.9 ± 8.5 
Run time (min:sec)* †  NS (19)  10:08 ± 00:59  9:26 ± 00:38 
 S (21)  10:07 ± 00:46  9:48 ± 00:32 
    Week of training 
Variable  Smoking Status  1  10 
Muscle Area (mm2)*  NS  8110 ± 895  8510 ± 1023 
 S  8354 ± 766  8698 ± 779 
Fat Area (mm2)  NS  1753 ± 631  1646 ± 496 
 S  1857 ± 584  1791 ± 576 
Fat/Muscle Area Ratio (%)*  NS  22.0 ± 8.8  19.9 ± 7.4 
 S  22.3 ± 7.0  20.7 ± 7.0 
Muscle Density (mg.cm-3)  NS  75.7 ± 2.2  75.9 ± 1.5 
  S  75.9 ± 1.0  76.1 ± 1.6 
Total Density (mg.cm-3)*  NS 
 66.5 ± 4.6  67.2 ± 3.6 
 S  65.8 ± 4.3  66.7 ± 3.8 
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Table 6.5. Lung function parameters across training weeks organised by group. 
Values are means ± SD. 
Note:*  denotes a significant effect of training (p≤0.05) irrespective of group.  # 
signifies a significant effect of smoking status (p≤0.05) 
 
 
6.3.10 Endocrine markers 
Serum testosterone concentrations for weeks 1, 5 and 10 for non-smokers 
were 10.62 (±0.68), 10.53 (±0.58) and 11.40 (±0.59) ng⋅mL-1, respectively and 
11.27 (±0.57), 10.39 (±0.62) and 11.10 (±0.62) ng⋅mL-1, respectively, for smokers.  
No statistically significant effects were found (p>0.05).  Testosterone 
concentrations for weeks 1, 5 and 10 for subgroups were not significantly different 
irrespective of time, and contained no significant interaction effect (p>0.05). 
Subgroup analysis did reveal a significant effect of training (p=0.03) whereby 
irrespective of group, week 5 values were lower than those of weeks 1 and 10 
(Figure 6.6; Panel A). 
Cortisol concentrations for weeks 1, 5 and 10 for non-smokers were 145 
(±7), 144 (±4) and 131 (±6) ng⋅mL-1, respectively and 143 (±7), 149 (±6) and 136 
(±8) ng⋅mL-1, respectively, for smokers.  Cortisol concentrations for subgroups are 
presented in Figure 6.6 (Panel B).  Both comparisons contained a significant 
training effect from reduction between week 5 and week 10 (p<0.05), but no 
significant interaction or group effects were present (p>0.05). 
    Week of training 
Lung Function 
Variable  Smoking Status (n)  1  10 
FEV1 (L)  NS (21)  4.2 ± 0.6  4.1 ± 0.7 
 S (24)  4.2 ± 0.4  4.2 ± 0.4 
FVC (L)*  NS (21)  4.7 ± 0.9  4.5 ± 1.0 
 S (24)  5.1 ± 0.5  4.7 ± 0.5 
FER (%)*#  NS (21)  88.5 ± 7.3  92.2 ± 8.4 
 S (24)  83.5 ± 5.0  88.8 ± 6.6 
PEF (mL-1)*  NS (20)  529 ± 104  560 ± 105 
  S (24)  487 ± 116  528 ± 80 
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Serum IGF-1 concentrations for weeks 1, 5 and 10 for non-smokers were 
270 (±14), 249 (±10) and 264 (±14) ng⋅mL-1, respectively and 267 (±12), 242 (±11) 
and 242 (±10) ng⋅mL-1, respectively, for smokers.  Serum IGF-1 concentrations for 
non-smokers, light, moderate and heavy smokers are presented in Figure 6.7.  In 
both analyses, irrespective of group, IGF-1 significantly decreased from baseline to 
week 5 (p<0.01).  No significant interaction or group effects were found (p>0.05).   
 
5.3.11 Intramuscular proteins and enzymes 
Mean values (±SE) for myoglobin in weeks 1, 5 and 10 were 57.3 (±5.8), 
89.3 (±12.4) and 73.6 (±8.2) ng⋅mL-1 for non-smokers (n=22), and 49.6 (±3.8), 69.7 
(±4.7) and 55.0 (±1.9) ng⋅mL-1 for smokers (n=23), respectively.  No significant 
interaction or group effects existed (p>0.05), but a significant effect of training was 
present (p<0.001).  Post hoc analyses showed significant differences between all 
time points irrespective of group.  For both groups, myoglobin peaked in week 5 
and then decreased in week 10 to values between those measured in weeks 1 and 5.  
In non-smokers, baseline values were similar to those of week 5 in smokers. 
Mean values (±SE) for creatine kinase in weeks 1, 5 and 10 were 200 ± 29, 
407 ± 45 and 350 ± 47 U⋅L-1 for non-smokers (n=21), and 252 ± 69, 395 ± 38 and 
232 ± 22 U⋅L-1 for smokers (n=24), respectively.  Creatine kinase followed a similar 
pattern to myoglobin across time points; peaking in week 5.  Statistical analysis 
showed a significant effect of training (p<0.001) irrespective of group.  Post hoc 
analyses demonstrated the training effect comprised significant differences between 
weeks 1 and 5, and between weeks 5 and 10.  No other significant interaction or 










Fig 6.1. Mean serum concentration of MDA (nmol⋅mL-1) across weeks 1, 5 and 10 
of training. A: Groups NS (Open triangle) and S (Closed circle). B: Groups NS 
(Open triangle), LS (Open circle), MS (Closed triangle) and HS (Closed circle).  
Values are means with standard error bars.  #and parentheses denote significant 




















































Fig 6.2. Mean serum concentration of LOOL (μmol⋅L-1) in groups NS (Open 
triangle), LS (Open circle), MS (Closed triangle) and HS (Closed circle) across 




6.3.12 Full blood count  
The population of neutrophils was shown to be significantly greater in 
smokers irrespective of training (p=0.035).  ANOVA showed that a significant 
training effect (p<0.05) was present in all haematological factors over training 
weeks with the exception of populations of neutrophils and eosinophils.  Full blood 































Fig 6.3. Mean serum concentration of CRP (mg⋅L-1) across weeks 1, 5 and 10 of 
training. A: Groups NS (Open triangle) and S (Closed circle). B: Groups NS (Open 
triangle), LS (Open circle), MS (Closed triangle) and HS (Closed circle).  Values 
are means with standard error bars.  #and parentheses denote significant effect of 














































Fig 6.4. Mean serum concentration of IL-6 (pg⋅mL-1) between groups NS (Open 
triangle), LS (Open circle), MS (Closed triangle) and HS (Closed circle) across 
weeks 1, 5 and 10 of training.  Values are means with standard error bars.   
 
Fig 6.5. Mean serum ALT activity (U⋅L-1) between groups NS (Open triangle), LS 
(Open circle), MS (Closed triangle) and HS (Closed circle) across weeks 1, 5 and 
10 of training.  Values are means with standard error bars.  *and parentheses denote 














































Fig 6.6. Comparison of mean serum concentration of testosterone (A; ng⋅mL-1) and 
cortisol (B; ng⋅mL-1; NS, n=23; S, n=40) determined by immunoassay between 
groups NS (Open triangle), LS (Open circle), MS (Closed triangle) and HS (Closed 
circle) across weeks 1, 5 and 10 of training.  Data are presented as means with 
























































Fig 6.7. Mean serum concentration of IGF-1 (ng⋅mL-1) between groups NS (Open 
triangle), LS (Open circle), MS (Closed triangle) and HS (Closed circle) across 



























Note:  * denotes a significant effect of training (p≤0.05) # signifies a significant effect of smoking status (p≤0.05). 
      Week of training 
Variable  Smoking Status  Normal Range  1  5  10 
(HB) Haemoglobin (g.dL-1)*  NS 
 
13-18  15.5 ± 0.3  14.5 ± 1.0  14.8 ± 0.2 
 S   15.1 ± 0.2  14.6 ± 0.1  14.5 ± 0.2 
WBC (109⋅L-1)  NS 
 
4-11.0  7.92 ± 0.47  7.33 ± 0.47  7.39 ± 0.38 
 S   8.42 ± 0.33  8.96 ± 0.67  8.18 ± 0.42 
(PLT) Platelets (109⋅L-1)*  NS 
 
150-400  247 ± 13  280 ± 12  270 ± 10 
 S   263 ± 13  324 ± 24   297 ± 14 
RBC (1012⋅L-1)*  NS 
 
4.5-6.5  5.2 ± 0.1  4.9 ± 0.1  5.0 ± 0.1 
 S   5.0 ± 0.1  4.9 ± 0.1  4.9 ± 0.1 
(HCT) haematocrit (%)*  NS 
 
0.40-0.54  0.43 ± 0.01  0.41 ± 0.01  0.43 ± 0.01 
 S   0.43 ± 0.00  0.42 ± 0.00  0.42 ± 0.00 
(MCV) Mean corpuscular volume (fl)*  NS 
 
78-98  82.9 ± 0.6  84.1 ± 0.8  85.0 ± 0.9 
 S   85.5 ± 0.8  86.0 ± 0.8  85.9 ± 0.8 
(MCH) Mean corpuscular haemoglobin 
(pg)* 
 NS  27.5-32.5  29.9 ± 0.3  29.6 ± 0.3  29.4 ± 0.3 
 S   30.4 ± 0.3  30.1 ± 0.3  29.6 ± 0.3 
Neutrophils (109⋅L-1)#  NS 
 
2-7.5  3.86 ± 0.37  3.85 ± 0.38  3.63 ± 0.26 
 S   4.44 ± 0.26  5.31 ± 0.60  4.57 ± 0.38 
Lymphocytes (109⋅L-1)*  NS 
 
1.5-4.0  3.01 ± 0.28  2.48 ± 0.22  2.85 ± 0.26 
 S   2.85 ± 0.16  2.49 ± 0.14  2.60 ± 0.16 
Monocytes (109⋅L-1)*  NS 
 
0.2-0.8  0.61 ± 0.04  0.61 ± 0.04  0.52 ± 0.03 
 S   0.70 ± 0.05  0.76 ± 0.06  0.62 ± 0.05 
Eosinophils (109⋅L-1)  NS 
 
0.0-0.4  0.24 ± 0.03  0.21 ± 0.02  0.09 ± 0.02 
 S   0.26 ± 0.03  0.24 ± 0.02  0.26 ± 0.02 
Basophils (%)*  NS 
 
0.0-0.2  0.65 ± 0.16  0.15 ± 0.11  0.28 ± 0.15 
 S   0.41 ± 0.13  0.26 ± 0.10  0.23 ± 0.10 
Table 6.6. Full blood count data. Populations of cell types across training weeks organised by smoking status (NS, n=17; S, n=20). Data are 
means ± SE 




The current study was designed to examine differences in physical 
performance, muscular adaptation, oxidative stress, inflammatory markers and 
hormones between smokers and non-smokers in response to 10 weeks of military 
training.  Further to this, smokers were separated into subgroups classified by 
cigarette consumption to examine whether a dose-response existed in these 
biochemical markers during training.  The main findings of the study were that 
performance improvement and muscular adaptation were evident as a result of 
military training irrespective of group, but adaptations in most physical 
performance parameters were not different between smokers and non-smokers.  
There was, however, a non-significant trend for improvement in run time to be 
greater in non-smokers.  Concentrations of the oxidative stress marker MDA and 
the acute phase protein CRP were significantly higher in smokers irrespective of 
time.  Smoking status imparted no significant effect on resting concentrations of the 
other measured endocrine or inflammatory parameters and the existence of a dose-
response to smoking in biochemical markers was not supported. 
Compared to non-smokers, habitual smokers are reported to have reduced 
physical fitness (Hirsch et al. 1985; Bernaards et al. 2003; Kobayashi et al. 2004) 
and impaired run performance in military training (Marti et al. 1988; Haddock et al. 
2007).  However, only one study has examined changes in physical performance in 
response to a standardised training programme in smokers and non-smokers, 
demonstrating significantly impaired adaptation in smokers over 6 months of Army 
officer cadet training (Hoad & Clay 1992).  In contrast, the current study observed 
little effect of habitual smoking on improvement in performance variables.  A trend 
for non-smokers to have greater improvement in run performance was observed but 
was not significant (p=0.067).  In comparison to the above study, the duration of the 
current study is shorter, which alongside differences in training environment and 
training itself, might explain why similar findings were not observed.  In light of 
this, however, it is possible that if the trend for impaired improvement in run 
performance continued over the entire 26 week training course, the difference 
between habitual smokers and non-smokers might increase.  Bench press 
performance showed greater improvement in smokers than non-smokers, but this 
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could be a product of some individuals partaking in recreational weight training, 
given the absence of upper body maximal strength training in the military course. 
As expected, military training elicited muscular adaptation in the lower leg.  
The observed increase in muscle area and decrease in fat-to-muscle ratio were 
concurrent with whole body anthropometric data, which indicated an overall 
increase in lean mass.  These findings demonstrate changes expected as a result of 
endurance training (Williams 2005).  Additionally, a novel finding of the study was 
that height decreased during training, which could be a function of extended periods 
involving heavy load carriage.  The study rationale proposed that habitual smoking 
may impair muscle cell signalling and recovery from exercise, potentially causing 
less pronounced muscular hypertrophy from training in smokers.  Muscle 
characteristics, unlike performance variables, could not be confounded by fatigue or 
lethargy and given adaptations in smokers and non-smokers were similar, provide 
little evidence for an influence of smoking on muscle adaptation to training. 
Malondialdehyde (MDA), a marker of oxidative stress, was significantly 
higher in smokers than non-smokers, irrespective of training.  As MDA is a 
relatively stable end-product of lipid peroxidation, its elevation is considered to be 
associated with long-term oxidative stress (Del Rio et al. 2005).  Typically, 
circulatory markers of oxidative stress are chronically elevated in habitual smokers 
in comparison to non-smokers (Reilly et al. 1996; Helmersson et al. 2005; 
Tanriverdi et al. 2006; Isik et al. 2007), in agreement with the present study and the 
previous chapter.  Some authors have suggested that in muscle an upper limit for 
oxidative stress exists (Andrade et al. 2001), above which the beneficial effects of 
redox signalling on muscular contractility and adaptation to exercise are disrupted 
(Andrade et al. 1998; Andrade et al. 2001; Close et al. 2005; Yamada, Mishima, et 
al. 2006).  If a circulatory elevation in ROS influences local accumulation of 
oxidants then the pro-adaptive process to exercise training may be disrupted in 
smokers.  The current study suggests, however, that chronically elevated circulatory 
ROS did not impart this effect, as performance improvements and muscular 
adaptations were similar in smokers and non-smokers.  Conversely, lipid 
hydroperoxides (LOOH), typically associated with short-term increases in oxidative 
stress, were similar in smokers and non-smokers.  However, as acute markers of 
oxidative stress rise in response to smoking an individual cigarette (Morrow et al. 
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1995), this finding may be explained by overnight cessation from smoking in the 
present study, prior to collecting blood samples.  
An elevation of MDA alone over time suggests that habitual smoking 
increases lipid peroxidation via oxidative stress, with potential implications for 
increased systemic inflammation (Van der Vaart et al. 2004).  Equally, it has also 
been postulated that a chronic state of low-grade inflammation, like that reported 
previously in smokers (Bazzano et al. 2003; O’Loughlin et al. 2008), may serve to 
increase oxidative stress by increased phagocytic production of ROS as part of host 
defence (Cross et al. 1998).  In our previous study, no significant differences were 
found in CRP between smokers and non-smokers at entry to training, despite the 
existence of elevated resting MDA.  In the current study, CRP levels in both groups 
were also similar at baseline but became distinct at weeks 5 and 10, suggesting that 
military training evokes an increase in resting inflammation, and that this is greater 
in habitual smokers.  At weeks 5 and 10 smokers exhibited concentrations of CRP 
greater than or close to 3 mg⋅L-1, which is higher than is expected for a group of this 
age and activity level (Woloshin & Schwartz 2005). These results suggest that 
military training elicited an inflammatory response which was exacerbated or 
persisted above normal due to the presence of elevated oxidative stress in smokers.   
Elevated CRP in the circulation of smokers in the absence of elevated IL-6 
could be explained by two hypotheses.  First, in a chronic inflammatory state, the 
two markers can be elevated independently of one another (Dixon et al. 2009), 
though underlying mechanisms have not been elucidated.  Oxidative stress, and 
associated oxidative damage, could potentially provide a stimulus for CRP 
remaining in circulation without the stimulation of IL-6 (Van der Vaart et al. 2004; 
Helmersson et al. 2005; Yanbaeva et al. 2007).  However, MDA decreased between 
weeks 1 and 10, which is a different time-course from CRP, possibly indicating the 
changes in these markers are not responsible for one another.  Second, observed 
CRP concentrations could indicate acute inflammatory responses to training stimuli. 
As CRP possesses a longer half-life than IL-6, it could be present in circulation 
longer after initial stimulation from IL-6 (Heinrich et al. 1990).  This notion would 
also correspond with similar CRP levels in smokers and non-smokers at baseline, 
before training commenced.  Factors associated with military training environments 
may incite acute inflammatory responses, such as reduced sleep duration (Booth et 
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al. 2006), high incidence of minor infections (Blacker et al. 2005) and intense or 
unaccustomed exercise training.  In either case, the findings suggest that there is a 
greater tendency for inflammation in habitual smokers than non-smokers in 
response to the factors described above, or that smoking itself incites substantial 
daily inflammatory responses when combined with training.   
Although long term exercise training results in antioxidant-like processes 
(Gomez-Cabrera, Domenech & Viña 2008) and a decrease in CRP levels over time 
(Plaisance & Grandjean 2006; Wilund 2007), it is unknown whether elevated CRP 
and MDA indicate a state that would be detrimental to physical fitness 
development.  Given current findings, the elevated levels of MDA and CRP in 
smokers over 10 weeks of training could only have potentially influenced 
endurance exercise.  As discussed earlier, oxidative stress can have local inhibitory 
effects on muscle function (Andrade et al. 1998; Moopanar & Allen 2005), 
potentially accelerating muscular fatigue (Morse et al. 2007; Wüst et al. 2008).  
This may be particularly relevant when comparatively greater increases in oxidative 
stress in response to graded treadmill running have been observed in young smokers 
(Bloomer et al. 2007).  Oxidative stress in smokers may affect performance in 
endurance exercise that cumulatively influences long term improvement in 
performance.  A distinct lack of research into the effect of chronically elevated CRP 
on muscular or cardiorespiratory development means it is unclear how it may have 
influenced the adaptive response to military training.  
The days prior to blood sampling in week 5 contained more arduous training 
than those for week 1 or week 10, which was reflected in significant decreases in 
testosterone and IGF-1, increases in ALT and markers potentially indicating muscle 
damage, and peaks in CRP and cortisol.  The changes in these markers are similar 
to those observed in frequent periods of energy deficit, intense physical activity and 
low sleep quality during military training (Nindl et al. 2003; Booth et al. 2006; 
Nindl, Barnes, et al. 2007; Kyröläinen et al. 2008; Tyyskä et al. 2010). Previously, 
both short and long term military training have resulted in hormonal changes 
tending towards an ostensibly catabolic state, presenting decreased concentration 
and bioavailability of IGF-1, while increasing circulating cortisol (Nindl et al. 2003; 
Tanskanen, Uusitalo, et al. 2011).  Currently, the exact role of hormones in 
regulation of muscle mass and long-term exercise adaptation are participant to great 
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debate (Urhausen, Gabriel & Kindermann 1995; Izquierdo et al. 2006; Spangenburg 
et al. 2008; West et al. 2009). However, changes in resting hormone concentrations 
are likely to be reflective of recent periods of intense training and therefore might 
be useful in future as indicators of the effectiveness of adaptation following that 
period of training. 
Hormone concentrations were not different in smokers versus non-smokers, 
or as a result of greater smoking exposure.  Previous research in habitual smokers 
consistently demonstrates increased blood or salivary cortisol concentrations 
(Kirschbaum et al. 1992; Field et al. 1994; Steptoe & Ussher 2006) and decreased 
endogenous IGF-1 (Holmes et al. 2002; Renehan et al. 2004), while the effects on 
testosterone have presented mixed results (Zmuda et al. 1997; English et al. 2001; 
Svartberg & Jorde 2007; Richthoff et al. 2008).  However, no studies have 
measured the effects of training on resting hormone concentrations within smokers 
and non-smokers.  It is possible that smoking does not affect waking concentrations 
of hormones, but overall secretion, secretion at specific times of the day, or acutely 
following exercise.  As such, the collection of blood samples only at waking may 
have limited the observation of any influence of smoking on hormones that follow a 
circadian rhythm.  Additionally, the effect of smoking on IGF-1 and testosterone 
may be manifest within the production of transport proteins and subsequent 
bioavailability as opposed to total concentration (Kaklamani et al. 1999; Steptoe & 
Ussher 2006).   
An extended period of exercise training would ordinarily improve lung 
function variables.  As a result of training, forced expiratory ratio and peak 
expiratory flow increased significantly, irrespective of group.  Forced vital capacity, 
however, decreased.  Additionally, the adverse effect of smoking is typically 
evident on all lung function variables, but only forced expiratory ratio was affected, 
indicating that smoking did not substantially influence lung function.  Neutrophil 
population was significantly increased in smokers over training duration (p<0.05), 
in agreement with the purported up-regulation of these cells first in lung tissue and 
subsequently in the circulation in response to smoking (Taylor, 2010).  This further 
supports that smoking did not have as substantial effect as expected on immune 
response and lung health, potentially due to the youth and activity level of the 
population.    
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The present study contained several factors that may have influenced the 
effect of smoking on development of physical fitness and on examined biochemical 
markers.  It is apparent that 10 weeks of training may not be long enough to identify 
differing responses to exercise training between smoking groups.  Additionally, it 
may be that positive changes in physical fitness imparted by military training are 
substantial enough to mask what small adverse effects smoking may have on 
physical fitness development.  Similarly, it should be noted that the original sample 
size in this study was 107 and reduced to a sample of 46 owing to drop out from 
military training from injury, unacceptable physical performance, military discharge 
or participant choice.  As such, it may be that the sample is unintentionally biased 
towards those who have adapted more positively to training.   
Physical performance improvement was evident irrespective of group across 
training weeks and was indicative of military-type tasks such as load-bearing 
marches.  No effects of habitual smoking on muscular adaptation parameters or 
physical performance measures were apparent with the exception of a non-
significant trend for greater run time improvement in non-smokers.  Elevated 
oxidative stress in smokers may have exacerbated inflammatory responses to 
military training, demonstrated by elevated CRP.  However, it is impossible to 
establish causality, and it is likely that the complex interplay of inflammation and 
oxidative stress during training cannot be fully understood from the current 
findings.  Aside from MDA and CRP, other inflammatory markers and hormones 
which were expected to be altered in smokers were found to be similar to non-
smokers.  Given that overall fitness did not differ between smokers and non-
smokers, this may indicate that the relative youth and limited years of smoking 
exposure of participants could explain smokers not exhibiting different performance 
adaptation and endocrine and inflammatory markers from non-smokers.  Habitual 
smoking appears to have a profound effect on chronically elevating oxidative stress 
and, during training, exacerbating inflammation, but neither process appears to 
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The Influence of Smoking on Military Physical Fitness 
Test Performance during Initial Training 
 
7.1 Introduction 
Smoking prevalence in military populations is typically greater than that of 
the general population (Chapter 4; Fear et al. 2010).  Epidemiological evidence 
exists indicating habitual smoking is associated with lower physical fitness 
(Bernaards et al. 2003; Kobayashi et al. 2004) and performance in strength tasks 
(Al-Obaidi et al. 2004).  In a military setting, regular smoking has been reported to 
be predictive of lower physical fitness at entry to training (Haddock et al. 2007), to 
adversely affect athletic performance during training (Zadoo et al. 1993) and to 
result in poorer training outcomes (Marti et al. 1988).  Lower physical fitness in 
habitual smokers at entry to training could be explained, in part, by smokers also 
typically having lower physical activity and participation in exercise compared to 
non-smokers (Larsson & Orlander 1984; Larson et al. 2007).  Once in prolonged 
standardised training, however, little evidence exists as to whether habitual smoking 
directly affects the development of physical fitness.   
Improvement in physical performance over a six month officer training 
programme was significantly greater in non-smokers when compared to habitual 
smokers (Hoad & Clay 1992).  Contrary to this, similar research studying British 
infantry trainees found no significant differences between smokers and non-
smokers in muscular adaptation or improvement in physical performance tests 
during 14 weeks of training (Chapter 6). It was noted, however, that trends existed 
for smaller improvement in run performance in smokers that may lead to poorer 
training outcomes over a greater training duration. To date, no further research has 
been completed to further test this hypothesis. 
Military training, with long-duration standardised training programmes, 
regular physical fitness testing and high levels of physical activity, is a suitable 
platform for testing development of physical fitness in a large sample.  
Additionally, the relatively high prevalence of smoking in this population gives an 
opportunity to study the effect of smoking on long term training.  As such, this 
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study aims to explore whether habitual smoking impairs improvement in 
performance of military physical fitness tests during 24 weeks of initial training in a 





A cohort of male British infantry trainees (n=2087) took part in this study. 
  
7.2.2 Study design 
Performance in routine military fitness tests at weeks 1, 14 and 24 were 
collected for trainees who completed a military pre-training questionnaire to 
determine smoking status and self-reported physical activity level prior to entry to 
training. Two analyses were completed using 1) all trainees observed and 2) all 
trainees who completed training with physical performance data at each time point. 
 
7.2.3 Physical performance test data 
Military fitness tests consisted of press ups and sit ups when allowing 2 
minutes for each exercise, and a best effort 2.4 km run.     
As expected over the 24 week course, substantial drop out occurred causing 
each time point to include fewer participants.  Additionally, owing to circumstances 
such as injury or illness some participants did not complete every test within each 
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7.2.4 Statistical analysis 
Statistical analyses were completed using PASW 18.0 for Windows (SPSS 
Inc, Chicago, Illinois).  A linear mixed model (LMM) was used to identify any 
significant differences between non-smokers and smokers in the full data set and 
significant effects of time or interaction.  LMM has been shown to be an 
appropriate statistical test to account for missing data.  A first order auto-regressive 
structure (AR(1)) was chosen to model variance, which assumes that values will be 
less correlated with one another if further apart in time.  This structure produced the 
lowest Akaike Information Criterion, demonstrating the most appropriate goodness 
of fit for the data.  Physical activity score for each participant was entered in the 
linear mixed model as a covariate.  The LMM used all observations in all time 
points to model the relationship over time and produce estimated marginal means 
for each variable for weeks 1, 14 and 24.  A two-way mixed model ANOVA was 
used to identify significant group, time or interaction effects when only including 
those who reached the end of training. Post-hoc analysis with stepwise bonferroni 
adjustment was used to determine the location of variance in the event of a 
significant interaction or training effect when analysing more than two time points 
or groups. Greenhouse Geisser ANOVA outputs were used in cases where 
Mauchley’s test of sphericity showed data to be aspherical   Statistical significance 
was identified at p<0.05. Data are presented as estimated marginal mean ± SE (with 
self-reported physical activity score as a covariate) for results of LMM and mean ± 




From the original sample of 2087 trainees physical fitness test data could be 
obtained for 1182 (707 smokers) trainees in week 1, 896 (529 smokers) trainees in 
week 14 and 755 (421 smokers) trainees in week 24.  Exact sample numbers used in 
the linear mixed model are presented in Table 7.1, grouped by performance 
variables. 
 




7.3.1 Military physical fitness test performance 
Estimated marginal means (±SE) for number of press ups performed for 
weeks 1, 14 and 24 for non-smokers (48.3 (±0.6), 54.6 (±0.7), 57.0 (±0.7)) and 
smokers (44.2 (±0.5), 51.8 (±0.5), 54.5 (±0.6)), are shown in Figure 7.1 (Panel A).  
Figure 7.2 (Panel A) displays the estimated marginal means for sit up performance 
for weeks 1, 14 and 24 for non-smokers (57.5 (±0.5), 62.8 (±0.6), 66.0 (±0.6)) and 
smokers (53.9 (±0.4), 60.6 (±0.5), 63.2 (±0.5)).  Estimated marginal means for 2.4 
km run performance for weeks 1, 14 and 24 in non-smokers (612 (±2), 579 (±2) and 
567 (±2) secs) and smokers (622 (±2), 586 (±2) and 571 (±2) secs) are displayed in 
Figure 7.3 (Panel A).  LMM analysis demonstrated significant group effects in all 
physical performance measures, such that non-smokers performed better at all time 
points (p<0.01).  Additionally, a significant effect for improvement in performance 
over time for all physical performance variables existed, irrespective of group 
(p<0.01).  No interaction effects were present (p>0.05).   
When only including individuals with complete data sets, ANOVA 
identified significant time and group effects in press ups (Figure 7.1; Panel B), sit 
ups (Figure 7.2; Panel B) and run performance (Figure 7.3; Panel B) (p<0.05).  
ANOVA also identified a significant interaction effect in run performance in those 
who finished training but post-hoc adjustment meant the individual data points were 
not significantly different (p>0.05). 
 
Table 7.1. Participant numbers organised by smoking status and total number of 




    Week 1   Week 14   Week 24    
Variable  NS  S  NS  S  NS  S   Total Observations 
Press up  475  707  367  528  301  423  2801 
Sit up  475  707  367  529  302  424  2804 
Run   472   701   334   493   334   421   2755 





Fig 7.1. Press ups completed in two minutes in groups NS (Open triangle) and S (Closed 
triangle) at weeks 1, 14 and 24 of training. A: Values are estimated marginal means with 
standard error bars for all participants. B: Values are means with standard error bars for all 
participants with complete data sets.  *significant effect of time, irrespective of group 




















































Fig 7.2. Sit ups completed in two minutes in groups NS (Open triangle) and S (Closed 
triangle) at weeks 1, 14 and 24 of training. A: Values are estimated marginal means with 
standard error bars for all participants. B: Values are means with standard error bars for all 
participants with complete data sets.  *significant effect of time, irrespective of group 


















































Fig 7.3. 2.4km run performance in groups NS (Open triangle) and S (Closed triangle) at 
weeks 1, 14 and 24 of training in all participants. A: Values are estimated marginal means 
with standard error bars for all participants. B: Values are means with standard error bars 
for all participants with complete data sets *significant effect of time, irrespective of group 



















































The present study was designed to determine whether habitual smoking 
affected development of physical fitness during 24 weeks of initial military training.  
Training elicited a similar significant improvement in press up, sit up and 2.4 km 
run performance in both smokers and non-smokers.  Physical performance data 
analysed by linear mixed model using all participants were similar to when solely 
including those who completed training.  As such, cigarette smoking did not appear 
to impact on the development of physical fitness. However, trainees who smoked 
were significantly less fit than non-smoking trainees throughout the duration of 
training. 
It has been postulated that smoking can attenuate the ability to develop 
physical fitness during long term training (Hoad & Clay 1992).  However, no 
difference in the improvement in physical performance between non-smokers and 
smokers in the present study suggests that habitual smoking did not impair the rate 
of development of physical fitness in this population.  Similarly, habitual smoking 
did not influence performance improvement or muscular adaptation in 14 weeks of 
British infantry training (Chapter 6).  This was observed alongside chronically 
elevated markers of oxidative stress and inflammation in habitual smokers, which 
have previously been suggested as possible mediators for impaired adaptation to 
exercise training in smokers.  These studies give novel evidence for there being no 
adverse effect of smoking on the progression of physical fitness during training. 
Although improvement in performance in smokers was not significantly 
smaller than that of non-smokers, it is interesting to note that on average smokers 
performed significantly more poorly in all parameters in both analyses.  In 
agreement with the majority of current research, this supports the association 
between habitual smoking and lower overall physical fitness in comparison to non-
smokers (Zadoo et al. 1993; Bernaards et al. 2003).  Participation in fewer health 
promoting behaviours in smokers is proposed as having an impact on their lower 
physical fitness (Larson et al. 2007), and could explain the difference between 
smokers and non-smokers at entry to training.  Additionally, habitual smoking can 
have effects on the cardiorespiratory system that can adversely affect exercise 
performance, such as reduced lung function (De & Tripathi 1988), cardiac response 
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to exercise (Mendonca et al. 2011) or increased blood pressure (Al-Safi 2005).  The 
current study is the first, however, to suggest an association between smoking and 
reduced performance in muscular endurance tasks.  Alongside factors already 
discussed, smokers exhibit impaired microcirculation (Siafaka et al. 2007) and 
lower fatigue resistance (Morse et al. 2007; Morse et al. 2008; Wüst et al. 2008) 
within muscles, which could be detrimental to performance in these tasks.    
Linear mixed model analysis of physical performance data using the entire 
data set presents similar findings to when only including those individuals that 
completed training.  Although the linear mixed model attempts to correct for 
missing data, the trainees in the latter stages of training are those that have adapted 
more positively to training, and could give an unintentionally biased sample.  
However, identical significant group and training effects existed in both analyses, 
providing confidence that the modelling approach was suitably robust even with 
some incomplete datasets. Therefore, while it is still possible there would be a 
greater adverse influence of smoking on performance improvement in those 
discharged from training the present study suggests this was unlikely to have 
markedly affected training outcome.   
Some limitations concerned with military training may have also limited the 
observation of different adaptive responses between groups.  Military training is 
designed to prepare trainees for the physically demanding roles necessary to be an 
effective soldier.  This is supported in the current study by significant temporal 
improvements in all fitness parameters, irrespective of group.  As such, the 
effectiveness of the progression of physical training may be such that any 
deleterious effect of smoking is too small to be measurable by comparison.   
Additionally, given trainees have knowledge of pass criteria in Army physical 
fitness tests, fitter individuals may not perform maximally if the successful 
completion of the test is assured.  Alternatively, the opportunity for fitter 
individuals to improve performance may be hindered in this training environment.  
With an aim for all trainees to reach comparable fitness, a large proportion of 
military physical tasks are completed as a group at a set pace, where trainees work 
at different intensities relative to their own absolute fitness.  For non-smokers this 
has negative implications given the evidence supporting typically higher physical 
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fitness than smokers (Larson et al. 2007). These factors suggest results from these 
tests may not be a true reflection of the extent of adaptation to training in the cohort. 
The performance parameters measured in the current study are used by the 
military as a fitness indicator of military readiness relative to age and gender.  Yet 
the absolute size of the discrepancy observed between smokers and non-smokers is 
small, such that the average performance of smokers in the present study would still 
be sufficient to pass military physical fitness tests.  As such, the adverse influence 
of habitual smoking on physical fitness is unlikely to markedly affect operational 
effectiveness. 
The current study has shown that while British infantry initial training 
significantly improves performance in physical tasks, habitual smoking can 
potentially impair physical fitness.  There is, however, no evidence for an impact of 
habitual smoking on improvement in performance during long-term exercise 
training.  Similar performance improvement was found when using a modelled 
approach based on data from all trainees to those trainees who completed training, 
which supports that sample bias from trainee drop-out was not a substantial 
confounder to study validity.  Despite effects potentially being lessened by the 
limited nature of the military physical tests administered, smoking-induced 
differences in physical performance did not greatly affect attainment of military 
performance goals.  As such, habitual smoking in this population is unlikely to have 
considerable impact on operational effectiveness solely based on physical fitness.  
However, the effects on physical fitness observed in this study do highlight 
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The Effect of Smoking Status on the Acute Responses of 




Both habitual smoking and arduous military field training have been 
observed to have marked effect on concentrations of circulatory hormones and 
immune markers (Andelid et al. 2007; Steptoe & Ussher 2006; Nindl, Barnes, et al. 
2007; Tanskanen, Kyröläinen, et al. 2011).  However, it is unclear whether smokers 
respond differently from non-smokers to these intense periods of military exercise.  
This is particularly relevant given that in military training populations, smoking is 
highly prevalent (Heir & Eide 1997; Klesges et al. 2001) and is associated with 
reduced physical fitness (Zadoo et al. 1993; Haddock et al. 2007) and poorer 
training outcome (Marti et al. 1988; Reynolds et al. 1999; Knapik, Sharp, et al. 
2001).  Examining resting markers of inflammation and endocrine status both at 
entry (Chapter 5) and during ten weeks of initial military training (Chapter 6) have 
shown few differences aside from elevated C-reactive protein (CRP) in smokers 
compared with non-smokers.   
Exercise evokes a transient elevation in inflammatory cytokines and 
alterations in hormone secretion into the circulation.  In response to acute exercise, 
skeletal muscle releases interleukin (IL)-6 into the circulation which is thought to be 
responsible for the subsequent stimulation of both anti- and pro-inflammatory 
cytokines (Petersen & Pedersen 2005), and the increase in CRP in the hours after 
exercise (Wilund 2007).  The predominance of studies have observed that as an 
immediate response to exercise circulating insulin-like growth factor (IGF)-1 
remains relatively unchanged (Meckel et al. 2009; Stokes et al. 2010; Wahl et al. 
2010) but basal levels significantly reduce in response to chronic exercise, military 
field exercise or intensive periods of overtraining (Nindl et al. 2003; Nindl & Pierce 
2010).  Typically, the testosterone/cortisol ratio increases acutely following exercise 
as characterised by elevations in testosterone and either relatively smaller increases 
or unchanged concentrations of cortisol (Hayes et al. 2010; Wahl et al. 2010; 
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Hansen et al. 2012), before returning to pre-exercise values within an hour (Daly et 
al. 2005; Fry & Lohnes 2010). 
Currently, the hormonal and inflammatory responses of habitual smokers to 
singular or multiple bouts of exercise are not well described.  To our knowledge, 
only the response of oxidative stress to exercise has been examined in smokers and 
non-smokers, reporting a proportionally greater response in smokers to maximal 
graded exercise (Bloomer et al. 2007; Gochman et al. 2007; El Abed et al. 2011).  
Despite purported links to oxidative stress, neither inflammatory nor hormonal 
factors have been examined in habitual smokers and non-smokers in response to 
exercise.  It may be that different acute responses of hormones and inflammatory 
markers to arduous training stresses in smokers may indicate whether smokers 
experience greater physiological strain during military exercise on consecutive 
days. 
This study examined the acute responses of hormones and markers of 
inflammation to arduous bouts of military exercise on two consecutive days in 
habitual smokers and non-smokers.  The study objectives were to examine whether 
the responses of biochemical parameters to exercise or to two days of simulated 





Thirty five British Army parachute regiment trainees (age 22 ± 3 yr; mass 
76.9 ± 8.0 kg; height 178 ± 6.0 cm) undertaking the Pegasus Company (P 
Company) selection week took part in the study. 
 
8.2.2 P Company week 
P Company week takes place at the end of the 26 week parachute regiment 
training course at ITC(C).  It is designed to assess trainee readiness to join the 
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parachute regiment by examining performance in a selection of arduous physical 
tasks simulating operational stress and testing various components of muscular and 
endurance fitness.   
 
8.2.3 Study protocol 
The study was a pre-post repeated measures independent group comparison 
with two exercise bouts.  The study took place over two consecutive days of P 
Company testimg week, containing a military exercise task on each morning; the 
“10-miler” on day 1 and the “log race” on day 2.  The 10-miler required trainees, as 
a platoon, to cover 10 miles of varying terrain within 1 hour and 50 minutes with 
each trainee carrying a pack weighing 33 lbs (15 kg).  The log race required trainees 
in groups of 6-8 to carry a 120 kg log over approximately 2 miles of varying terrain 
in as short a time as possible within 18 minutes.  Blood samples were taken on 
waking (0500-0600) prior to the 10-miler (waking pre-10-miler) and following the 
10-miler (post-10-miler) on day 1, and on waking prior (0500-0600) to the log race 
(waking pre-log race) and immediately following log race (post-log race) on day 2.  
Both events started at approximately 0900 after the participants had consumed 
breakfast. 
 
8.2.4 Anthropometric data 
Body mass, height and estimated body fat percentage were measured on the 
night prior to the beginning of data collection. 
 
8.2.5 Blood biochemistry analysis 
Blood samples were analysed for concentrations of CRP, IL-6, testosterone, 
cortisol and IGF-1. 
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8.2.6 Statistical analyses 
Statistical analyses were performed using SPSS software (SPSS for 
Windows: Version 16.0).  Initially, an independent t-test was performed on baseline 
anthropometric data to test for any initial differences between groups.  As the study 
design is a repeated measures independent group comparison with one unpaired 
(smoking) and one paired (time) independent variable all biochemical variables 
were analysed by two-way mixed model analysis of variance (ANOVA).  Post-hoc 
analysis with bonferroni adjustment was used to determine the location of variance 
in the event of a significant interaction or training effect.  Tests for normality were 
not performed as it is established that when analysing physiological data an 
ANOVA is robust to skews to the mean (Maxwell & Delaney, 1990). An alpha 
level of p≤0.05 was used to define the statistical significance of within- or between- 
participant effects.  Greenhouse Geisser ANOVA outputs were used in cases where 
Mauchley’s test of sphericity showed data to be aspherical.  Population 
characteristics are presented as mean ±SD. Biochemical data are presented as mean 





Participant characteristics and anthropometric data organised by group are 
presented in Table 8.1.  The non-smoking and smoking groups comprised 20 and 15 
trainees, respectively.  The smoking group had a mean (±SD) cigarette consumption 
of 11.8 (±5.3) per day for an average of 7.0 (±2.8) years.  Independent t-test results 









Table 8.1. Participant characteristics by group. Values are means ± SD.  
 
8.3.2 Inflammatory markers 
Serum CRP concentrations were not different between smokers and non-
smokers (p>0.05, Figure 8.1), but there was a significant effect of time (p<0.001). 
Post hoc analyses showed that CRP concentrations were significantly higher at both 
time points on the second day (waking-pre- and post- log race) than on the first 
(waking-pre- and post-10-miler; p<0.001).  Serum IL-6 concentrations did not 
significantly differ between groups (p>0.05, Figure 8.2).  In contrast to CRP, IL-6 
concentrations increased in response to exercise, with post exercise values (post-10-
miler and post-log race) significantly higher than their respective pre-exercise 
resting values (pre-10-miler and pre-log race; p<0.001).  Additionally, IL-6 
concentrations immediately after the 10 miler were significantly higher than after 
the log race.  ANOVA did not identify any significant interaction effects in either 
inflammatory marker (p>0.05).   
 
8.3.3 Endocrine markers 
Neither serum testosterone nor cortisol concentrations were different 
between groups (p>0.05, Figure 8.3).  Both markers demonstrated a significant 
effect of time (p<0.001), and post hoc analyses showed that both exercise bouts 
resulted in a significant increase in cortisol and decrease in testosterone 
concentrations.  A significant effect of time irrespective of group was evident on the 
         Smoking Status 
Variable  Smokers (n=15)  Non-smokers (n=20)  All (n=35) 
Age (yr)  22 ± 3  22 ± 3   22 ± 3 
Body Mass 
(kg)  75.9 ± 6.9  77.8 ± 8.9   76.9 ± 8.0 
Height (m)  1.77 ± 0.05  1.78 ± 0.07   1.78 ± 0.06 
Body Fat (%)  12.7 ± 2.1 (n=13)    14.2 ± 2.7 (n=18)  13.6 ± 2.6 
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ratio of testosterone to cortisol, reducing in response to both exercise bouts (p<0.05, 
Figure 8.4). No significant overall effects of smoking status or interaction effects 
were present in IGF-1 (p>0.05, Figure 8.5).  A non-significant trend existed for a 
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Fig 8.1. Mean serum concentration of CRP (mg⋅L-1) between NS (Open triangle) 
and S (Closed circle), across time points. Values are means with standard error bars.  
Time effects (p≤0.05) irrespective of group: *significant difference from waking 
pre-10-miler. #significant difference from post-10-miler. 
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Fig 8.2. Mean serum concentration of IL-6 (pg⋅mL-1) between NS (Open triangle) 
and S (Closed circle) across time points. Values are means with standard error bars. 
Time effects (p≤0.05) irrespective of group: *significant difference from waking 
pre-10-miler. #significant difference from post-10-miler. †significant difference 













     
Fig 8.3. Mean serum concentrations of Testosterone (A; ng⋅mL-1) and Cortisol (B; 
nmol⋅L-1) between NS (Open triangle) and S (Closed circle) across time points. 
Values are means with standard error bars.  Time effects (p≤0.05) irrespective of 
group: *significant difference from waking pre-10-miler. #significant difference 
from post-10-miler. †significant difference from waking-pre-log race. 
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Fig 8.4. Mean serum concentrations of testosterone to cortisol ratio between NS 
(Open triangle) and S (Closed circle) across time points. Values are means with 
standard error bars. Time effects (p≤0.05) irrespective of group: *significant 
difference from waking pre-10-miler. #significant difference from post-10-miler. 
†significant difference from waking-pre-log race. 
 
Fig 8.5. Mean serum concentration of IGF-1 (ng⋅mL-1) between NS (Open triangle) 
and S (Closed circle) across time points. Values are means with standard error bars.  
Non-significant trend for an effect of time (p=0.055). 
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We examined inflammatory and endocrine markers in smokers and non-
smokers both at rest and after intense bouts of exercise during two days of arduous 
military training.  The responses of these markers to a period of simulated 
operational stress could reflect the extent of physiological strain.  The results 
indicate that both bouts of exercise elicited acute increases in IL-6 and cortisol, 
acute decreases in testosterone, an elevation in CRP evident at rest the day 
following exercise, and a general decline of IGF-1 over the two-day period.  
However, none of the responses were different between smokers and non-smokers. 
We are not aware of any study that has examined the responses of hormonal 
and inflammatory markers to exercise in smokers and non-smokers.  The main 
finding of the current study is that smokers and non-smokers did not respond 
differently to the log race and 10-miler in any of the markers measured.  Previously, 
the oxidative stress response to maximal graded cycling exercise has been 
compared in smokers and non-smokers, with an exacerbated response reported in 
smokers (Bloomer et al. 2007; Gochman et al. 2007).  Given that both acute and 
chronic systemic inflammation in smokers is associated with oxidative stress  (Van 
der Vaart et al. 2004; Helmersson et al. 2005; Yanbaeva et al. 2007), and oxidative 
stress response is greater in smokers, it was hypothesised that acute inflammatory 
responses to exercise would also be greater in smokers than non-smokers.  The fact 
that the inflammatory responses were not different suggests that, in this population 
during intense training, the effect of habitual smoking on inflammation is 
comparatively smaller than that elicited by exercise.  It should be noted that trainees 
who participated in this study were nearing the end of the 26 week training course.  
As such, the chronic anti-inflammatory effect of long term exercise training 
(Plaisance & Grandjean 2006) may have counteracted the elevated CRP we 
observed in smokers during the early stages of training (Chapter 6), resulting in a 
similar inflammatory response to non-smokers. 
Military field exercise, involving consecutive days of arduous training, has 
been shown to elicit alterations in hormone concentrations.  Specifically, 
suppression of IGF-1 and testosterone, alongside increased circulatory cortisol have 
been demonstrated during periods of intensive military training  (Nindl, Barnes, et 
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al. 2007; Kyröläinen et al. 2008).  During prolonged training, increases in cortisol in 
particular correlate with daily and weekly training volume (Purge, Jürimäe & 
Jürimäe 2006; Tyyskä et al. 2010) and sleep disruption (Booth et al. 2006).  As 
such, previous research suggests military field exercise potentially evokes a period 
of metabolic stress and an ostensibly catabolic state.  In support of this, a trend for a 
decline in IGF-1 from rest on day one, to post-exercise on day two approached 
significance (p=0.055).  These findings could indicate that continuation of military 
training of this nature would incite a state of physiological strain, similar to that of 
energy deficit or overtraining.  
Changes in the testosterone-cortisol ratio to both bouts of exercise were 
similar, with increases in cortisol and reductions in testosterone.  Typically, exercise 
induces secretion of purportedly anabolic (e.g. testosterone) and catabolic (e.g. 
cortisol) hormones (Spiering et al. 2009; Hayes et al. 2010; Vingren et al. 2010).  It 
is perhaps unexpected therefore, that testosterone concentrations were lower after 
exercise than at rest.  This finding is likely explained by the resting blood sample 
being taken upon waking rather than immediately before exercise.  The circadian 
rhythm of testosterone means it is possible the resting sample reflects early morning 
peak concentrations (Hayes et al. 2010), against which post-exercise concentrations 
appear substantially reduced.  Additionally, given that resistance (Wilkinson et al. 
2006; Fry & Lohnes 2010; Hansen et al. 2012) and endurance exercise (Daly et al. 
2005; Cadore et al. 2012; Hansen et al. 2012) have previously shown opposing 
testosterone responses, the combination of load carriage and aerobic exercise 
involved in these military tasks may demonstrate an entirely different physical 
challenge from previous research. 
Given the lack of extant literature, it was unknown whether hormone 
responses to exercise would differ between smokers and non-smokers.  Numerous 
mechanisms linked to the actions of nicotine and immune-inflammatory signalling 
have been suggested to explain alterations in resting hormone levels in smokers 
(Kirschbaum et al. 1994; Steptoe & Ussher 2006).  In the present study, the 
responses of cortisol, testosterone and IGF-1 to military exercise were not different 
between smokers and non-smokers.   
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Current literature agrees that IL-6 increases transiently as a result of 
exercise, supporting the observation of significant increases in IL-6 above baseline 
following both exercise bouts.  Additionally, the magnitude of this response is 
affected by exercise intensity and duration (Petersen & Pedersen 2005).  The 
response of IL-6 to the 10-miler was significantly greater than to the log race, 
suggesting that the longer duration (1 hour 50 mins instead of <20 mins) of the 10-
miler had a greater effect on the magnitude of the inflammatory response than the 
higher intensity of the log race.   
Exercise on the first day caused significantly elevated resting levels of CRP 
on the morning of the second day, while there was no acute effect (i.e., pre- to post- 
exercise) of exercise on CRP.  It is well-established that the rise in CRP associated 
with exercise can continue to develop over 24 hours (Plaisance & Grandjean 2006; 
Mathur & Pedersen 2008), explaining the delayed exercise-induced increase in CRP 
observed in the current study.  The rise in resting inflammation elicited by the 10-
miler has implications for consecutive days of arduous exercise without sufficient 
recovery.  In the current study, the log race was initiated while resting CRP was 
elevated from exercise on the previous day to a level greater than 3 mg⋅L-1, and 
higher than normal for a population of this age and physical fitness.  These data 
suggest CRP levels on the day following the log race could have risen further, albeit 
following a comparatively lower stimulation from IL-6.  These findings indicate 
that continual repetition of consecutive days of particularly arduous exercise 
without sufficient recovery could induce substantial inflammation even in a young 
population of high physical fitness. Taking this further, we were interested to know 
whether the response to exercise on the second day would be different in smokers 
compared with non-smokers, given that this was superimposed on the challenges of 
the previous day. However, the responses were not different between groups. 
This field study investigated inflammatory and endocrine responses to 
consecutive days of military exercise in a real-world setting, and how these might 
differ between smokers and non-smokers.  Habitual smoking did not have a 
significant effect on markers of inflammation or hormones during the two day 
training period. Previous laboratory studies have demonstrated differing responses 
of oxidative stress markers to exercise in smokers compared with non-smokers 
(Bloomer et al. 2007), and it is possible that with the greater experimental control 
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afforded by a laboratory setting, the findings of the present study might have been 
different. Similarly, including an immediately pre-exercise blood sample would 
have allowed a clearer differentiation between the exercise-induced changes in 
inflammatory markers and hormones from the effects of circadian rhythms and 
meals consumed between samples.  However, the responses examined are an 
externally valid and accurate representation of exercise in the military, whereby the 
absence of differences between smokers and non-smokers challenge the relevance 
of a laboratory study.  It is clear that the nature of exercise performed during this 
study had a profound effect on markers that indicate physiological strain similar to 
energy deficit and overtraining.  These responses did not differ between smokers 
and non-smokers, indicating that habitual smoking did not influence the 
physiological strain experience by trainees during a two-day military exercise 
period. 
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The Influence of Smoking Status on Injury Incidence in 
British Infantry Initial Training 
 
9.1 Introduction 
Arduous physical training in a military setting is associated with a high 
incidence of musculoskeletal and overuse injuries (Knapik, Canham-Chervak, et al. 
2001), especially during initial training (Blacker et al. 2005).  Injuries to trainees are 
costly, both to the individual and the military organisation, due to the potential loss 
of training time, long and expensive rehabilitation and, in some severe cases, 
medical discharge from service.  In an attempt to reduce injury risk, research has 
been carried out to describe injury incidence (Kaufman et al. 2000; Knapik, 
Canham-Chervak, et al. 2001), identify risk factors for training injuries (Altarac et 
al. 2000; Knapik, Sharp, et al. 2001; Blacker et al. 2008) and develop interventions 
for the prevention of injury (Knapik et al. 2004; Bullock et al. 2010) within military 
populations.  
Cigarette smoking is the most widely identified independent risk factor for 
training-related injury in military populations (Reynolds et al. 1999; Altarac et al. 
2000; Knapik, Sharp, et al. 2001; Etherington & Owen 2002).  It has been reported 
that during Royal Marine training, the relative risk of training-related injury for 
habitual cigarette smokers was 1.7 times that of non-smoking counterparts 
(Munnoch & Bridger 2007).  Additionally, a dose-response association has been 
suggested, where risk of injury increases with cigarette consumption rate (Knapik, 
Sharp, et al. 2001).  Numerous mechanisms for heightened injury risk in habitual 
smokers have been postulated, including lower physical fitness (Kobayashi et al. 
2004), physical activity (Conway & Cronan 1992) and nutritional intake (Klesges et 
al. 1990); increased risk-taking behaviour (Zuckerman & Kuhlman 2000); impaired 
immune function (Arcavi & Benowitz 2004), recovery (Sherwin & Gastwirth 1990) 
and bone health (Wong et al. 2007); and alterations in oxidative and inflammatory 
processes (Cross et al. 1998; van der Vaart et al. 2004).   
Previous research into injury incidence is abundant in United States (US) 
and Scandinavian military populations, demonstrating values as high as 51% in US 
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infantry (Knapik et al. 1993), 40% in US marines (Almeida et al. 1999), 24% in 
Norwegian basic training (Heir & Eide 1997) and 32% in Royal Norwegian Navy 
personnel (Morken et al. 2007).  In British training establishments incidence has 
been reported to range from 4% (Greeves 2006) to 26.5% (Blacker et al. 2005).  
Considerable variation in injury incidence might be a result of differences in 
training environment, duration and location in addition to methodological 
differences between studies.  Within British Army training establishments both the 
highest medical discharge rate (Blacker et al. 2005) and lowest first-time pass rate 
(40-50%; Carter et al. 2006) have been reported at infantry training centre 
(Catterick) (ITC(C)).  Despite this, previous studies at ITC(C) have not quantified 
more than medical discharge rates, warranting a more comprehensive study of 
injury in this population   
Injuries most commonly reported in military populations are 
musculoskeletal overuse injuries predominantly in the knee and lower leg (Ross 
1993; Kaufman et al. 2000).  In British Army recruit training, injuries to the back, 
foot and lower leg were the most common, comprising between 50% (Greeves 
2006) and 70% (Wilkinson et al. 2011) of all training injuries.  Specifically, high 
incidence of lower back pain, shin splints, and overuse knee injuries such as patella-
femoral syndrome, patellar tendinitis and iliotibial band syndrome have been 
reported (Jones et al. 1993; Kaufman et al. 2000).  Injuries of this nature are highly 
indicative of the physical stresses produced by repetitive exhaustive load-bearing 
exercise common to military training, and largely affecting the lower-limb and 
supporting musculature.   
The aim of this study was to examine overall injury incidence and 
prevalence of training-related injuries specifically to the lower-limb and lumbar 
spine in the British infantry training population at ITC(C), and to investigate 
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9.2  Methods 
9.2.1 Participants 
Questionnaire data were collected in week 1 of training from a cohort of 
male infantry trainees. 
 
9.2.2 Study design 
Volunteers were asked to complete the Military Pre-training Questionnaire 
(MPQ) at entry to training to determine individual smoking characteristics. Lower 
limb and lumbar spine injury data were collected, retrospectively, from military 
medical records.  Injuries were organised by those that occurred from training, those 
that resulted in training time-loss and those that had acute or chronic causes.  
Anatomical location and injury type were also recorded.  Injury incidence and 
clinical injury incidence were calculated for non-smokers and smokers, as well as 
smokers organised by cigarette consumption.  To compare groups, relative risk and 
odds ratio were calculated for smokers with non-smokers acting as a control group.  
Entry and exit dates from military databases, alongside time lost to injury, were 
used to determine average injury severity and total training exposure of the 
population.  Total training exposure allowed quantification of incidence rate and 
average burden of injuries in 1000 trainee-days. Rate ratios were calculated to 
compare incidence rate and burden of injuries between smoking and non-smoking 
groups.  The proportion and severity of separate injury types were also calculated.    
 
9.2.3 Statistical analyses 
Odds and rate ratios were used to compare injury incidence and incidence 
rate, respectively, between non-smokers and smoking groups.  Differences between 
groups from odds ratio and rate ratio were determined by calculated z-scores.   
ݖ = 	 logܴܴ
ܵܧ(௟௢௚ோோ) 
Where RR can be substituted by any ratio value.   
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Subsequently, two-tailed P values were calculated from the z scores such 
that p<0.05 would signify a significant difference between non-smokers and 
smokers, as well as smoking subgroups.  Injury incidence and injury proportion are 
presented as percentages.  Injury incidence rate is presented per 1000 trainee-days 
and average injury severity is median days lost to injury with interquartile range 




  In total, 1972 trainees completed the present study.  Sufficient medical data 
were available for 1810 trainees to be used in analysis of injury incidence.  Injury 
data in this study refer to injury to the lower limb and lumbar spine.  All-cause 
injury incidence to the lower limb and lumbar spine in initial training was 63%, 
where trainees who sustained one or more injury of any kind to these locations 
totalled 1142.  A total of 1045 of these were attributable to training, representing a 
training-related injury incidence of 58% (Table 9.1). 
A total of 1682 trainees had sufficient training data to calculate exposure 
time and were included in analysis of clinical incidence and incidence rate.  This 
sample showed that 0.98 training injuries and 0.57 time-loss training injuries were 
sustained per trainee during initial training.  Median (IQR) severity of time-loss 
training injury was 14 (43) training days lost per injury.  Burden calculations 
showed that time-loss training injuries resulted in 123 training days lost per 1000 
trainee-days.    
 
Table 9.1. Training injury incidence (trainees with one of more training-related 
injury within trainees at risk), organised by injury classification (n=1810). 
Injury Classification  Trainees Injured   Incidence (%) 
Training-related  1045  58 
   Time-loss  583  32 
   Acute time-loss  216  12 
   Overuse time-loss  367  20 
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9.3.1 Injury incidence in non-smokers and smokers 
From the 1810 trainees, 595 were non-smokers and 893 were regular 
smokers, who averaged (mean (±SD)) 11.7 (±5.7) cig/day for 6.0 (±3.2) years. 
Relative risk of sustaining a training injury in smokers was 1.09 (0.99-1.19) that of 
non-smokers.  Odds ratios demonstrated that the incidence of training injury (95% 
CI) in smokers (60 (57-63)%) was significantly higher than that in non-smokers (55 
(51-59)%; p<0.01).  Furthermore, incidence of both time-loss training injuries and, 
more specifically, time-loss overuse injuries were significantly greater in smokers 
(Table 9.2; p<0.01).  The risk of sustaining acute time-loss training injuries was not 
significantly different between smokers and non-smokers.   
Compared with non-smokers, groupings of smokers by cigarette 
consumption exhibited significantly higher risk of training-related injuries and of 
overuse time-loss training injuries.  With the exception of the moderate smoking 
group, higher risk of time-loss training injury existed in smoking subgroups.    
 
9.3.2 Injury incidence rate in non-smokers and smokers 
The overall incidence rate for training injuries was 5.95 (5.66-6.24) injuries 
per 1000 trainee-days.  Incidence rates of both training-related injuries and time-
loss training injuries were significantly higher in smokers (p<0.02) than non-
smokers (Table 9.3).  Median (IQR) severity of time-loss training injury was 
identical in non-smokers (14 (38)) and smokers (14 (44)).  Burden (CI 95%) 
calculations, however, showed that the 132 (120-144) training days lost per 1000 
trainee days from time-loss training injury in smokers was significantly higher than 
the 104 (92-116) days lost in non-smokers (p<0.01). 
Significantly higher incidence rates of training and time-loss training 
injuries were observed in light smokers when compared to non-smokers (p<0.05), 
but were not evident in moderate and heavy smokers.  Neither acute nor overuse 
time-loss injury incidence rate were significantly different in smokers and smoking 
groups from non-smokers. 
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Table 9.2. Injury incidence, relative risk and odds ratio among training injuries 
organised by smoking group (n=1810). 








Injury Classification  
Incidence 
 (95% CI)  
Relative Risk 
(95% CI)  
Odds Ratio 
(95% CI) 
Injured in Training   58 (56-60)     
       
     Non-smokers   55 (51-59)  -  - 
     Smokers   60 (57-63)  1.09 (0.99-1.19)  1.22 (1.12-1.34)* 
Light smokers   59 (53-65)  1.07 (0.94-1.21)  1.17 (1.03-1.33)* 
Moderate smokers   60 (56-64)  1.09 (0.98-1.20)  1.22 (1.10-1.35)* 
Heavy smokers   62 (54-70)  1.12 (0.97-1.31)  1.33 (1.14-1.54)* 
       
Time-loss   32 (30-34)     
       
     Non-smokers   30 (26-34)  -  - 
     Smokers   34 (31-38)  1.15 (0.99-1.34)  1.23 (1.06-1.44)* 
Light smokers   37 (31-43)  1.22 (1.00-1.50)  1.35 (1.10-1.66)* 
Moderate smokers   33 (29-37)  1.11 (0.93-1.32)  1.16 (0.98-1.38) 
Heavy smokers   36 (28-44)  1.20 (0.93-1.55)  1.31 (1.01-1.69)* 
       
Time-loss Acute   12 (10-13)     
       
     Non-smokers   13 (10-16)  -  - 
     Smokers   13 (11-15)  0.97 (0.74-1.26)  0.96 (0.73-1.26) 
Light smokers   13 (9-18)  1.02 (0.70-1.49)  1.03 (0.70-1.50) 
Moderate smokers   13 (10-15)  0.96 (0.70-1.30)  0.95 (0.70-1.30) 
Heavy smokers   11 (6-17)  0.85 (0.51-1.44)  0.84 (0.50-1.41) 
       
Time-loss Overuse   20 (18-22)     
       
     Non-smokers   17 (14-20)  -  - 
     Smokers   22 (19-25)  1.30 (1.05-1.62)  1.38 (1.11-1.72)* 
Light smokers   23 (18-28)  1.38 (1.03-1.84)  1.49 (1.12-1.99)* 
Moderate smokers   21 (17-24)  1.23 (0.96-1.57)  1.28 (1.00-1.64)* 
Heavy smokers   25 (17-32)  1.47 (1.04-2.07)  1.62 (1.14-2.29)* 
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 Table 9.3. Incidence rate (per 1000 trainee-days) and rate ratio of injury 
classifications within training-related injuries by smoking group (n=1682). 








Injury Classification  Incidence rate (95% CI)  Rate Ratio (95% CI) 
All Training Injuries  5.95 (5.66-6.24)   
     
     Non-smokers  5.44 (4.97-5.92)  - 
     Smokers  6.28 (5.86-6.70)    1.15 (1.09-1.22)* 
Light smokers  6.58 (5.75-7.40)    1.21 (1.12-1.31)* 
Moderate smokers  6.08 (5.53-6.63)  1.12 (1.05-1.19) 
Heavy smokers  6.56 (5.40-7.71)  1.20 (1.09-1.33) 
     
Time-loss Injuries  3.43 (3.21-3.64)   
     
     Non-smokers  3.09 (2.70-3.45)  - 
     Smokers  3.65 (3.33-3.97)    1.18 (1.10-1.27)* 
Light smokers  4.00 (3.36-4.64)     1.30 (1.17-1.43)* 
Moderate smokers  3.45 (3.04-3.87)  1.12 (1.03-1.22) 
Heavy smokers  3.75 (2.88-4.63)  1.22 (1.06-1.39) 
     
Time-loss Acute  1.23 (1.10-1.37)   
     
     Non-smokers  1.19 (0.97-1.41)  - 
     Smokers  1.37 (1.18-1.57)  1.15 (1.02-1.30) 
Light smokers  1.58 (1.18-1.99)  1.33 (1.13-1.56) 
Moderate smokers  1.30 (1.05-1.55)  1.09 (0.95-1.25) 
Heavy smokers  1.22 (0.72-1.71)  1.02 (0.81-1.28) 
     
Time-loss Overuse  2.19 (2.02-2.37)   
     
     Non-smokers  1.90 (1.62-2.18)  - 
     Smokers  2.27 (2.02-2.53)  1.20 (1.09-1.32) 
Light smokers  2.42 (1.92-2.92)  1.27 (1.12-1.45) 
Moderate smokers  2.15 (1.83-2.48)  1.13 (1.02-1.26) 
Heavy smokers  2.54 (1.82-3.26)  1.34 (1.14-1.58) 
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9.3.3 Injury types 
The most prevalent training-related injury type sustained was non-specific 
soft tissue injury (51%), followed by muscle strain (12%) and blisters (12%).  
Similar injury types were observed for time-loss training injuries (Table 9.4).  The 
most common anatomical sites for training-related injury were knee (25%), foot 
(24%), ankle (17%) and tibia/fibula (9%).  As such, injuries to the lower leg 
contained >75% of all lower body injuries sustained in training.   
 Further analysis using both site and type revealed that non-specific soft 
tissue injuries to the knee, ankle and foot were the most common time-loss training 
injuries (Table 9.5).  The highest median injury severity was observed in non-
specific soft tissue injury for the shin (33 days lost), followed by non-fracture bone 
injury of the shin (30 days lost).  Highest burden values were observed for soft 
tissue of the knee and ankle, lumbar muscle strain and non-fracture bone injury of 
the shin. 
Table 9.6 shows the incidence rate, severity and estimated burden of time-
loss training injuries that could be categorised as knee pain and medial-tibial stress 
syndrome, both shown to be prevalent in military populations.  Of these categories, 
MTSS exhibited the higher severity with 28 training days lost per injury, while knee 
pain had the higher average injury burden, with 21 training days lost per 1000 
training-days.  Incidence rate of these injuries did not significantly differ between 
smokers and non-smokers (p>0.05).  However, for knee pain, average days lost per 
1000 training days in smokers was significantly higher (24 (19-29)) than non-
smokers (17 (12-22)). 
A total of 62 recurrent injuries were sustained, whereby cause, anatomical 
site, side of body and type were the same as a previous injury.  Forty-five of these, 
14 in non-smokers and 22 in regular smokers, resulted in a loss in training-time.  
The calculated training days lost per 1000 trainee-days from recurrent time-loss 
training injuries was 5.4 (5.0-5.9) for non-smokers and 6.9 (6.5-7.4) for smokers, 
and did not significantly differ (p>0.05).  
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Table 9.4. Proportion of types and sites of injury within training-related injuries 
 
 
  Training Injuries  Time-loss  Training Injuries 
  Injuries Proportion (%) 
 Injuries Proportion (%) 
Type       
   Non-specific soft tissue  899 50.5  516 29.0 
   Muscle strain  216 12.1  117 6.6 
   Blister  208 11.7  60 3.4 
   Non-fracture bone  81 4.6  66 3.7 
   Ligament  72 4.0  65 3.7 
   Tendon  65 3.7  42 2.4 
   Stress Fracture  27 1.5  27 1.5 
   Fracture  26 1.5  25 1.4 
   Laceration  21 1.2  11 0.6 
   NFCI  20 1.1  18 1.0 
   Bruising  14 0.8  1 0.1 
   Cartilage  5 0.3  4 0.2 
       
Anatomical Site       
   Knee  436 24.5  270 15.2 
   Foot  435 24.4  207 11.6 
   Ankle  308 17.3  195 11.0 
   Tibia/Fibula  165 9.3  110 6.2 
   Lumbar  135 7.6  74 4.2 
   Thigh  118 6.6  46 2.6 
   Pelvis  57 3.2  50 2.8 
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Table 9.5. Incidence rate (1000 trainee-days), average severity (training days lost to injury) and burden (training days lost per 1000 trainee-days) 
of the most prevalent time-loss training injuries. 






(Median(IQR))  Burden (95% CI) 
Non-specific soft tissue  Knee 225  0.81  15 (40)  26 (22-29) 
Non-specific soft tissue  Ankle 112  0.40  14 (33)  13 (11-16) 
Non-specific soft tissue  Foot 96  0.35  10 (35)  9 (7-11) 
Muscle strain  Lumbar Spine 65  0.23  21 (45)  10 (8-12) 
Blister  Foot 56  0.20  4 (6)  2 (1-2) 
Ligament  Ankle 53  0.19  9 (26)  5 (4-6) 
Non-fracture bone  Tibia/Fibula 50  0.18  30 (52)  9 (7-12) 
Non-specific soft tissue  Tibia/Fibula 40  0.14  33 (50)  7 (5-9) 
 
Table 9.6. Incidence rate (1000 trainee-days), average severity (training days lost to injury) and burden (training days lost per 1000 trainee-days) 
of key injury categories within time-loss training injuries, organised by smoking status. 






(Median(IQR))  Burden (95% CI) 
Knee pain 156  0.56  20 (40)  21 (17-24) 
     Non-smokers 43  0.46  24 (43)  17 (12-22) 
     Smokers 88  0.65  19 (33)   24 (19-29)* 
Medial-tibial stress syndrome 92  0.33  28 (50)  16 (13-20) 
     Non-smokers 25  0.27  37 (43)  15 (9-21) 
     Smokers 51  0.38  26 (45)  17 (12-22) 
*indicates that rate ratio demonstrates burden is significantly different from non-smokers 




The current study investigated the risk of training-related injury to the lower 
limb and lumbar spine in regular smokers compared with non-smokers during 
British infantry training.  The results indicate that 58% of individuals sustained one 
or more training-related injury during initial training, and 32% of trainees sustained 
an injury that resulted in loss of training time.  Trainees who smoked regularly had 
significantly greater risk of training-related injury, time-loss training injury and 
injuries specifically attributed to overuse.  Moreover, average training time lost due 
to time-loss training injuries was greater in habitual smokers. 
This study is the first to comprehensively describe incidence of training 
injuries in the largest training centre in the British Army.  A high incidence of 
injury has previously been reported in military training populations (Knapik, Sharp, 
et al. 2001; Etherington & Owen 2002; Blacker et al. 2008), with basic military 
training incurring injuries in an average of 25% of trainees (Jones & Knapik 1999).  
Injury epidemiology in British military training populations have reported lower 
incidence of training injuries than the current study.  Training injuries requiring 
referral to a remedial instructor occurred in 4% (Greeves 2006), 5.6% (Blacker et al. 
2008) and 16.7% (Blacker et al. 2005) of trainees in various British Army training 
locations, compared with time-loss training injuries in 32% of trainees in the current 
study.  This is particularly noteworthy given the current study focused on injuries to 
the lumbar spine and lower limb only, where the above studies included all 
anatomical sites.  Training establishment attended has been shown to be a risk 
factor for injury (Blacker et al. 2005), which suggests that characteristics of the 
trainees involved or the training courses themselves, such as duration and training 
content, incur different degrees of injury risk.  Other than greater duration, exact 
differences in content between the training course at the current study location and 
others in the British Army are not easily quantified.  It is possible that those 
differences could explain the comparatively high injury incidence observed at 
ITC(C), and high medical discharge rate reported previously (Blacker et al. 2005; 
Carter et al. 2006).  
In military training populations, previous research has identified habitual 
smoking as an independent risk factor for injury (Reynolds et al. 1999; Altarac et al. 
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2000; Knapik, Sharp, et al. 2001; Etherington & Owen 2002).  Altarac et al. (2000) 
also reported significantly higher risk of overuse injuries in US Army basic training, 
in agreement with the current study.  Additionally, Munnoch and Bridger (2007) 
observed higher relative risk of injury in Royal Marine trainees who smoked >10 
cigarettes per day compared to light smokers (1-9 cig/day), showing evidence of a 
dose-response.  In the current study, light and/or heavy smoking groups, but not 
moderate smokers, exhibited significantly higher incidence in certain injury types.  
If higher injury risk in smokers was mediated solely by the act of smoking, it would 
follow that injury incidence would be more pronounced with increased 
consumption.  As such, it is likely that the explanation for greater injury risk in 
smokers is multifaceted, influenced, in part, by intrinsic risk factors of smokers 
other than smoking itself.  Employing univariate analysis to examine risk associated 
with smoking, it is possible to demonstrate that regular smokers have higher risk of 
training-related injury than non-smokers, but not to identify smoking per se as the 
cause of this difference.  Nevertheless, possible causal mechanisms for higher 
injury risk in smokers have been proposed, including lower typical physical activity 
(Conway & Cronan 1992; Jones et al. 2000), lower physical fitness (Kobayashi et 
al. 2004), greater risk taking behaviour (Zuckerman & Kuhlman 2000) and reduced 
recovery to injury and exercise (Arcavi & Benowitz 2004; Silverstein 1992), 
possibly mediated by impaired immunological responses (Sopori 2002; Gonçalves 
et al. 2011). 
Significantly higher duty days lost per 1000 trainee-days from time-loss 
injury in smokers in the current study is a novel finding.  As the current study and 
others (Altarac et al. 2000) have observed higher incidence of overuse injury in 
smokers, it is possible that smoking adversely affects processes of regeneration and 
recovery to injury over prolonged periods.  Significantly higher burden from time-
loss injuries in smokers supports this, as well as the absence of differences between 
smokers and non-smokers in either incidence or incidence rate of acute injury.  
Smoking has been associated with both reduced production of collagen (Jorgensen 
et al. 1998) and impaired bone metabolism (Wong et al. 2007), influencing long 
term bone mass loss, which might be a mechanism responsible for higher incidence 
of stress fractures and other overuse injuries in smokers (Lappe et al. 2001; 
Vestergaard & Mosekilde 2003).  It should be noted that when expressed relative to 
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total training time incidence of time-loss overuse training injuries did not differ 
between groups, thereby not supporting the assertion that smoking impairs recovery 
processes that prevent overuse injuries.  However, the analysis of rate ratio showed 
this difference approached significance (p=0.054), and the variation between this 
result and that of injury incidence could be explained by the slightly smaller sample 
used for analysis of incidence rate.  
The current study examined only training injuries to the lumbar spine and 
lower limb, previously shown to represent between 70% (Wilkinson et al. 2011) and 
83% (Etherington & Owen 2002) of all injuries sustained in military training, also 
suggesting that observed injury incidence may not have been markedly changed in 
the current study with the inclusion of other anatomical sites.  The majority of 
observed training injuries were to the knee, ankle and foot.  Injuries to the lumbar 
spine and lower limb are indicative of physical stresses from exercise commonly 
performed during military training.  Injury categories representing both MTSS and 
knee pain were also assessed, given their reported prevalence in military 
populations (Jones et al. 1993; Kaufman et al. 2000), and clinical association of 
MTSS with stress fracture (Detmer 1986; Bouché & Johnson 2007).  The burden 
associated with knee pain was one week greater in smokers, further supporting the 
tempered recovery increasing injury severity in smokers.    
A limitation of the current study is that the analysis used does not elucidate 
why smokers are at greater risk of injury, or what other factors influencing injury 
risk may exist concurrently within the smoking group.  However, few studies 
examining smokers have studied the potential effect of increased cigarette 
consumption on greater injury risk.  By doing this, the current study gives evidence 
that increasing magnitude of smoke exposure has negligible effect on injury risk, 
supporting a likely multivariate reason for injury risk in smokers.  Overall, the 
current findings are in keeping with those in the literature, finding an injury 
incidence in excess of 25% during initial military training, and a higher risk of time-
loss and overuse injuries in smoking trainees.  Differences from previous literature 
may be due to differences in training location as well as methodological definitions 
and diagnosis of injuries.  Due to higher incidence of overuse injuries in smokers, 
and greater burden from time-loss injuries, it is possible that there is an effect of 
smoking on injury risk related to impairment of physiological processes mediating 
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recovery from exercise and injury.  However, mechanistic discussion for the 
influence of smoking on injury risk can only be speculated from previous research, 
and could be explored further possibly by seeking to identify intrinsic risk factors 
within smoking populations and extrinsic risk factors of different Army training 
courses.  It is clear from the current study that there is a greater incidence of injury 
at ITC(C) than reported for other British Army training populations, but also that 
injury risk and potential time lost due to injury are significantly increased in 










































This series of studies established several differences between habitual 
smokers and non-smokers within a scarcely examined military training population, 
and observed potential influences of smoking on selected biochemical markers both 
at entry and during initial military training.  While the health effects of cigarette 
smoking are well established, this programme of work was designed with the novel 
aim of demonstrating whether smoking influences the development of physical 
fitness; what biological processes might be responsible; and if this occurs, where in 
the time-course of training this influence may be manifest.  A possible reason for an 
apparent lack of previous research to this end is the inherent probability that a 
population seeking positive health and fitness outcomes is unlikely to habitually 
smoke, and that habitual smokers are unlikely to partake in, and indeed continue 
smoking through, standardised progressive training.  Military trainees provide a 
relatively unique opportunity to examine a population with a potentially high 
proportion of smokers, and a high adherence to both the continuance of smoking, 
and to prolonged exercise training.  Further rationale for the research was based on 
the lack of extensive understanding of smoking behaviour and injury risk in the 
British army training population. These studies include the first description of 
smoking habits and comprehensive analysis of injury incidence in the largest 
training establishment in the British Army.  To provide basis for further central 
discussion, the main findings of completed studies are summarised below.   
 
Study 1 (Chapter 4) 
Aim: To describe smoking prevalence at Infantry Training Centre, Catterick 
(ITC(C)) and to give a more comprehensive understanding of the smoking 
behaviour of the British Army trainee population. 
Key Findings: 
― Regular smokers (>1 cig/day) comprised 48% of trainees on entry to 
training. 
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― Regular smokers averaged (mean (±SD)) 11.5 (±5.8) cigarettes per day for 
6.0 (±3.3) years. 
― 85% of trainees remained the same smoking status, and the majority of those 
that changed were former smokers recommencing regular smoking. 
 
Study 2 (Chapter 5)  
Aim:  To examine whether smokers exhibit increased resting markers of oxidative 
stress and systemic inflammation, and altered hormone concentrations compared 
with non-smokers at entry to training, and whether greater differences would result 
from greater cigarette consumption. 
Key Findings: 
― Resting serum concentration of marker of oxidative stress malondialdehyde 
(MDA) was significantly higher in habitual smokers and each subgroup 
categorised by cigarette consumption in comparison to non-smokers. 
― No significant differences in resting serum concentrations of CRP, IL-6, 
ALT, testosterone, cortisol or IGF-1 existed between smoking groups and 
non-smokers.    
 
Study 3 (Chapter 6)  
Aim: To examine whether training elicits different changes in resting markers of 
oxidative stress, systemic inflammation, hormone concentrations, physical 
performance variables and lower leg muscle characteristics in smokers compared to 
non-smokers during 10 weeks of military training.   
Key Findings: 
― Military training elicited significant improvement in the majority of 
performance measures, irrespective of group.  
― Performance improvement was not significantly impaired in smokers in any 
performance measure when compared to non-smokers, and muscular 
adaptation did not differ between groups.  Though not significant, a trend 
existed for greater improvement in run performance in non-smokers 
(p=0.067). 
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― Resting serum concentrations of MDA and CRP were significantly higher in 
habitual smokers than non-smokers, irrespective of training time.  MDA, 
irrespective of group, significantly reduced during training.  CRP was 
similar in smokers and non-smokers at baseline and increased to a greater 
extent in smokers during training.  
― No differences between smokers and non-smokers existed in resting IL-6, 
ALT, testosterone, cortisol or IGF-1 during training, and no evidence of a 
dose-response existed on any biochemical marker.  
 
Study 4 (Chapter 7) 
Aim: To explore whether habitual smoking impairs improvement in performance of 
military physical fitness tests (PFT) during 26 weeks of initial training in a large 
sample of trainees. 
Key Findings: 
― No interaction effects occurred, demonstrating that improvement in 
performance did not differ between smokers and non-smokers in press up, 
sit up or run performance. 
― In all performance measures, non-smokers performed significantly better 
irrespective of time. 
 
Study 5 (Chapter 8) 
Aim: To examine whether the responses of inflammatory markers and hormones to 
bouts of military exercise and to two days of simulated operational stress would 
differ between smokers and non-smokers.    
Key Findings: 
― No differences between smokers and non-smokers existed in responses to 
acute exercise or to two consecutive days of training in concentration of 
CRP, IL-6, testosterone, cortisol or IGF-1. 
― The “10-miler” event elicited a greater IL-6 response than the “log race” 
event, likely due to greater duration.  
― CRP was significantly increased at rest the day following the “10-miler”.  
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Study 6 (Chapter 9) 
Aim: The aim of this study was to examine overall injury incidence and prevalence 
of training-related injuries specifically to the lower-limb and lumbar spine in the 
British infantry training population at ITC(C), and to investigate whether habitual 
smokers are at greater risk of training-related injury than non-smokers. 
Key Findings: 
― 58% of trainees sustained at least one training-related injury to the lower-
limb and lumbar spine. 
― Risk of training-related injuries and time-loss training injuries was 
significantly greater in smokers than non-smokers, and specifically in 
injuries attributed to overuse.  
― Duty days lost to time-loss injury per 1000 trainee days was significantly 
higher in smokers than non-smokers.   
― The most common injuries were non-specific soft tissue injury to the knee, 
ankle and foot.  
 
This programme of work improved on previous research, first, by the 
measures employed to determine smoking behaviour using more precise definitions 
of smoking groups, and more accurately attaining data on smoking history and not 
solely current status.  The administered questionnaire investigated years smoked, 
and distinguished between former and non-smokers, and occasional and regular 
smokers.  These methods and those to ensure anonymity lend confidence to the 
finding that smoking prevalence (48%) in infantry training was higher than 
previously observed in other British training populations and in the British general 
public.  By establishing prevalence and average tobacco exposure in a large cohort, 
Study 1 demonstrated that if the mechanistic rationale was accepted and adverse 
influences of smoking did exist in this training population that they would affect a 
substantial proportion of trainees.  The findings of Study 1 give a value for average 
tobacco exposure (cigarette consumption rate and years smoked) in this population, 
which by means of comparison show that the smoking habits of each study sample 
are representative of the overall training population.  
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Perhaps the most unexpected finding from this series of studies was that 
smokers did not exhibit poorer development in physical performance than non-
smokers, either in a battery of performance measures in 46 trainees over 10 weeks, 
or in physical fitness test performance in a large cohort over 26 weeks.  The larger 
sample size, and therefore greater statistical power in Study 4, as well as control for 
physical activity indicates that the trend for greater improvement in run time 
(p=0.067) observed in non-smokers over 14 weeks (Study 3) did not occur across 
the full course duration.  Previously, the comparison between the magnitude of 
performance improvement between smokers and non-smokers appears to have been 
examined in only one study (Hoad & Clay 1992), demonstrating significantly 
greater improvement in non-smokers.  The study by Hoad and Clay (1992) lasted 26 
weeks, and measured a variety of body weight strength exercises completed to 
failure and a 2.4 km run in British Army officer cadets.  The tests employed are 
designed to test aerobic and muscular endurance, and included similar exercises to 
those in the PFT in the current studies.  Given the course duration and similar 
fitness tests used, it is surprising that Study 4 did not present similar findings to 
those of Hoad and Clay (1992). 
Taken together, the findings that smokers performed worse in PFT criteria in 
Study 4; the run time trend in Study 3; and the work of Hoad and Clay, and others 
(Ward et al. 2003; Al-Obaidi et al. 2004; Haddock et al. 2007) suggest that poorer 
performance in smokers may occur in endurance and muscular endurance tasks.  
This provides some support that smoking affects the performance of exercises that 
involve a high number of repeated contractions, possibly highlighting a mechanism 
involved in the modulation of muscular fatigue.  This agrees with two studies that 
demonstrated that where maximum force of muscle contraction did not differ 
between smokers and non-smokers, fatigue resistance was reduced in smoking 
individuals (Morse et al. 2007; Wüst et al. 2008).  The precise explanation for how 
smoking could limit resistance to fatigue and performance in endurance exercise 
could involve a vast array of mechanisms, several of which may not be discernible 
from the findings of this work.  However, the accumulation of reactive oxygen 
species (ROS) have been implicated in the development of muscular fatigue 
(Moopanar & Allen 2005; Reid & Moylan 2011), and reduced lactate threshold 
(Aguiló et al. 2007).  This is particularly noteworthy given that in the current 
Chapter 10 General Discussion 
169 
 
programme of work oxidative stress was elevated in smokers at rest (Studies 2 and 
3).  Additionally, Bassett & Howley (2000) described the provision of oxygen and 
oxygen carrying capacity of the blood as limiting factors in aerobic capacity.  The 
chronic inhalation of carbon monoxide may reduce oxygen carrying capacity 
(Silverstein 1992), potentially explaining significantly larger but less abundant red 
blood cells observed in smokers in Study 2. Though not measured in this 
programme of work, smoking is also associated with decreased secretion of 
parathyroid hormone (PTH), which would reduce peripheral vasodilation (Iseki 
1990; Mandsager, Brewer & Myatt 1994), potentially increasing blood pressure and 
limiting blood transport to muscles.  Although the underlying mechanisms remain 
unclear, the current work gives evidence that a regular smoker may exhibit poorer 
muscular fatigue resistance in physical tasks similar to those that typify military 
fitness testing or military occupational tasks.  
Where the findings of the programme of work and the mechanistic rationale 
do not coalesce, is there being no impairment in adaptation in smokers despite 
evidence of elevated resting oxidative stress and, during training, greater 
inflammation than non-smokers.  The rationale for examining markers of oxidative 
stress, inflammation and hormones at rest during training alongside adaptation was 
that smokers have previously exhibited distinct levels of these markers from non-
smokers, and that the systemic concentration of these markers could mediate 
aspects of adaptation to training.  It was postulated that these chronic differences 
from non-smokers would disrupt the processes of adaptation within the muscle cell, 
impairing adaptation in smokers when compared to non-smokers.  Study 2 sought to 
indicate the chronic physiological status of smokers at entry to training and 
demonstrated, via MDA concentrations, significantly greater oxidative stress in 
smokers.  It was surprising that this was not accompanied by significantly elevated 
inflammation, given the established links between these processes (Helmersson et 
al. 2005; Peake, Suzuki & Coombes 2007).  However, significantly higher CRP in 
smokers was subsequently observed in Study 3.  Similar to Study 2, baseline levels 
of CRP were alike among smokers and non-smokers, and therefore the effect of 
smoking status appears to be a function of an exacerbated rise in inflammation in 
smokers when combined with training.   
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It would be reasonable that heightened inflammatory response to training in 
smokers may be caused by the presence of chronically elevated oxidative stress.  
Elevated CRP at weeks 5 and 10 of training was likely to be a result of recent 
physical training.  In Study 5, the “10-miler” elicited such a response on resting 
CRP the day following exercise.  Bloomer et al. (2007) showed a significantly 
greater oxidative response to exercise stimulus in smokers than non-smokers in 
young active men.  Possessing elevated resting oxidative stress could be the 
precursor for an exacerbated oxidative response to a stimulus, and could have 
evoked the same in inflammation in smoking individuals in Study 3.  This is 
supported by dietary intervention of antioxidants being shown to attenuate cytokine 
response to exercise (Fischer et al. 2004).  In Study 5, as neither greater 
inflammation nor acute inflammatory responses in smokers were observed in either 
exercise bout, it may be that oxidative stress was not elevated in smokers in this 
sample, in contrast to those in Study 3.  Trainees involved in Study 5 were at the 
pinnacle of parachute regiment training, where higher fitness standards are 
enforced, and were likely to be substantially fitter than trainees at week 10 in Study 
3.  In Study 3, MDA concentrations showed a significant decline from weeks 1-10, 
suggesting a reduction in oxidative stress may be an adaptation to prolonged 
training.  This is supported by research showing redox sensitive cells become more 
proficient at modulating oxidative stress from repeated exercise (McArdle et al. 
2001; McArdle, Spiers, et al. 2004; Ji 2007).  Similarly, in trained individuals when 
compared to untrained, the presence of antioxidant protein content and 
cytoprotective heat shock proteins were significantly higher at rest and following 
exercise, suggesting more effective protective mechanisms via mediation of redox 
balance (Morton et al. 2008).  As such, similar to the anti-inflammatory effect of 
long term exercise, the longer duration of training and greater physical fitness of 
trainees in Study 5 may have reduced resting oxidative stress resulting in similar 
levels between groups.  The implications here are that in a young otherwise healthy 
population of smokers, achieving a high level of physical fitness may counteract 
elevated inflammation and oxidative stress, and subsequently attenuate the 
potentially greater inflammatory response to training stimuli.   
The mechanistic rationale behind adaptation in the current studies relies on 
the link between circulatory markers and the actions within local tissue.  Since the 
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initiation of this project the scientific domain has experienced growing debate 
surrounding the extent to which circulatory markers correlate with the environment 
within local tissue.  The evidence that links inflammation and oxidative stress in the 
circulatory system centres around the association between elevated inflammation 
and oxidative stress in disease states (Federico et al. 2007; Peake et al. 2007; 
Lozovoy et al. 2011).  Locally, the two are linked by the cellular interplay of redox 
balance with cytokine mediation via transcription factors (Kosmidou et al. 2002; 
Aoi et al. 2004; Close et al. 2005).  The persistent elevation of both inflammation 
and oxidative stress within muscle has implications on blunting the adaptive 
signalling and promotion of protein synthesis and hypertrophy (Goodman 1994; 
Close et al. 2005; Haddad et al. 2005; Yamada, Tomiyama, et al. 2006).  Yet 
muscle cross sectional area or total area in Study 3, which would be indicative of 
net myofibril hypertrophy, did not differ between smokers and non-smokers despite 
the potential effects of elevated systemic oxidative stress and inflammation.  
It is well-established that oxidative stress is elevated within lung tissue and 
bronchoalveolar lavage from the acute act of smoking (McCrea et al. 1994; Faux et 
al. 2009; Barreiro et al. 2010), but it is not clear whether the increase in oxidative 
stress in the circulation of smokers is as a direct result of this (ie- the efflux of lipid 
peroxidation into the circulation from the lung tissue), or an increase in systemic 
oxidative stress as a result of the circulatory rise in inflammatory markers signalled 
by lung tissue, or a combination of both.  Similarly, it is not certain whether a 
chronically elevated state of circulatory oxidative stress or inflammation will elicit a 
paralleled environment within the muscle cellular environment.  This uncertainty 
may explain how the observation of significantly elevated circulatory oxidative 
stress and inflammation in smokers during training was not accompanied by any 
impaired muscular adaptation in smokers. 
A similar debate exists in the relevance of circulatory versus local 
measurement of IGF-1 and testosterone, alongside whether there is any significance 
in shifts in endogenous hormones after maturation.  With regard to testosterone, 
some uncertainty may be caused by assay variability and the definitions of when 
testosterone is biologically active.  Examination of the methods for measuring 
testosterone has elucidated a number of differences in assays and blood sample 
timing that are pivotal for correctly determining testosterone concentrations (Gray 
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et al. 1991).  The majority of circulatory testosterone (65-80%) is bound to sex 
hormone binding globulin (SHBG), and is therefore biologically inactive.  
Theoretically, the proportion of bioavailable testosterone is reduced by an increased 
circulating concentration of SHBG.  However, some assays cause the unbinding of 
testosterone from SHBG and others from albumin, where some use calculations to 
estimate the bioavailable fraction.  As such, despite apparent increases in SHBG, 
some studies have observed no significant differences in bioavailable testosterone 
(Field et al. 1994; English et al. 2001).  Interestingly, although only measured in a 
handful of studies, SHBG has been shown to be elevated in smokers (Field et al. 
1994; English et al. 2001; Svartberg et al. 2003).  It is therefore entirely possible 
that smoking influences bioavailability of testosterone instead of the total 
concentration as measured in the current programme of work.    
It is increasingly considered that the local production and action of IGF-1 
within muscle has far greater implications for maintenance of muscle mass than 
hepatic production (Stewart & Pell 2010).  While there is increasing concern that 
circulatory concentration of both IGF-1 (Criswell et al. 1998; Friedlander et al. 
2001) and testosterone (Wilkinson et al. 2006; West et al. 2009) do not correlate 
with what occurs on a cellular level.  The current scheme of work appears to 
support the growing consensus of work that suggests circulatory markers may not 
ultimately be concurrent with the effects observed in the presence of those same 
markers in cell lines.  Given the debate, it may be that attempting to assess cellular 
effects of elevated IGF-1 is less relevant, certainly to the current work, than 
endogenous IGF-1 acting as an indicator of physiological or metabolic strain 
(Nindl, Alemany, et al. 2007; Nindl et al. 2011).  In Study 3, a significant reduction 
in IGF-1 was observed following days with the largest training volume, while the 
implementation of arduous military exercise in Study 5 elicited a decline that 
approached significance (p=0.055).  Although the decline in IGF-1 in neither of 
these studies was more pronounced in smokers, the wider implication for all 
trainees is that repeated days of training of this nature in quick succession without 
sufficient recovery is likely to elicit a severe state of metabolic stress. 
Study 6 demonstrated a significantly greater incidence, and therefore risk, of 
training injury in smokers as well as those resulting in training time-loss, and 
specifically those attributed to overuse.  Studies 2 to 5 demonstrated that greater 
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oxidative stress and inflammation in habitual smokers did not influence adaptation 
in muscle or changes in performance with training.  However, these could, via a 
number of interlinked mechanisms, weaken the musculoskeletal system, increasing 
susceptibility to injury.   Circulatory markers of oxidative stress have been shown to 
be negatively associated with bone mass (Basu et al. 2001) and ROS stimulate 
osteoclastic bone resorption (Garrett et al. 1990).  The interactions of PTH and 
inflammatory markers, both affected by smoking, have been linked to the mediation 
of bone turnover (Lips 2001; Ragab et al. 2002; Swarthout et al. 2002).  
Additionally, chronic nicotine exposure has been shown to increase insulin 
resistance and impair muscle glycogen repletion (Price, Krishnan-Sarin & Rothman 
2003).  The plethora of possible biochemical effects of cigarette smoking are 
complex and it can be asserted that many other pathways for the long term effect of 
smoking on injury susceptibility exist in addition to those proposed in the current 
work.  The specific observation of higher overuse injury and time-loss injury 
occurrence in smokers would suggest a long-term impairment of recovery of soft 
tissue and/or bone in comparison to non-smokers.  This is supported by lower bone 
mass (Joseph, Kenny, et al. 2005; Wong et al. 2007) and collagen production 
(Jorgensen et al. 1998) in smokers, as well as increased stress fracture risk (Lappe et 
al. 2001).  Though speculative, in relation to soft-tissue, it is possible that with less 
effective resorption-formation coupling of bone an excess of physical training could 
substantially increase physical strain on joints and supporting musculature, 
potentially increasing risk of muscular or connective tissue injury. 
Greater resting inflammation in smokers, as evidenced from data in Study 3, 
could also have implications on recovery.  This is particularly relevant given that a 
significantly higher number of duty days were lost per 1000 trainee days from time-
loss injuries in smokers than non-smoking trainees.  Elevated inflammation and 
oxidative stress observed in smokers may prolong injury recovery time or enhance 
severity of a present injury.  Both chronically elevated inflammation (Barbe & Barr 
2006) and the presence of MDA (Freeland et al. 2002) have been implicated in 
increased severity of injuries.  It seems that the balance of neutrophils and 
macrophages, and indeed the subsequent modulation of oxidising agents, is integral 
to the process of tissue repair (Toumi & Best 2003), and as proposed with muscular 
adaptation, may be disrupted by systemic inflammation and redox balance.  An 
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aspect of the research area also emerged in support of the premise that increased 
injury risk in smoking is likely to be multivariate, and not solely as an indirect result 
of the act of smoking.  The observation of higher risk in light smokers than heavy 
smokers in some injury types suggests an absence of a dose-response, and that 
smoking itself is not the inciting factor in the mechanisms for higher risk.  This 
highlights that a smoking population has a number of inherent factors whose 
interplay warrant examination.  For instance, it is possible that poorer lifestyle 
choices such as lower dietary intake of nutritious foods, lower physical activity and 
participation in sport, and greater risk taking in smokers could affect both injury and 
recovery, such as via reduced adherence to rehabilitation or correct nutritional 
intake.     
 
 
Discussion of methodological approach 
 The scheme of work completed for this thesis investigated several novel 
aspects of the influence of habitual smoking on young, physically active humans.  
Studies were designed with an aim to observe an accurate representation of the 
population in its real-world setting.  Therefore, it is acknowledged that this thesis 
presents a series of explorative field-based studies, where the controlled 
experimental rigour of laboratory controlled trials, could not always be 
implemented.   
Studies were designed such that they did not conflict with normal daily 
training and habitual routines of participants.  It can therefore be assured that 
trainees examined in this research followed the same training regime as all British 
infantry trainees and, as such, present as an ecologically valid representation of the 
training population.  It could also be suggested that the training environment itself 
acted, in part, similar to laboratory-based experimental control.  Typically, dietary 
intake, waking hours and physical training will have been similar between trainees 
during each specific training week, and trainees would be confined to the training 
base for the majority of time.  In a free-living study there would be greater concern 
that these factors may have been confounders to primary outcomes measures, such 
Chapter 10 General Discussion 
175 
 
as performance in physical tasks and potentially the levels of resting inflammation, 
oxidative stress and hormones.  As such, it should be acknowledged that the use of 
a regimented training environment establishes substantially more control than some 
other free-living field-based research. It is clear, though, that extreme alterations in 
training environment or lifestyle would limit this control.  As observed in military 
training programmes previously, severely restricted hours of wakefulness combined 
with consecutive days of intense physical work could produce responses in 
inflammation and hormones with high inter-individual variability (Booth et al. 
2006; Alemany et al. 2008).  Similarly, illness, timing of blood sample or hydration 
status could interfere with interpretation of biochemical marker analysis.  Systemic 
concentrations in response to exercise can be influenced by infection or changes in 
plasma volume.  Several of these factors could be improved upon in future work, 
but were not feasible currently without further disruption of the lifestyle of military 
trainees. 
In the context of cigarette smoking, previous studies have reported several 
limitations to self-report smoking behaviour.  In this programme of work, every 
effort was made to reduce these limitations, including security and anonymity 
measures to limit social bias, and tailoring questions to more accurately distinguish 
between smoking behaviours than solely smoking or never-smoking.  One concern 
was that smoking status may drastically fluctuate during training, whereby self-
report responses could be confounded by memory.  However, where possible the 
follow-up questionnaire was used to ascertain the occurrence of changes in smoking 
status, and conflicting respondents removed.  Equally, without social bias, there is 
little reason for a smoker to respond as non-smokers or vice versa.  It is also noted 
that this research took place following the national smoking ban, meaning no 
smoking in working environments and included all military buildings on camp. As 
smoking trainees would be required to smoke in well-ventilated outdoor shelters, it 
is likely that environmental tobacco smoke or passive smoking was minimal. 
In addition, it was a major concern that military drop-out from the 
population being examined was unavoidable.  With regard to adaptation across 
training weeks, this indirectly reduced sample size and introduced potential bias 
towards those who may have responded more positively to military training, or not 
become injured.  To counteract this, in Study 4, a modelling process was 
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implemented to use data from all participants at all time points, and did not 
markedly alter findings.  Unfortunately, this process of analysis was not possible for 
studies 2 and 3 which used the same pool of trainees, with 110 (45 non-smokers, 65 
smokers) at entry and 65 (24 non-smokers and 41 smokers) by week 10.  Of those 
41 smokers, only 24 completed the majority of physical performance tests, showing 
17 smokers who may have altered findings if they had agreed to complete the final 
battery of tests.  Despite these instances, the aim of the research, and potential 
impact, was to present the responses and outcomes of individuals in real-world 
training without greatly disrupting the lifestyle of trainees, and present the findings 
assuming those individuals are a representative sample of the population under 
examination.  As with many field based and epidemiological studies, the aim is to 
achieve a large enough sample size to counteract the possible variation incited by 
lower experimental control.  It is believed that not only did the programme of work 
achieve greater control than similar free-living examples, but that the current studies 




 Arguably, as military trainees are one of few populations that have a high 
proportion of individuals who habitually smoke while attempting to develop 
physical fitness, and that differences in training adaptation were not observed here, 
it may be there is no necessity for further work to show whether smoking elicits this 
effect.  With this in mind, the implications for the military would be that being a 
smoker even in a young active population may increase risk of injury, elongate 
recovery from those injuries, and physical performance itself may be affected.  It is 
also clear that oxidative stress and inflammation are aspects of the influence of 
smoking on the examined physiological status of smokers, highlighting a potentially 
adverse impact on health further into service.   
It would be challenging to quantify the cumulative adverse effects of the 
alteration in selected biochemical markers observed in the current work, but given 
that both oxidative stress and inflammation are implicated in poorer health 
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outcomes, it may be that future work should try to determine whether these effects 
are reversible at different stages of life.  The potential adverse effect of smoking 
and these baseline differences from non-smokers on health once trainees become 
serviceman could be a concern for military organisations in terms of economic cost 
and occupational effectiveness.  However, the current programme of work does 
give some indication for there being a beneficial effect of long-term exercise 
training on the reduction of oxidative stress and inflammation without smoking 
cessation, certainly in a younger adult population.  Longitudinally, the comparison 
of the health profiles of physically active smokers versus sedentary smokers could 
indicate how potent a protective measure exercise can be against some adverse 
effects of smoking.  This would be with an aim to assess at what stages of life 
physical activity can be sufficient to counteract smoking-induced alterations in 
physiological potentially more beneficial to overall health.   
On a more mechanistic level, any underlying mechanisms for an association 
between smoking and physical fitness, and on injury susceptibility, are still 
unknown.  As discussed, the plethora of potential pathways for increased injury risk 
in smokers could highlight the need for the examination of many markers, possibly 
integrating biochemical markers of bone metabolism and soft tissue repair during 
the recovery phase of injury in smokers and non-smokers.  In the context of fatigue, 
the interaction between basal levels of oxidative stress and inflammation and their 
responses to exercise with relation to rest are not understood.  This may contain 
implications for both the short-term effects of exercise on habitual smokers and 
modulation of contractile fatigue.  In a laboratory setting, specifically with 
controlled pre-trial diet, hydration and physical activity- and fitness-matched 
participants, a comparison of the oxidative and inflammatory responses to exercise, 
taking into account resting levels of these markers in a group of smokers and non-
smokers would add to the work of Bloomer et al. (2007).  This may provide insight 
into whether an elevated resting level of oxidative stress or inflammation as 
observed in chronic disease states might mediate an exacerbated response to 
exercise.  As the area is still relatively unclear, a test for muscular fatigue resistance 
could be employed pre- and post- an exercise training intervention as this may be 
where smoking-induced oxidative stress is most influential.  On a grander scale, 
these studies may begin to explain whether the chronic effects of smoking could 
Chapter 10 General Discussion 
178 
 
alter physiological responses to physical activity.  If research managed to outline 
underlying mechanisms it may be that steps could be taken to protect from this, 
such as the involvement of oxidative stress being tempered by dietary antioxidant 
supplementation. 
Of course, there is also a speculative discussion around the potential harm of 
smoking following training.  If, as proposed by the current research, there is a 
relatively protective effect of exercise training on some adverse effects of smoking 
there is the added possibility that physical activity, and subsequently physical 
fitness, may reduce once trainees become serviceman.  This is combined with the 
additional smoking exposure that may result from war deployment.  If inflammatory 
markers and oxidative stress are elevated at rest from smoking and continue to 
increase with age, it may be that over a serviceman’s career the health risks could 
be, ultimately, more serious in smokers than non-smokers.  It would be of interest, 
then, to longitudinally study the inflammatory profile of servicemen who smoke and 
possibly eventual health outcomes. 
 From the data provided on increase injury risk, attenuated recovery and 
poorer overall fitness, it would appear to be prudent for the British military to 
maintain efforts in anti-smoking policy.  From the current research, the health costs 
associated with greater injury prevalence, longer rehabilitation and more common 
occurrence of illness are not quantifiable, but may be a concern to military 
organisations.  As the data suggests that being a smoker brings with it a 
combination of potentially harmful lifestyle choices, programmes encouraging 
smoking cessation and adherence to a healthy lifestyle may go some way to 











 This series of studies demonstrated that any adverse effects of smoking 
could potentially influence a large proportion of military trainees.  Habitual smokers 
exhibited elevated resting oxidative stress compared with non-smokers, and more 
pronounced inflammatory changes as a result of training, which may have possible 
implications on future health outcomes and recovery from injury.  Habitual 
smoking, and differences in inflammation and oxidative stress as a result of 
smoking, did not appear to effect training adaptation.  However, habitual smokers 
are likely to perform worse in physical tasks which require aerobic and muscular 
endurance, potentially mediated by reduced resistance to muscular fatigue.  There 
was evidence that in a young, otherwise healthy smoking population, partaking in 
the full duration (26 weeks) of initial military training may counteract the adverse 
effects of smoking on elevated inflammation and oxidative stress.  Additionally, 
although the mechanisms are unknown, habitual smokers are at a greater risk of 
training-related injury and injuries attributed to overuse, indicating a potentially 
attenuated recovery response to exercise training.  Ultimately, despite the likelihood 
that injury risk in smokers is a function of many interlinking factors inherent with a 
smoking population and may not be solely caused by smoking per se, this work 
demonstrates a habitual smoker may exhibit poorer performance in military training 
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Appendix A – Consent form used to accompany each study participant information 
sheet 
CONSENT FORM     
Project title 
Risk factors for injury during British Army Infantry recruit training. 
 
Ministry of Defence Research Ethics Committee Reference:  
0805/160 
Please read the following carefully and circle either ‘yes’ or ‘no’: 
 The nature, aims and risks of the research have been explained to me. 
 
 I have read and understood the Participant Information Sheet.  
 
 I understand what is expected of me.  
 
 I understand that I can withdraw from the study at any time without giving a 
reason. 
 
 I understand that if I do withdraw it will not affect my Army career in any way. 
 
 I understand that participating in this study is not part of my Army training course or 
assessment. 
 
 I consent to the processing of my personal information for the purposes of this research 
study.   
 
 I understand that my information will be treated as strictly confidential in 
accordance with the Data Protection Act 1998. 
 
 I understand that Army staff will not have access to my results. 
 
 I am aware that my consent is specific to this study and this study only. 
 
 I agree to volunteer as a subject for the study described in the information sheet 
and I give full consent to my participation in this study. 
 
Participant’s Statement: 
I (insert name)     agree that the research project named 
above has been explained to me to my satisfaction and I agree to take part in the study. I 
have read both the notes written above and the Participant Information Sheet about the 
project and understand what the research study involves. 
Signed    Date      
 
Yes  /   No 
Yes  /   No 
Yes  /   No 
Yes  /   No 
Yes  /   No 
Yes  /   No 
Yes  /   No 
Yes  /   No 
Yes  /   No 
Yes  /   No 




Witness Name     Signature     
 
 





I (insert name)    confirm that I have carefully communicated the 
nature, demands and any foreseeable risks (where applicable) of the proposed 
research to the participant. 
 
 
Signed                                  Date     
 
 
Name and contact details of Independent Medical Officer (if appropriate):  
Dr Mark Langham, Senior Medical Officer, Vimy Barracks, Infantry Training Centre, 
Catterick Garrison, Catterick. Phone: 01748 872653 
 
Name and contact details of Principal Investigator:  
Dr Keith Stokes 
Lecturer in Human and Exercise Physiology 
Sport and Exercise Science 
School for Health 

































































































Appendix C - Log Transforms and back-transforms for determination of 95% 
confidence intervals (CI) in risk, odds and rate ratio of injury performed in Study 6 
(Chapter 9) 
 
Log transform for standard error (SE) and 95% CI for risk and odds ratio. 
Log-transformed SE was calculated as follows: 
ܵܧ(୪୭୥ோோ) = 	ඨ൤ 1ܫ݆݊ݑݎ݁݀ா௑௉ − 1݊ா௑௉ + 1ܫ݆݊ݑݎ݁݀஼ைே − 1݊஼ைே൨ 
 Where log RR is the natural log of risk or odds ratio, SE(log RR) is the 
standard error of log RR, n is the group sample size, EXP is the exposure group 
(Smokers) and CON is the control group (Non-smokers). 
Confidence interval was back-transformed using the following formula: 
ܥܫோோ = 	 ܴܴ
݁ൣଵ.ଽ଺	×ௌாౢ౥ౝೃೃ൧ 	ܽ݊݀	ܴܴ × ݁ൣଵ.ଽ଺	×ௌாౢ౥ౝೃೃ൧	 
 
 
Log transform for SE and 95% CI for rate ratio. 
ܵܧ௅௢௚	ோ௔௧௘	௥௔௧௜௢ = ඨ 1ܫ݆݊ݑݎ݁݀ா௑௉ + 1ܫ݆݊ݑݎ݁݀஼ைே 
Confidence interval was back-transformed using the following formula: 
CI = ோ௔௧௘	௥௔௧௜௢








Appendix D – Full blood count data from Study 2 (Chapter 5) organised by 
smoking sub-group. 




 NS (n=36)  S (n=57) 
(HB) Haemoglobin (g/dl)  
 
















(PLT) Platelets (10^9/l) 
 
















(HCT) haematocrit (%)  
 







(MCV) Mean corpuscular 
volume (fl) 
 







(MCH) Mean corpuscular 
haemoglobin (pg) 
 




















































Note: Values are Mean (Standard Error).  Subgroups are light smokers (LS; 1-9 cigarettes 
per day; n=16), moderate smokers (MS; 10-19 cigarettes per day; n=29) and heavy smokers 
(HS; ≥20 cigarettes per day; n=12). * indicates MCV is significantly higher in MS than NS 
(p=0.04).  
 
 
